data_2na4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2na4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 CA--C 1.545 0.767 0 CA-C-O 117.598 -1.191 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.646 -1.168 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.569 -1.205 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 117.498 -1.239 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 117.497 -1.239 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.502 ' CD2' HH21 ' A' ' 24' ' ' ARG . 14.6 t60 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.502 HH21 ' CD2' ' A' ' 20' ' ' HIS . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 117.631 -1.176 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.43 55.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 125.487 1.515 . . . . 0.0 111.739 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -141.84 149.73 40.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.379 1.471 . . . . 0.0 111.498 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.64 153.01 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.552 1.541 . . . . 0.0 109.923 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.23 55.52 0.6 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.162 1.785 . . . . 0.0 112.533 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.69 -52.75 7.92 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.783 1.633 . . . . 0.0 113.049 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt -68.0 -20.17 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.47 -42.39 74.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.519 1.527 . . . . 0.0 112.635 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.87 -40.08 72.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.031 0.532 . . . . 0.0 111.469 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.95 78.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.404 0.682 . . . . 0.0 111.868 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.13 -34.56 73.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.66 -41.6 92.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.581 0.752 . . . . 0.0 111.118 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -66.57 -31.76 72.66 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -169.62 110.02 0.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.622 1.569 . . . . 0.0 110.526 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.99 68.74 1.14 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.289 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.25 159.41 7.73 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.85 0.833 . . . . 0.0 112.925 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.07 155.76 40.14 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -154.41 21.85 0.48 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -107.83 -56.13 2.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.133 0.973 . . . . 0.0 113.01 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -156.07 92.63 1.37 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.464 1.106 . . . . 0.0 110.586 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.18 -44.44 21.9 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.092 1.757 . . . . 0.0 112.056 -176.314 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.51 134.1 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.493 1.517 . . . . 0.0 110.132 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -140.99 121.91 14.5 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.347 1.459 . . . . 0.0 110.75 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -143.81 149.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.76 54.61 0.81 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.393 1.477 . . . . 0.0 112.515 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.95 -55.37 4.04 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.594 1.558 . . . . 0.0 112.614 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt -69.4 -16.89 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.04 -39.8 72.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.513 1.125 . . . . 0.0 112.851 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -35.17 67.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.3 0.64 . . . . 0.0 111.931 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.35 -40.71 73.92 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.646 0.779 . . . . 0.0 112.509 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.75 -31.47 59.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.97 -29.28 65.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.015 0.926 . . . . 0.0 112.171 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 53.95 45.6 27.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.092 1.757 . . . . 0.0 112.517 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -33.47 71.9 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -157.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.42 18.25 13.68 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.551 1.548 . . . . 0.0 114.435 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.53 -176.64 4.47 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.851 1.66 . . . . 0.0 112.547 -166.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -57.81 134.84 56.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.992 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -161.36 105.76 1.3 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.208 1.403 . . . . 0.0 110.2 168.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -133.05 -55.23 0.92 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 113.185 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.12 38.58 0.89 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.378 1.071 . . . . 0.0 111.89 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.02 -38.37 75.88 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.112 -0.992 . . . . 0.0 113.414 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 126.785 2.034 . . . . 0.0 112.859 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.07 135.18 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.449 1.5 . . . . 0.0 109.996 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -130.6 156.39 44.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.551 1.54 . . . . 0.0 111.558 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.2 t -133.2 150.37 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.248 1.419 . . . . 0.0 109.734 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.29 52.46 0.6 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.805 1.642 . . . . 0.0 112.611 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.5 -54.39 5.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.722 1.609 . . . . 0.0 112.509 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt -69.72 -18.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.01 -41.57 75.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.86 1.264 . . . . 0.0 112.556 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -69.56 -42.31 74.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.907 0.483 . . . . 0.0 111.307 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.2 92.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.665 0.786 . . . . 0.0 112.427 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.31 -30.78 62.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 tp -73.67 -38.6 64.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.697 0.799 . . . . 0.0 111.738 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -57.33 -26.51 61.06 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -114.69 13.46 17.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.191 1.796 . . . . 0.0 113.448 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.91 53.16 0.32 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.157 1.36 . . . . 0.0 112.476 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.07 157.58 18.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.161 0.982 . . . . 0.0 113.578 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.29 160.34 31.41 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.42 1.088 . . . . 0.0 113.184 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.23 25.15 1.01 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -115.67 -49.76 2.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.27 43.97 2.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.794 1.638 . . . . 0.0 112.113 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.7 -42.69 84.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.556 1.142 . . . . 0.0 113.451 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.254 1.422 . . . . 0.0 112.62 -167.238 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.62 160.72 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.778 1.631 . . . . 0.0 111.779 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -137.88 146.02 42.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.009 1.324 . . . . 0.0 111.059 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 32.28 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.151 1.381 . . . . 0.0 111.76 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 57.48 35.62 26.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.902 . . . . 0.0 112.9 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.8 -51.53 38.44 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -69.2 -18.98 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.01 -41.45 71.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.226 1.41 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.99 -42.43 69.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.181 0.592 . . . . 0.0 111.335 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.09 87.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.012 0.925 . . . . 0.0 112.054 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.28 -18.86 60.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -84.71 -56.39 3.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 112.084 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -147.16 -22.2 0.4 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -171.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.8 m -89.45 50.79 1.98 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -159.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.93 9.99 85.59 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.061 1.315 . . . . 0.0 116.149 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -109.82 171.83 7.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.323 1.449 . . . . 0.0 113.286 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -58.88 158.07 8.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.691 0.796 . . . . 0.0 112.488 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.86 27.12 0.72 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -85.48 -43.27 13.72 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.19 35.15 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.618 1.167 . . . . 0.0 111.814 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.06 -25.26 25.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -161.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.9 p90 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 128.062 2.545 . . . . 0.0 113.555 -168.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.18 134.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.371 1.468 . . . . 0.0 110.199 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -147.93 123.73 10.58 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.142 1.377 . . . . 0.0 110.061 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.46 148.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.834 1.254 . . . . 0.0 109.463 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.3 54.8 0.92 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.466 1.506 . . . . 0.0 112.416 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -73.19 -55.53 3.73 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.596 1.558 . . . . 0.0 112.879 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt -65.4 -21.83 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -47.38 -39.11 14.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.277 2.231 . . . . 0.0 113.482 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.41 -31.6 54.21 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.726 0.811 . . . . 0.0 112.554 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.5 61.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.883 0.873 . . . . 0.0 112.05 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.39 -20.89 59.9 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.43 -26.56 68.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 113.699 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.5 m 52.5 65.49 1.49 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.354 1.461 . . . . 0.0 112.966 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.3 p -65.79 -19.04 65.74 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.95 -1.0 87.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.091 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -77.75 163.27 26.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.342 1.057 . . . . 0.0 111.771 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.24 137.49 58.24 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.487 -0.758 . . . . 0.0 112.102 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.01 34.94 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.891 1.276 . . . . 0.0 112.112 166.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.33 123.19 47.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.171 1.388 . . . . 0.0 111.907 -162.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t0 54.34 35.93 24.12 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.007 1.723 . . . . 0.0 113.743 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.88 -30.5 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.249 1.82 . . . . 0.0 112.086 -174.791 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.53 127.81 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.12 1.368 . . . . 0.0 110.497 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -139.96 144.74 37.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.391 1.876 . . . . 0.0 110.31 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.99 148.5 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.358 1.463 . . . . 0.0 109.163 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.14 53.55 0.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.04 1.336 . . . . 0.0 112.69 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.18 -55.39 3.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.909 1.684 . . . . 0.0 112.981 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.42 -19.04 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.53 -38.56 63.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.489 1.116 . . . . 0.0 112.276 169.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -66.41 -27.8 68.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 112.861 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.76 -40.77 14.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.233 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.22 -29.61 42.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.66 -52.54 50.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.835 0.854 . . . . 0.0 112.029 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -155.32 -71.01 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 0.0 111.9 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -175.87 106.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.707 2.003 . . . . 0.0 110.401 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.82 28.33 72.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.478 1.037 . . . . 0.0 114.265 172.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.7 170.74 4.85 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.362 1.465 . . . . 0.0 114.219 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -65.44 161.54 19.71 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.577 -0.702 . . . . 0.0 112.622 167.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.87 29.71 1.68 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.307 1.043 . . . . 0.0 112.5 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.31 125.14 39.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.291 1.037 . . . . 0.0 112.355 -165.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 55.74 29.35 13.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.157 1.783 . . . . 0.0 113.964 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -74.74 -25.95 59.45 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -172.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.456 1.902 . . . . 0.0 112.096 -173.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.38 160.47 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.661 1.584 . . . . 0.0 111.88 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 158.3 33.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 112.277 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.39 150.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.007 1.323 . . . . 0.0 109.833 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.54 45.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.551 1.941 . . . . 0.0 114.231 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.95 -53.44 34.19 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.776 1.63 . . . . 0.0 113.11 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt -69.12 -19.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -42.87 80.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.734 1.214 . . . . 0.0 112.412 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -69.52 -40.32 76.99 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.963 0.505 . . . . 0.0 111.462 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.85 75.41 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.422 0.689 . . . . 0.0 111.816 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 pp -69.93 -34.12 73.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.84 -41.76 91.33 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.635 0.774 . . . . 0.0 111.036 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -30.84 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -168.98 108.83 0.47 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.534 1.533 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.09 67.2 1.04 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.545 168.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.24 159.6 9.63 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.912 0.863 . . . . 0.0 113.097 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -70.84 158.64 36.02 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.241 1.016 . . . . 0.0 113.685 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.85 25.54 0.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -148.11 -62.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.38 -0.825 . . . . 0.0 113.075 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -85.76 46.21 1.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.426 1.09 . . . . 0.0 112.485 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.87 -28.05 55.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.057 1.343 . . . . 0.0 114.489 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.239 1.816 . . . . 0.0 113.029 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.69 150.04 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.064 1.346 . . . . 0.0 111.257 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.92 161.78 35.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.956 1.702 . . . . 0.0 112.351 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.23 148.33 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.201 1.4 . . . . 0.0 109.43 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.67 52.78 0.3 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.474 1.91 . . . . 0.0 113.471 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.78 -52.67 31.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.169 1.788 . . . . 0.0 112.921 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -68.82 -18.46 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.62 -40.44 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.366 1.466 . . . . 0.0 112.47 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -72.7 -39.39 67.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.257 0.623 . . . . 0.0 111.822 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.29 82.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.336 0.654 . . . . 0.0 111.923 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.0 -33.07 70.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.6 tp -62.6 -43.06 99.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 110.803 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -69.62 -35.26 75.09 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.1 m -156.54 97.28 1.72 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.249 1.82 . . . . 0.0 109.921 -171.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.55 63.74 0.82 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.305 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.28 157.99 5.85 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.56 159.99 33.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.247 1.019 . . . . 0.0 113.218 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.74 1.36 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -108.27 -47.04 3.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.494 1.118 . . . . 0.0 113.469 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.77 58.93 1.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.507 1.123 . . . . 0.0 111.508 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.68 -40.86 93.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.908 1.683 . . . . 0.0 112.121 -176.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -147.87 147.15 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.108 1.363 . . . . 0.0 111.144 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -133.47 146.22 50.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.52 24.39 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 56.9 38.36 29.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.059 1.744 . . . . 0.0 112.937 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.17 -52.35 15.9 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.23 -20.78 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -35.32 65.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.942 1.297 . . . . 0.0 112.827 171.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.3 -43.0 61.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.14 75.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.56 -30.27 69.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.417 -0.802 . . . . 0.0 112.809 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.56 -41.83 59.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.638 1.175 . . . . 0.0 111.639 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -66.06 -20.72 66.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.736 0.815 . . . . 0.0 112.72 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -97.55 34.05 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.068 1.747 . . . . 0.0 111.411 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.44 40.82 1.56 Allowed Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.139 1.828 . . . . 0.0 114.58 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.67 163.61 26.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.123 1.369 . . . . 0.0 113.737 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.86 156.85 38.45 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.4 25.81 0.6 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.97 1.308 . . . . 0.0 112.887 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.39 -33.25 17.98 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.94 26.09 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.926 1.291 . . . . 0.0 112.715 -172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -74.4 -30.03 61.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.133 0.973 . . . . 0.0 113.407 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.481 1.912 . . . . 0.0 111.823 -177.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.77 -34.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -144.65 123.48 12.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.234 . . . . 0.0 110.39 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.91 149.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.255 1.422 . . . . 0.0 109.397 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.09 42.97 0.12 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.305 1.842 . . . . 0.0 114.42 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.75 -53.16 29.44 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.758 1.623 . . . . 0.0 113.294 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.61 -18.57 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.67 -35.81 63.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.056 1.343 . . . . 0.0 112.86 172.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -73.45 -44.25 58.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.661 0.784 . . . . 0.0 110.978 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.69 91.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.863 0.865 . . . . 0.0 112.861 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.37 -23.19 57.11 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.3 tp -87.83 -34.48 18.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.095 1.358 . . . . 0.0 112.924 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -88.17 39.01 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.726 1.61 . . . . 0.0 112.778 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -85.63 24.1 1.27 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.928 2.091 . . . . 0.0 113.98 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.45 56.44 2.45 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.723 2.106 . . . . 0.0 114.247 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.02 -174.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.468 2.307 . . . . 0.0 114.735 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.13 132.78 47.11 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.035 -1.04 . . . . 0.0 110.92 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.64 24.64 0.39 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -150.52 -51.2 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.351 -0.843 . . . . 0.0 113.257 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.99 41.7 0.52 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.51 . . . . 0.0 112.827 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.2 -36.84 84.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.548 1.539 . . . . 0.0 114.19 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.038 1.335 . . . . 0.0 112.745 -167.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.5 159.8 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.325 1.45 . . . . 0.0 112.063 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 26.14 9.58 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.177 1.791 . . . . 0.0 113.949 -167.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.47 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 113.883 -167.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.33 38.14 29.48 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.429 1.892 . . . . 0.0 112.569 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -66.97 -53.26 26.98 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.88 -19.13 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.46 -41.61 80.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.923 1.289 . . . . 0.0 112.448 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -71.75 -41.52 68.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.126 0.57 . . . . 0.0 111.24 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.52 93.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.266 0.626 . . . . 0.0 111.915 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.1 -35.26 71.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -68.9 -30.95 69.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.514 1.125 . . . . 0.0 111.575 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.5 m -79.52 38.67 0.38 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.397 1.479 . . . . 0.0 112.503 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m 57.4 56.12 5.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.956 2.103 . . . . 0.0 112.058 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -126.86 22.05 5.8 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.205 1.383 . . . . 0.0 115.354 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -67.36 161.48 25.05 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.53 1.165 . . . . 0.0 113.047 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.39 165.27 16.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.011 0.924 . . . . 0.0 112.926 166.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.01 32.57 2.17 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.485 1.114 . . . . 0.0 112.22 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -96.1 112.08 23.92 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.992 0.917 . . . . 0.0 112.05 -161.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t0 50.31 41.04 23.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.055 1.742 . . . . 0.0 113.947 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.55 -33.22 68.95 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -167.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.052 1.741 . . . . 0.0 112.173 -174.66 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.06 52.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 125.339 1.456 . . . . 0.0 111.467 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -123.48 26.68 7.75 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.382 1.473 . . . . 0.0 112.291 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.1 t -129.45 151.24 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.846 1.658 . . . . 0.0 109.823 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.83 55.51 0.69 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.931 1.693 . . . . 0.0 112.384 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -70.91 -53.83 8.32 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.793 1.637 . . . . 0.0 112.66 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.55 -17.46 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.59 -39.28 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 113.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.89 -42.06 67.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.357 0.663 . . . . 0.0 111.23 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.1 90.13 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 0.0 112.414 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.24 -28.97 62.45 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.2 tp -76.97 -42.14 40.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.43 1.092 . . . . 0.0 112.021 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.2 t -153.91 -46.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.8 p -89.67 -9.58 49.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -155.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.7 -44.75 6.31 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.002 0.819 . . . . 0.0 113.862 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -156.36 167.69 29.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.576 1.55 . . . . 0.0 112.157 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -63.95 162.41 13.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.814 0.845 . . . . 0.0 112.924 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.18 32.92 1.34 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.3 1.04 . . . . 0.0 113.047 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -71.37 -43.39 66.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.58 36.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.908 0.883 . . . . 0.0 112.961 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.07 -35.75 74.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.765 -1.209 . . . . 0.0 113.602 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.195 1.798 . . . . 0.0 112.006 -174.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.61 143.93 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.273 1.429 . . . . 0.0 111.157 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -144.52 105.43 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.288 1.035 . . . . 0.0 110.39 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 52.9 t -143.03 150.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.963 1.705 . . . . 0.0 108.889 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -74.91 53.24 0.58 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.21 1.404 . . . . 0.0 112.899 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.21 -53.98 7.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.838 1.655 . . . . 0.0 112.543 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.84 -19.76 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -49.14 -39.53 29.12 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.504 1.122 . . . . 0.0 113.068 170.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -59.58 -38.88 82.36 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.955 0.902 . . . . 0.0 112.159 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.4 -50.88 9.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.673 0.789 . . . . 0.0 112.08 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.45 -20.54 66.07 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -20.22 65.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.482 1.513 . . . . 0.0 113.559 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 m 59.15 40.63 21.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.553 1.541 . . . . 0.0 114.487 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.4 m -134.45 75.88 1.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.563 1.545 . . . . 0.0 109.08 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.27 -3.6 9.62 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.437 1.494 . . . . 0.0 115.721 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -133.33 166.43 22.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.056 1.743 . . . . 0.0 112.148 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.37 159.19 18.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.947 0.899 . . . . 0.0 113.051 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.12 27.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -78.52 -47.4 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.66 37.32 0.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.906 1.282 . . . . 0.0 113.225 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.36 -41.57 89.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.348 1.059 . . . . 0.0 113.79 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.263 1.825 . . . . 0.0 111.871 -173.136 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.06 155.44 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.454 1.502 . . . . 0.0 111.929 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.33 156.11 33.61 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.925 0.89 . . . . 0.0 112.442 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.65 150.43 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.072 1.349 . . . . 0.0 109.59 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.07 55.52 0.93 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.325 1.45 . . . . 0.0 112.493 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.44 -53.84 9.56 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.968 1.707 . . . . 0.0 112.84 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.502 ' CD2' HH21 ' A' ' 24' ' ' ARG . 14.6 t60 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.502 HH21 ' CD2' ' A' ' 20' ' ' HIS . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt -67.68 -18.68 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -51.14 -35.89 37.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.144 0.978 . . . . 0.0 113.372 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -63.23 -45.73 90.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.848 0.859 . . . . 0.0 111.452 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.82 54.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.146 0.978 . . . . 0.0 111.925 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.09 -27.61 67.49 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.57 -45.82 64.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.893 0.877 . . . . 0.0 111.041 168.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.1 t -63.12 -33.18 74.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.331 0.652 . . . . 0.0 112.664 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.3 p -84.5 -39.46 18.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.083 0.953 . . . . 0.0 112.739 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.06 14.91 76.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.693 1.14 . . . . 0.0 115.3 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.88 159.43 33.74 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.327 1.063 . . . . 0.0 113.301 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.48 138.52 55.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.96 87.2 0.85 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.282 1.433 . . . . 0.0 110.631 164.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -113.34 -51.89 2.79 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.76 36.7 0.96 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.617 1.167 . . . . 0.0 111.952 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.12 -28.14 62.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -171.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.405 1.882 . . . . 0.0 111.943 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.05 -2.09 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.53 149.92 39.74 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.141 1.376 . . . . 0.0 111.385 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.37 27.11 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.321 1.448 . . . . 0.0 112.13 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.15 38.68 30.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.269 1.828 . . . . 0.0 112.897 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.24 -50.95 47.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -66.04 -20.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -50.1 -38.75 40.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.958 0.903 . . . . 0.0 113.136 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.57 -33.04 74.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.323 1.049 . . . . 0.0 112.482 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.87 -47.72 10.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.422 1.089 . . . . 0.0 112.31 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.12 -23.36 63.98 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.26 -15.42 62.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.624 1.57 . . . . 0.0 113.641 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.4 m 51.17 44.24 28.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.06 1.344 . . . . 0.0 114.1 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m 57.62 36.1 26.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.399 1.48 . . . . 0.0 113.524 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.44 -14.6 64.75 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 124.605 1.098 . . . . 0.0 114.802 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -131.88 167.87 18.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.706 2.002 . . . . 0.0 111.138 170.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.88 154.26 26.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.731 0.812 . . . . 0.0 113.116 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -153.91 23.27 0.51 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.309 1.044 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -75.8 -32.25 59.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -160.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -140.84 24.7 2.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.871 1.268 . . . . 0.0 112.401 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -82.58 -36.35 26.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.099 -1.0 . . . . 0.0 113.168 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.915 2.086 . . . . 0.0 111.531 -177.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.659 0.266 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t 54.38 60.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.934 1.694 . . . . 0.0 112.447 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -119.88 124.07 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.412 1.485 . . . . 0.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.53 25.12 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.757 1.223 . . . . 0.0 112.127 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 57.57 38.03 27.76 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.215 1.806 . . . . 0.0 112.929 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.18 -53.27 11.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt -69.19 -18.05 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -48.64 -36.91 16.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.332 1.053 . . . . 0.0 113.388 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.55 -31.61 70.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.04 0.936 . . . . 0.0 112.873 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.14 -49.25 6.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.763 1.225 . . . . 0.0 112.844 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.31 -19.81 64.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.57 -21.67 66.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.187 1.395 . . . . 0.0 113.183 170.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.4 m 55.23 72.95 0.44 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.909 1.684 . . . . 0.0 112.783 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -60.48 -29.84 69.32 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.63 36.85 1.62 Allowed Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.678 1.609 . . . . 0.0 114.542 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.68 -172.25 0.08 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.283 2.233 . . . . 0.0 114.298 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 tp -63.75 128.21 34.81 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.61 -1.306 . . . . 0.0 110.927 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -166.67 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.58 -61.55 0.4 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.4 95.32 1.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.635 0.774 . . . . 0.0 110.951 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.42 -44.58 64.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -171.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.255 1.368 0 C-N-CA 125.853 1.661 . . . . 0.0 112.238 -173.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.08 143.56 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.775 1.63 . . . . 0.0 110.267 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 55.27 56.44 6.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.443 1.497 . . . . 0.0 113.13 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.3 148.41 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.082 1.353 . . . . 0.0 109.842 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.86 49.66 0.24 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.426 1.891 . . . . 0.0 113.642 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.54 -53.17 23.84 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.241 1.816 . . . . 0.0 112.878 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.24 -17.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.89 -41.24 64.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 113.065 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -70.98 -35.58 72.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.27 0.628 . . . . 0.0 112.243 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.66 -38.72 70.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.815 0.846 . . . . 0.0 112.454 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.5 -25.33 36.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 66.1 tp -61.48 -33.34 73.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.367 1.067 . . . . 0.0 112.621 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 52.33 52.56 13.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.773 1.229 . . . . 0.0 113.352 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m -57.72 -28.63 64.04 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.131 1.373 . . . . 0.0 114.437 -168.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.68 -0.01 83.13 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 115.35 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -126.88 -158.52 0.87 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.108 2.563 . . . . 0.0 110.268 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.71 131.17 43.03 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.912 -1.117 . . . . 0.0 110.667 162.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.31 99.33 1.62 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.818 1.247 . . . . 0.0 110.37 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -143.08 -53.1 0.38 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -141.99 36.13 1.57 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.168 0.987 . . . . 0.0 112.428 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.73 -27.48 61.21 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.825 2.05 . . . . 0.0 112.887 177.256 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.34 140.33 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.717 1.607 . . . . 0.0 109.823 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.23 157.86 23.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.153 1.381 . . . . 0.0 112.332 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.24 24.08 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.813 1.245 . . . . 0.0 112.564 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.79 38.48 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.906 1.682 . . . . 0.0 112.705 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.92 -52.37 41.45 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 -173.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt -68.69 -18.46 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -50.53 -38.03 42.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.059 -1.026 . . . . 0.0 113.16 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.2 -32.28 72.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.16 0.984 . . . . 0.0 112.742 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.35 -48.51 7.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.351 1.06 . . . . 0.0 112.16 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.56 -30.74 70.45 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -174.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.89 -39.65 94.69 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 111.144 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.9 m -80.29 -17.91 50.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -169.79 106.84 0.36 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.36 65.27 1.16 Allowed Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.755 1.169 . . . . 0.0 113.579 171.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.71 153.63 10.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.724 0.809 . . . . 0.0 112.561 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.42 135.2 48.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.85 21.37 0.79 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 164.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.17 -49.62 7.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.086 0.954 . . . . 0.0 112.83 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -153.2 91.93 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 110.168 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.98 -42.22 57.99 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.773 1.629 . . . . 0.0 112.131 -175.416 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.2 142.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.26 1.424 . . . . 0.0 111.021 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.94 133.47 33.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.763 1.225 . . . . 0.0 111.986 176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.76 149.61 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.262 1.425 . . . . 0.0 109.329 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.9 54.01 0.8 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.6 1.56 . . . . 0.0 112.558 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.7 -55.84 2.44 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.646 1.578 . . . . 0.0 112.787 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.11 -19.09 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -34.41 70.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.978 1.311 . . . . 0.0 113.158 175.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.44 -44.95 41.63 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.071 0.548 . . . . 0.0 111.089 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.55 -36.43 83.76 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.15 -25.17 61.6 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -87.93 -40.01 14.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.365 1.466 . . . . 0.0 112.931 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.4 p -74.54 -7.17 52.22 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.0 t -60.55 -19.98 58.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.346 1.458 . . . . 0.0 114.496 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.57 47.71 1.48 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.86 1.695 . . . . 0.0 114.791 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -66.5 164.56 16.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.215 1.406 . . . . 0.0 113.631 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -64.22 162.73 14.04 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.112 0.965 . . . . 0.0 113.032 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.13 26.8 1.64 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.499 1.119 . . . . 0.0 112.856 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.5 -43.69 54.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.924 0.89 . . . . 0.0 113.095 -163.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -137.65 23.8 2.89 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.761 1.624 . . . . 0.0 111.761 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -80.36 -30.59 37.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -168.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.302 1.841 . . . . 0.0 112.079 -176.337 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 145.45 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.865 1.666 . . . . 0.0 110.224 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 56.11 53.07 9.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.278 1.431 . . . . 0.0 113.03 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.69 152.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.011 1.325 . . . . 0.0 110.209 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.61 53.79 0.57 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.891 1.677 . . . . 0.0 112.585 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.68 -54.45 3.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.783 1.633 . . . . 0.0 112.725 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.36 -19.56 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -40.37 81.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.715 1.206 . . . . 0.0 112.636 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -71.99 -42.14 66.81 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.869 0.467 . . . . 0.0 111.129 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.75 98.19 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.44 -31.9 64.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.75 -39.97 91.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.463 0.705 . . . . 0.0 110.634 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.4 m -65.08 -16.29 63.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 m -76.29 -27.17 56.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.218 1.007 . . . . 0.0 112.205 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.84 12.82 82.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.253 0.93 . . . . 0.0 114.916 -176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -139.19 166.07 25.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.239 1.816 . . . . 0.0 111.672 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -66.85 157.43 33.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.68 28.14 0.55 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.277 1.031 . . . . 0.0 113.467 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -135.45 -50.68 0.74 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -168.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -80.04 39.43 0.44 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.331 1.453 . . . . 0.0 112.763 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.35 -25.39 46.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.52 1.528 . . . . 0.0 114.012 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.569 1.947 . . . . 0.0 112.138 -176.489 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 CA--C 1.545 0.767 0 CA-C-O 117.598 -1.191 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.646 -1.168 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.569 -1.205 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 117.498 -1.239 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 117.497 -1.239 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB3' HD12 ' A' ' 18' ' ' ILE . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' A' ' 18' ' ' ILE . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 117.631 -1.176 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.43 55.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 125.487 1.515 . . . . 0.0 111.739 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -141.84 149.73 40.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.379 1.471 . . . . 0.0 111.498 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.64 153.01 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.552 1.541 . . . . 0.0 109.923 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.23 55.52 0.6 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.162 1.785 . . . . 0.0 112.533 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.69 -52.75 7.92 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.783 1.633 . . . . 0.0 113.049 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt -68.0 -20.17 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.47 -42.39 74.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.519 1.527 . . . . 0.0 112.635 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.87 -40.08 72.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.031 0.532 . . . . 0.0 111.469 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.95 78.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.404 0.682 . . . . 0.0 111.868 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.13 -34.56 73.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.66 -41.6 92.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.581 0.752 . . . . 0.0 111.118 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -66.57 -31.76 72.66 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -169.62 110.02 0.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.622 1.569 . . . . 0.0 110.526 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.99 68.74 1.14 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.289 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.25 159.41 7.73 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.85 0.833 . . . . 0.0 112.925 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.07 155.76 40.14 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -154.41 21.85 0.48 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -107.83 -56.13 2.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.133 0.973 . . . . 0.0 113.01 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -156.07 92.63 1.37 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.464 1.106 . . . . 0.0 110.586 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.18 -44.44 21.9 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.092 1.757 . . . . 0.0 112.056 -176.314 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.51 134.1 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.493 1.517 . . . . 0.0 110.132 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -140.99 121.91 14.5 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.347 1.459 . . . . 0.0 110.75 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -143.81 149.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.76 54.61 0.81 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.393 1.477 . . . . 0.0 112.515 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.95 -55.37 4.04 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.594 1.558 . . . . 0.0 112.614 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt -69.4 -16.89 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.04 -39.8 72.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.513 1.125 . . . . 0.0 112.851 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -35.17 67.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.3 0.64 . . . . 0.0 111.931 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.35 -40.71 73.92 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.646 0.779 . . . . 0.0 112.509 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.75 -31.47 59.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.97 -29.28 65.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.015 0.926 . . . . 0.0 112.171 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 53.95 45.6 27.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.092 1.757 . . . . 0.0 112.517 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -33.47 71.9 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -157.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.42 18.25 13.68 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.551 1.548 . . . . 0.0 114.435 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.53 -176.64 4.47 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.851 1.66 . . . . 0.0 112.547 -166.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -57.81 134.84 56.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.992 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -161.36 105.76 1.3 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.208 1.403 . . . . 0.0 110.2 168.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -133.05 -55.23 0.92 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 113.185 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.12 38.58 0.89 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.378 1.071 . . . . 0.0 111.89 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.02 -38.37 75.88 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.112 -0.992 . . . . 0.0 113.414 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 126.785 2.034 . . . . 0.0 112.859 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.07 135.18 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.449 1.5 . . . . 0.0 109.996 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -130.6 156.39 44.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.551 1.54 . . . . 0.0 111.558 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.2 t -133.2 150.37 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.248 1.419 . . . . 0.0 109.734 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.29 52.46 0.6 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.805 1.642 . . . . 0.0 112.611 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.5 -54.39 5.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.722 1.609 . . . . 0.0 112.509 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt -69.72 -18.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.01 -41.57 75.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.86 1.264 . . . . 0.0 112.556 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -69.56 -42.31 74.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.907 0.483 . . . . 0.0 111.307 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.2 92.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.665 0.786 . . . . 0.0 112.427 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.31 -30.78 62.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 tp -73.67 -38.6 64.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.697 0.799 . . . . 0.0 111.738 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -57.33 -26.51 61.06 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -114.69 13.46 17.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.191 1.796 . . . . 0.0 113.448 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.91 53.16 0.32 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.157 1.36 . . . . 0.0 112.476 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.07 157.58 18.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.161 0.982 . . . . 0.0 113.578 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.29 160.34 31.41 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.42 1.088 . . . . 0.0 113.184 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.23 25.15 1.01 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -115.67 -49.76 2.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.27 43.97 2.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.794 1.638 . . . . 0.0 112.113 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.7 -42.69 84.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.556 1.142 . . . . 0.0 113.451 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.254 1.422 . . . . 0.0 112.62 -167.238 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.62 160.72 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.778 1.631 . . . . 0.0 111.779 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -137.88 146.02 42.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.009 1.324 . . . . 0.0 111.059 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 32.28 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.151 1.381 . . . . 0.0 111.76 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 57.48 35.62 26.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.902 . . . . 0.0 112.9 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.8 -51.53 38.44 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -69.2 -18.98 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.01 -41.45 71.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.226 1.41 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.99 -42.43 69.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.181 0.592 . . . . 0.0 111.335 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.09 87.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.012 0.925 . . . . 0.0 112.054 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.28 -18.86 60.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -84.71 -56.39 3.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 112.084 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -147.16 -22.2 0.4 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -171.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.8 m -89.45 50.79 1.98 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -159.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.93 9.99 85.59 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.061 1.315 . . . . 0.0 116.149 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -109.82 171.83 7.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.323 1.449 . . . . 0.0 113.286 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -58.88 158.07 8.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.691 0.796 . . . . 0.0 112.488 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.86 27.12 0.72 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -85.48 -43.27 13.72 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.19 35.15 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.618 1.167 . . . . 0.0 111.814 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.06 -25.26 25.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -161.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.9 p90 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 128.062 2.545 . . . . 0.0 113.555 -168.742 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.18 134.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.371 1.468 . . . . 0.0 110.199 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -147.93 123.73 10.58 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.142 1.377 . . . . 0.0 110.061 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.46 148.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.834 1.254 . . . . 0.0 109.463 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.3 54.8 0.92 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.466 1.506 . . . . 0.0 112.416 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -73.19 -55.53 3.73 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.596 1.558 . . . . 0.0 112.879 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt -65.4 -21.83 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -47.38 -39.11 14.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.277 2.231 . . . . 0.0 113.482 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.41 -31.6 54.21 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.726 0.811 . . . . 0.0 112.554 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.5 61.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.883 0.873 . . . . 0.0 112.05 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.39 -20.89 59.9 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.43 -26.56 68.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 113.699 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.5 m 52.5 65.49 1.49 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.354 1.461 . . . . 0.0 112.966 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.3 p -65.79 -19.04 65.74 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.95 -1.0 87.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.091 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -77.75 163.27 26.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.342 1.057 . . . . 0.0 111.771 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.24 137.49 58.24 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.487 -0.758 . . . . 0.0 112.102 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.01 34.94 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.891 1.276 . . . . 0.0 112.112 166.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.33 123.19 47.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.171 1.388 . . . . 0.0 111.907 -162.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t0 54.34 35.93 24.12 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.007 1.723 . . . . 0.0 113.743 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.88 -30.5 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.249 1.82 . . . . 0.0 112.086 -174.791 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.53 127.81 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.12 1.368 . . . . 0.0 110.497 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -139.96 144.74 37.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.391 1.876 . . . . 0.0 110.31 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.99 148.5 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.358 1.463 . . . . 0.0 109.163 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.14 53.55 0.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.04 1.336 . . . . 0.0 112.69 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.18 -55.39 3.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.909 1.684 . . . . 0.0 112.981 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.42 -19.04 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.53 -38.56 63.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.489 1.116 . . . . 0.0 112.276 169.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -66.41 -27.8 68.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 112.861 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.76 -40.77 14.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.233 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.22 -29.61 42.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.66 -52.54 50.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.835 0.854 . . . . 0.0 112.029 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -155.32 -71.01 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 0.0 111.9 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -175.87 106.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.707 2.003 . . . . 0.0 110.401 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.82 28.33 72.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.478 1.037 . . . . 0.0 114.265 172.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.7 170.74 4.85 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.362 1.465 . . . . 0.0 114.219 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -65.44 161.54 19.71 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.577 -0.702 . . . . 0.0 112.622 167.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.87 29.71 1.68 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.307 1.043 . . . . 0.0 112.5 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.31 125.14 39.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.291 1.037 . . . . 0.0 112.355 -165.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 55.74 29.35 13.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.157 1.783 . . . . 0.0 113.964 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -74.74 -25.95 59.45 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -172.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.456 1.902 . . . . 0.0 112.096 -173.539 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.38 160.47 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.661 1.584 . . . . 0.0 111.88 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 158.3 33.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 112.277 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.39 150.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.007 1.323 . . . . 0.0 109.833 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.54 45.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.551 1.941 . . . . 0.0 114.231 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.95 -53.44 34.19 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.776 1.63 . . . . 0.0 113.11 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt -69.12 -19.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -42.87 80.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.734 1.214 . . . . 0.0 112.412 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -69.52 -40.32 76.99 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.963 0.505 . . . . 0.0 111.462 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.85 75.41 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.422 0.689 . . . . 0.0 111.816 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 pp -69.93 -34.12 73.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.84 -41.76 91.33 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.635 0.774 . . . . 0.0 111.036 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -30.84 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -168.98 108.83 0.47 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.534 1.533 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.09 67.2 1.04 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.545 168.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.24 159.6 9.63 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.912 0.863 . . . . 0.0 113.097 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -70.84 158.64 36.02 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.241 1.016 . . . . 0.0 113.685 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.85 25.54 0.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -148.11 -62.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.38 -0.825 . . . . 0.0 113.075 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -85.76 46.21 1.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.426 1.09 . . . . 0.0 112.485 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.87 -28.05 55.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.057 1.343 . . . . 0.0 114.489 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.239 1.816 . . . . 0.0 113.029 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.69 150.04 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.064 1.346 . . . . 0.0 111.257 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.92 161.78 35.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.956 1.702 . . . . 0.0 112.351 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.23 148.33 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.201 1.4 . . . . 0.0 109.43 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.67 52.78 0.3 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.474 1.91 . . . . 0.0 113.471 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.78 -52.67 31.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.169 1.788 . . . . 0.0 112.921 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -68.82 -18.46 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.62 -40.44 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.366 1.466 . . . . 0.0 112.47 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -72.7 -39.39 67.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.257 0.623 . . . . 0.0 111.822 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.29 82.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.336 0.654 . . . . 0.0 111.923 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.0 -33.07 70.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.6 tp -62.6 -43.06 99.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 110.803 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -69.62 -35.26 75.09 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.1 m -156.54 97.28 1.72 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.249 1.82 . . . . 0.0 109.921 -171.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.55 63.74 0.82 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.305 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.28 157.99 5.85 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.56 159.99 33.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.247 1.019 . . . . 0.0 113.218 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.74 1.36 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -108.27 -47.04 3.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.494 1.118 . . . . 0.0 113.469 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.77 58.93 1.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.507 1.123 . . . . 0.0 111.508 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.68 -40.86 93.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.908 1.683 . . . . 0.0 112.121 -176.511 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -147.87 147.15 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.108 1.363 . . . . 0.0 111.144 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -133.47 146.22 50.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.52 24.39 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 56.9 38.36 29.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.059 1.744 . . . . 0.0 112.937 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.17 -52.35 15.9 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.23 -20.78 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -35.32 65.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.942 1.297 . . . . 0.0 112.827 171.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.3 -43.0 61.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.14 75.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.56 -30.27 69.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.417 -0.802 . . . . 0.0 112.809 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.56 -41.83 59.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.638 1.175 . . . . 0.0 111.639 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -66.06 -20.72 66.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.736 0.815 . . . . 0.0 112.72 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -97.55 34.05 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.068 1.747 . . . . 0.0 111.411 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.44 40.82 1.56 Allowed Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.139 1.828 . . . . 0.0 114.58 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.67 163.61 26.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.123 1.369 . . . . 0.0 113.737 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.86 156.85 38.45 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.4 25.81 0.6 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.97 1.308 . . . . 0.0 112.887 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.39 -33.25 17.98 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.94 26.09 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.926 1.291 . . . . 0.0 112.715 -172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -74.4 -30.03 61.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.133 0.973 . . . . 0.0 113.407 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.481 1.912 . . . . 0.0 111.823 -177.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.77 -34.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -144.65 123.48 12.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.234 . . . . 0.0 110.39 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.91 149.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.255 1.422 . . . . 0.0 109.397 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.09 42.97 0.12 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.305 1.842 . . . . 0.0 114.42 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.75 -53.16 29.44 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.758 1.623 . . . . 0.0 113.294 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.61 -18.57 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.67 -35.81 63.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.056 1.343 . . . . 0.0 112.86 172.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -73.45 -44.25 58.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.661 0.784 . . . . 0.0 110.978 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.69 91.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.863 0.865 . . . . 0.0 112.861 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.37 -23.19 57.11 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.3 tp -87.83 -34.48 18.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.095 1.358 . . . . 0.0 112.924 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -88.17 39.01 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.726 1.61 . . . . 0.0 112.778 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -85.63 24.1 1.27 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.928 2.091 . . . . 0.0 113.98 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.45 56.44 2.45 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.723 2.106 . . . . 0.0 114.247 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.02 -174.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.468 2.307 . . . . 0.0 114.735 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.13 132.78 47.11 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.035 -1.04 . . . . 0.0 110.92 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.64 24.64 0.39 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -150.52 -51.2 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.351 -0.843 . . . . 0.0 113.257 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.99 41.7 0.52 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.51 . . . . 0.0 112.827 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.2 -36.84 84.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.548 1.539 . . . . 0.0 114.19 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.038 1.335 . . . . 0.0 112.745 -167.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.5 159.8 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.325 1.45 . . . . 0.0 112.063 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 26.14 9.58 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.177 1.791 . . . . 0.0 113.949 -167.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.47 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 113.883 -167.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.33 38.14 29.48 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.429 1.892 . . . . 0.0 112.569 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -66.97 -53.26 26.98 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.88 -19.13 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.46 -41.61 80.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.923 1.289 . . . . 0.0 112.448 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -71.75 -41.52 68.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.126 0.57 . . . . 0.0 111.24 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.52 93.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.266 0.626 . . . . 0.0 111.915 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.1 -35.26 71.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -68.9 -30.95 69.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.514 1.125 . . . . 0.0 111.575 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.5 m -79.52 38.67 0.38 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.397 1.479 . . . . 0.0 112.503 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m 57.4 56.12 5.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.956 2.103 . . . . 0.0 112.058 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -126.86 22.05 5.8 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.205 1.383 . . . . 0.0 115.354 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -67.36 161.48 25.05 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.53 1.165 . . . . 0.0 113.047 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.39 165.27 16.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.011 0.924 . . . . 0.0 112.926 166.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.01 32.57 2.17 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.485 1.114 . . . . 0.0 112.22 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -96.1 112.08 23.92 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.992 0.917 . . . . 0.0 112.05 -161.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t0 50.31 41.04 23.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.055 1.742 . . . . 0.0 113.947 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.55 -33.22 68.95 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -167.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.052 1.741 . . . . 0.0 112.173 -174.66 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.06 52.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 125.339 1.456 . . . . 0.0 111.467 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -123.48 26.68 7.75 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.382 1.473 . . . . 0.0 112.291 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.1 t -129.45 151.24 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.846 1.658 . . . . 0.0 109.823 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.83 55.51 0.69 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.931 1.693 . . . . 0.0 112.384 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -70.91 -53.83 8.32 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.793 1.637 . . . . 0.0 112.66 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.55 -17.46 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.59 -39.28 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 113.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.89 -42.06 67.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.357 0.663 . . . . 0.0 111.23 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.1 90.13 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 0.0 112.414 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.24 -28.97 62.45 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.2 tp -76.97 -42.14 40.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.43 1.092 . . . . 0.0 112.021 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.2 t -153.91 -46.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.8 p -89.67 -9.58 49.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -155.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.7 -44.75 6.31 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.002 0.819 . . . . 0.0 113.862 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -156.36 167.69 29.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.576 1.55 . . . . 0.0 112.157 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -63.95 162.41 13.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.814 0.845 . . . . 0.0 112.924 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.18 32.92 1.34 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.3 1.04 . . . . 0.0 113.047 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -71.37 -43.39 66.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.58 36.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.908 0.883 . . . . 0.0 112.961 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.07 -35.75 74.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.765 -1.209 . . . . 0.0 113.602 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.195 1.798 . . . . 0.0 112.006 -174.783 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.61 143.93 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.273 1.429 . . . . 0.0 111.157 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -144.52 105.43 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.288 1.035 . . . . 0.0 110.39 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 52.9 t -143.03 150.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.963 1.705 . . . . 0.0 108.889 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -74.91 53.24 0.58 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.21 1.404 . . . . 0.0 112.899 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.21 -53.98 7.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.838 1.655 . . . . 0.0 112.543 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.84 -19.76 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 p30 -49.14 -39.53 29.12 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.504 1.122 . . . . 0.0 113.068 170.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -59.58 -38.88 82.36 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.955 0.902 . . . . 0.0 112.159 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.4 -50.88 9.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.673 0.789 . . . . 0.0 112.08 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.6 pp -66.45 -20.54 66.07 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -20.22 65.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.482 1.513 . . . . 0.0 113.559 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 m 59.15 40.63 21.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.553 1.541 . . . . 0.0 114.487 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.4 m -134.45 75.88 1.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.563 1.545 . . . . 0.0 109.08 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.27 -3.6 9.62 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.437 1.494 . . . . 0.0 115.721 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -133.33 166.43 22.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.056 1.743 . . . . 0.0 112.148 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.37 159.19 18.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.947 0.899 . . . . 0.0 113.051 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.12 27.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -78.52 -47.4 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.66 37.32 0.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.906 1.282 . . . . 0.0 113.225 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.36 -41.57 89.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.348 1.059 . . . . 0.0 113.79 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.263 1.825 . . . . 0.0 111.871 -173.136 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.06 155.44 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.454 1.502 . . . . 0.0 111.929 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.33 156.11 33.61 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.925 0.89 . . . . 0.0 112.442 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.65 150.43 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.072 1.349 . . . . 0.0 109.59 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.07 55.52 0.93 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.325 1.45 . . . . 0.0 112.493 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.44 -53.84 9.56 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.968 1.707 . . . . 0.0 112.84 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB3' HD12 ' A' ' 18' ' ' ILE . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt -67.68 -18.68 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -51.14 -35.89 37.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.144 0.978 . . . . 0.0 113.372 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -63.23 -45.73 90.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.848 0.859 . . . . 0.0 111.452 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.82 54.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.146 0.978 . . . . 0.0 111.925 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.09 -27.61 67.49 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.57 -45.82 64.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.893 0.877 . . . . 0.0 111.041 168.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.1 t -63.12 -33.18 74.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.331 0.652 . . . . 0.0 112.664 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.3 p -84.5 -39.46 18.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.083 0.953 . . . . 0.0 112.739 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.06 14.91 76.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.693 1.14 . . . . 0.0 115.3 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.88 159.43 33.74 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.327 1.063 . . . . 0.0 113.301 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.48 138.52 55.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.96 87.2 0.85 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.282 1.433 . . . . 0.0 110.631 164.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -113.34 -51.89 2.79 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.76 36.7 0.96 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.617 1.167 . . . . 0.0 111.952 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.12 -28.14 62.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -171.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.405 1.882 . . . . 0.0 111.943 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.05 -2.09 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.53 149.92 39.74 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.141 1.376 . . . . 0.0 111.385 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.37 27.11 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.321 1.448 . . . . 0.0 112.13 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.15 38.68 30.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.269 1.828 . . . . 0.0 112.897 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.24 -50.95 47.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -66.04 -20.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 3.1 p30 -50.1 -38.75 40.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.958 0.903 . . . . 0.0 113.136 168.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.57 -33.04 74.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.323 1.049 . . . . 0.0 112.482 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.87 -47.72 10.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.422 1.089 . . . . 0.0 112.31 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.5 pp -69.12 -23.36 63.98 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.26 -15.42 62.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.624 1.57 . . . . 0.0 113.641 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.4 m 51.17 44.24 28.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.06 1.344 . . . . 0.0 114.1 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m 57.62 36.1 26.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.399 1.48 . . . . 0.0 113.524 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.44 -14.6 64.75 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 124.605 1.098 . . . . 0.0 114.802 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -131.88 167.87 18.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.706 2.002 . . . . 0.0 111.138 170.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.88 154.26 26.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.731 0.812 . . . . 0.0 113.116 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -153.91 23.27 0.51 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.309 1.044 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -75.8 -32.25 59.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -160.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -140.84 24.7 2.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.871 1.268 . . . . 0.0 112.401 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -82.58 -36.35 26.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.099 -1.0 . . . . 0.0 113.168 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.915 2.086 . . . . 0.0 111.531 -177.744 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.659 0.266 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t 54.38 60.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.934 1.694 . . . . 0.0 112.447 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -119.88 124.07 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.412 1.485 . . . . 0.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.53 25.12 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.757 1.223 . . . . 0.0 112.127 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 57.57 38.03 27.76 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.215 1.806 . . . . 0.0 112.929 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.18 -53.27 11.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' A' ' 18' ' ' ILE . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt -69.19 -18.05 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.4 p30 -48.64 -36.91 16.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.332 1.053 . . . . 0.0 113.388 169.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.55 -31.61 70.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.04 0.936 . . . . 0.0 112.873 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.14 -49.25 6.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.763 1.225 . . . . 0.0 112.844 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.6 pp -68.31 -19.81 64.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.57 -21.67 66.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.187 1.395 . . . . 0.0 113.183 170.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.4 m 55.23 72.95 0.44 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.909 1.684 . . . . 0.0 112.783 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -60.48 -29.84 69.32 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.63 36.85 1.62 Allowed Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.678 1.609 . . . . 0.0 114.542 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.68 -172.25 0.08 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.283 2.233 . . . . 0.0 114.298 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 tp -63.75 128.21 34.81 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.61 -1.306 . . . . 0.0 110.927 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -166.67 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.58 -61.55 0.4 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.4 95.32 1.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.635 0.774 . . . . 0.0 110.951 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.42 -44.58 64.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -171.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.255 1.368 0 C-N-CA 125.853 1.661 . . . . 0.0 112.238 -173.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.08 143.56 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.775 1.63 . . . . 0.0 110.267 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 55.27 56.44 6.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.443 1.497 . . . . 0.0 113.13 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.3 148.41 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.082 1.353 . . . . 0.0 109.842 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.86 49.66 0.24 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.426 1.891 . . . . 0.0 113.642 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.54 -53.17 23.84 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.241 1.816 . . . . 0.0 112.878 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.24 -17.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.89 -41.24 64.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 113.065 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -70.98 -35.58 72.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.27 0.628 . . . . 0.0 112.243 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.66 -38.72 70.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.815 0.846 . . . . 0.0 112.454 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.5 -25.33 36.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 66.1 tp -61.48 -33.34 73.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.367 1.067 . . . . 0.0 112.621 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 52.33 52.56 13.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.773 1.229 . . . . 0.0 113.352 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m -57.72 -28.63 64.04 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.131 1.373 . . . . 0.0 114.437 -168.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.68 -0.01 83.13 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 115.35 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -126.88 -158.52 0.87 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.108 2.563 . . . . 0.0 110.268 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.71 131.17 43.03 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.912 -1.117 . . . . 0.0 110.667 162.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.31 99.33 1.62 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.818 1.247 . . . . 0.0 110.37 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -143.08 -53.1 0.38 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -141.99 36.13 1.57 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.168 0.987 . . . . 0.0 112.428 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.73 -27.48 61.21 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.825 2.05 . . . . 0.0 112.887 177.256 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.34 140.33 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.717 1.607 . . . . 0.0 109.823 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.23 157.86 23.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.153 1.381 . . . . 0.0 112.332 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.24 24.08 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.813 1.245 . . . . 0.0 112.564 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.79 38.48 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.906 1.682 . . . . 0.0 112.705 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.92 -52.37 41.45 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 -173.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt -68.69 -18.46 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 p30 -50.53 -38.03 42.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.059 -1.026 . . . . 0.0 113.16 169.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.2 -32.28 72.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.16 0.984 . . . . 0.0 112.742 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.35 -48.51 7.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.351 1.06 . . . . 0.0 112.16 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.0 pp -67.56 -30.74 70.45 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -174.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.89 -39.65 94.69 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 111.144 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.9 m -80.29 -17.91 50.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -169.79 106.84 0.36 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.36 65.27 1.16 Allowed Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.755 1.169 . . . . 0.0 113.579 171.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.71 153.63 10.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.724 0.809 . . . . 0.0 112.561 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.42 135.2 48.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.85 21.37 0.79 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 164.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.17 -49.62 7.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.086 0.954 . . . . 0.0 112.83 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -153.2 91.93 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 110.168 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.98 -42.22 57.99 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.773 1.629 . . . . 0.0 112.131 -175.416 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.2 142.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.26 1.424 . . . . 0.0 111.021 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.94 133.47 33.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.763 1.225 . . . . 0.0 111.986 176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.76 149.61 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.262 1.425 . . . . 0.0 109.329 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.9 54.01 0.8 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.6 1.56 . . . . 0.0 112.558 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.7 -55.84 2.44 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.646 1.578 . . . . 0.0 112.787 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.11 -19.09 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -34.41 70.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.978 1.311 . . . . 0.0 113.158 175.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.44 -44.95 41.63 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.071 0.548 . . . . 0.0 111.089 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.55 -36.43 83.76 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.15 -25.17 61.6 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -87.93 -40.01 14.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.365 1.466 . . . . 0.0 112.931 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.4 p -74.54 -7.17 52.22 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.0 t -60.55 -19.98 58.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.346 1.458 . . . . 0.0 114.496 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.57 47.71 1.48 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.86 1.695 . . . . 0.0 114.791 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -66.5 164.56 16.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.215 1.406 . . . . 0.0 113.631 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -64.22 162.73 14.04 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.112 0.965 . . . . 0.0 113.032 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.13 26.8 1.64 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.499 1.119 . . . . 0.0 112.856 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.5 -43.69 54.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.924 0.89 . . . . 0.0 113.095 -163.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -137.65 23.8 2.89 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.761 1.624 . . . . 0.0 111.761 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -80.36 -30.59 37.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -168.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.302 1.841 . . . . 0.0 112.079 -176.337 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 145.45 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.865 1.666 . . . . 0.0 110.224 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 56.11 53.07 9.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.278 1.431 . . . . 0.0 113.03 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.69 152.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.011 1.325 . . . . 0.0 110.209 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.61 53.79 0.57 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.891 1.677 . . . . 0.0 112.585 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.68 -54.45 3.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.783 1.633 . . . . 0.0 112.725 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.36 -19.56 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -40.37 81.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.715 1.206 . . . . 0.0 112.636 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -71.99 -42.14 66.81 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.869 0.467 . . . . 0.0 111.129 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.75 98.19 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.44 -31.9 64.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.75 -39.97 91.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.463 0.705 . . . . 0.0 110.634 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.4 m -65.08 -16.29 63.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 m -76.29 -27.17 56.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.218 1.007 . . . . 0.0 112.205 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.84 12.82 82.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.253 0.93 . . . . 0.0 114.916 -176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -139.19 166.07 25.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.239 1.816 . . . . 0.0 111.672 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -66.85 157.43 33.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.68 28.14 0.55 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.277 1.031 . . . . 0.0 113.467 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -135.45 -50.68 0.74 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -168.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -80.04 39.43 0.44 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.331 1.453 . . . . 0.0 112.763 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.35 -25.39 46.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.52 1.528 . . . . 0.0 114.012 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.569 1.947 . . . . 0.0 112.138 -176.489 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 CA--C 1.545 0.767 0 CA-C-O 117.598 -1.191 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.646 -1.168 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.569 -1.205 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 117.498 -1.239 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 117.497 -1.239 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.513 ' CD2' HH21 ' A' ' 24' ' ' ARG . 14.6 t60 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.513 HH21 ' CD2' ' A' ' 20' ' ' HIS . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB3' HD12 ' A' ' 18' ' ' ILE . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' A' ' 18' ' ' ILE . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 117.631 -1.176 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.43 55.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 125.487 1.515 . . . . 0.0 111.739 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -141.84 149.73 40.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.379 1.471 . . . . 0.0 111.498 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.64 153.01 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.552 1.541 . . . . 0.0 109.923 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.23 55.52 0.6 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.162 1.785 . . . . 0.0 112.533 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.69 -52.75 7.92 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.783 1.633 . . . . 0.0 113.049 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.07 169.12 18.08 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.474 2.116 . . . . 0.0 112.935 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.65 143.29 3.86 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.275 1.417 . . . . 0.0 113.362 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.252 3.7 pp -143.7 35.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.39 111.31 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.233 0.613 . . . . 0.0 110.072 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.7 m -111.69 139.87 46.79 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.866 0.841 . . . . 0.0 110.869 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.94 59.58 0.36 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.774 2.03 . . . . 0.0 112.022 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -78.62 44.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.584 1.154 . . . . 0.0 110.464 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 69.5 p -133.23 134.26 43.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 112.148 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.93 33.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -123.53 150.03 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.83 1.652 . . . . 0.0 112.143 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m -59.16 -27.11 65.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -97.98 -43.22 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.222 1.409 . . . . 0.0 112.113 168.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.87 -28.85 73.96 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 120.401 -1.437 . . . . 0.0 114.489 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -66.11 -36.12 82.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -33.21 49.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.418 0.687 . . . . 0.0 112.064 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -54.77 -42.65 71.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.678 1.127 . . . . 0.0 111.363 174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -51.06 -53.51 33.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.41 0.55 . . . . 0.0 111.97 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -71.13 -44.47 65.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.0 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.11 97.23 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.187 0.595 . . . . 0.0 112.007 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.38 -52.47 63.48 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.609 -0.682 . . . . 0.0 110.401 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -65.75 -28.26 68.9 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -63.99 -33.02 74.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.87 1.268 . . . . 0.0 113.329 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.49 0.35 16.48 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.83 135.85 57.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.233 1.013 . . . . 0.0 112.942 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.0 144.68 19.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.114 1.766 . . . . 0.0 108.847 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -155.33 146.25 22.45 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -85.75 -27.45 25.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.843 0.857 . . . . 0.0 113.299 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -80.63 -172.39 3.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.554 1.142 . . . . 0.0 112.099 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -5.13 28.72 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.7 1.6 . . . . 0.0 113.98 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.83 23.1 68.96 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.231 -1.543 . . . . 0.0 115.87 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.51 66.71 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.205 -1.173 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.11 152.36 38.79 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.87 160.6 38.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.877 1.271 . . . . 0.0 111.982 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.3 mt -117.94 126.46 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.45 1.5 . . . . 0.0 108.96 -171.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.09 143.15 50.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.0 108.329 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.79 153.57 49.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.696 1.134 . . . . 0.0 113.744 170.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -118.04 116.68 35.81 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 124.297 1.039 . . . . 0.0 110.095 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.76 125.56 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.17 2.58 . . . . 0.0 110.052 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.8 m -140.79 89.48 2.26 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.761 1.224 . . . . 0.0 109.714 -170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.8 14.64 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -54.92 -28.71 53.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.059 1.344 . . . . 0.0 113.801 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.22 -28.72 0.14 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.17 -114.7 0.68 Allowed Glycine 0 N--CA 1.475 1.238 0 CA-C-N 120.283 1.401 . . . . 0.0 112.819 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.1 144.91 43.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.129 0.972 . . . . 0.0 113.291 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -80.36 133.12 35.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 158.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.57 131.88 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.143 1.377 . . . . 0.0 109.05 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -137.07 116.6 12.85 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.789 1.236 . . . . 0.0 109.141 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.27 129.73 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.988 0.915 . . . . 0.0 109.509 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -119.41 138.72 52.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.755 1.222 . . . . 0.0 110.933 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.36 116.49 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.302 1.441 . . . . 0.0 108.264 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 54.96 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.983 2.513 . . . . 0.0 113.841 -168.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.09 7.74 1.61 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.486 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.31 131.31 55.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.099 1.36 . . . . 0.0 111.504 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.85 138.43 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.191 -0.943 . . . . 0.0 111.248 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.84 -27.0 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.47 146.16 26.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.531 0.605 . . . . 0.0 110.749 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.56 146.26 23.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.904 0.882 . . . . 0.0 111.809 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -154.46 164.77 38.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.84 1.256 . . . . 0.0 111.804 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.39 130.88 43.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.863 0.865 . . . . 0.0 111.218 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -102.34 143.68 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.145 1.378 . . . . 0.0 111.61 170.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.47 130.29 24.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.612 1.165 . . . . 0.0 111.291 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.05 -29.44 2.04 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.754 2.969 . . . . 0.0 114.326 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.07 -20.26 38.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.684 0.794 . . . . 0.0 112.612 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -89.82 163.06 15.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.96 1.304 . . . . 0.0 111.966 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -107.85 19.33 20.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.536 1.535 . . . . 0.0 114.005 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -75.55 -17.03 60.19 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -46.4 -48.3 18.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.067 . . . . 0.0 113.39 -170.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.55 -41.5 98.42 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.519 -0.738 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.47 -44.99 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.705 1.202 . . . . 0.0 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.3 m -62.27 -38.74 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.462 1.505 . . . . 0.0 112.048 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.24 -54.5 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.289 0.95 . . . . 0.0 110.518 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.77 -38.68 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.888 0.767 . . . . 0.0 111.138 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.76 70.94 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.559 0.743 . . . . 0.0 112.209 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.52 68.73 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.755 -1.215 . . . . 0.0 112.205 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.69 -48.81 77.67 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.916 0.78 . . . . 0.0 110.123 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.26 -47.26 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.449 1.099 . . . . 0.0 109.979 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.19 -25.54 66.19 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.242 -0.912 . . . . 0.0 112.924 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -65.5 -47.75 74.92 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.639 0.776 . . . . 0.0 111.19 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.95 -29.67 60.99 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.025 -1.047 . . . . 0.0 112.293 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.07 -28.84 69.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.507 -1.371 . . . . 0.0 113.277 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.02 92.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.112 0.565 . . . . 0.0 112.191 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.24 -21.33 25.9 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.017 1.327 . . . . 0.0 112.59 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -62.76 -25.36 68.17 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.179 1.791 . . . . 0.0 113.601 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -102.52 -8.08 21.34 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.673 1.189 . . . . 0.0 113.683 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -85.92 -54.15 4.67 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.047 1.339 . . . . 0.0 112.288 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -141.15 -38.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mt -68.0 -20.17 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.702 0.683 . . . . 0.0 110.574 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.47 -42.39 74.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.519 1.527 . . . . 0.0 112.635 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.87 -40.08 72.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.031 0.532 . . . . 0.0 111.469 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.95 78.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.404 0.682 . . . . 0.0 111.868 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.13 -34.56 73.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.66 -41.6 92.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.581 0.752 . . . . 0.0 111.118 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -66.57 -31.76 72.66 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -169.62 110.02 0.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.622 1.569 . . . . 0.0 110.526 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.99 68.74 1.14 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.289 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.25 159.41 7.73 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.85 0.833 . . . . 0.0 112.925 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.07 155.76 40.14 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -154.41 21.85 0.48 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -107.83 -56.13 2.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.133 0.973 . . . . 0.0 113.01 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -156.07 92.63 1.37 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.464 1.106 . . . . 0.0 110.586 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.18 -44.44 21.9 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.092 1.757 . . . . 0.0 112.056 -176.314 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.51 134.1 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.493 1.517 . . . . 0.0 110.132 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -140.99 121.91 14.5 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.347 1.459 . . . . 0.0 110.75 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -143.81 149.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.76 54.61 0.81 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.393 1.477 . . . . 0.0 112.515 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.95 -55.37 4.04 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.594 1.558 . . . . 0.0 112.614 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.57 169.47 16.89 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.29 1.993 . . . . 0.0 112.589 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 142.6 3.94 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.088 1.328 . . . . 0.0 113.303 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.257 3.9 pp -143.13 35.34 1.36 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.48 109.12 1.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.103 0.561 . . . . 0.0 110.054 174.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -110.69 139.66 45.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.783 0.802 . . . . 0.0 110.688 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -71.3 60.15 0.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.563 1.945 . . . . 0.0 111.793 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.09 44.65 0.49 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.611 1.164 . . . . 0.0 110.302 170.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 71.6 p -133.82 133.86 42.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 0.0 112.029 -172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.96 35.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.638 1.175 . . . . 0.0 113.869 -170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.65 152.23 43.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.68 1.592 . . . . 0.0 111.587 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.1 p -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.313 -0.867 . . . . 0.0 113.184 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.37 -41.3 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.286 1.434 . . . . 0.0 111.792 171.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.87 73.15 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.436 -1.415 . . . . 0.0 114.17 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.58 -37.63 80.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.312 1.056 . . . . 0.0 111.354 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.05 -35.16 69.25 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.66 -0.65 . . . . 0.0 111.091 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -56.21 -43.19 78.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.372 0.987 . . . . 0.0 111.381 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -53.63 -53.78 47.01 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.579 0.627 . . . . 0.0 111.755 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -67.86 -44.34 77.35 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.753 0.821 . . . . 0.0 111.821 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.1 -43.11 88.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.48 0.712 . . . . 0.0 111.994 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.2 -51.91 67.03 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.408 -0.808 . . . . 0.0 110.402 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.93 -28.55 69.01 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.33 -32.8 74.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.529 1.132 . . . . 0.0 113.42 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.43 1.76 17.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -60.36 131.36 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 112.409 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.46 138.52 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.137 1.775 . . . . 0.0 109.088 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -149.92 154.51 38.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -166.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.33 -7.99 15.15 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.448 1.499 . . . . 0.0 113.694 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -100.61 -169.85 1.77 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.763 1.225 . . . . 0.0 111.494 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -8.75 44.6 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.594 1.558 . . . . 0.0 113.888 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.32 22.89 71.42 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.424 -1.423 . . . . 0.0 115.6 169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.67 65.87 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.304 -1.115 . . . . 0.0 112.448 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.24 151.23 39.46 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -136.0 160.63 38.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.785 1.234 . . . . 0.0 111.832 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -117.9 126.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.464 1.506 . . . . 0.0 108.784 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.57 142.39 50.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.166 1.386 . . . . 0.0 108.327 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.15 153.76 49.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -119.75 116.31 33.16 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 123.998 0.919 . . . . 0.0 110.309 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.64 123.2 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.348 2.699 . . . . 0.0 110.004 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.6 m -141.44 103.12 4.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.264 1.026 . . . . 0.0 110.603 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -10.65 19.63 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -52.74 -32.03 41.13 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.992 1.317 . . . . 0.0 113.617 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.25 -25.38 0.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.41 -112.57 0.6 Allowed Glycine 0 N--CA 1.474 1.214 0 CA-C-N 120.595 1.543 . . . . 0.0 112.848 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -136.22 143.51 44.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.911 0.884 . . . . 0.0 113.311 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -78.22 135.04 37.51 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 158.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.86 131.22 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.159 1.384 . . . . 0.0 108.989 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -136.81 116.39 12.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.746 1.218 . . . . 0.0 109.223 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.85 129.46 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.914 0.886 . . . . 0.0 109.449 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.46 138.77 52.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.09 115.83 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.172 1.389 . . . . 0.0 108.244 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 55.2 -73.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.992 2.517 . . . . 0.0 113.81 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.56 7.27 1.7 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.632 1.973 . . . . 0.0 113.494 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.61 130.89 56.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 111.425 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 138.14 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.06 -26.92 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -151.07 146.0 25.88 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.116 0.566 . . . . 0.0 110.911 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.28 147.11 24.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 111.953 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -154.17 162.97 40.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.925 1.29 . . . . 0.0 111.678 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.25 129.72 43.5 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.684 0.794 . . . . 0.0 111.147 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -100.45 143.32 30.78 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.119 1.368 . . . . 0.0 112.093 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -124.2 129.29 24.78 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.816 1.246 . . . . 0.0 110.777 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.1 -28.41 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.9 3.067 . . . . 0.0 113.679 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -78.57 -24.38 45.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.351 1.061 . . . . 0.0 112.355 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.69 154.58 20.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.209 1.404 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -96.77 0.07 48.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.019 1.328 . . . . 0.0 114.121 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -77.32 -4.18 43.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -44.13 -44.32 7.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.365 1.466 . . . . 0.0 113.113 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.45 -41.35 98.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -42.88 75.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.533 1.133 . . . . 0.0 110.44 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -59.45 -41.51 89.81 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.196 0.999 . . . . 0.0 112.092 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.68 -53.75 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.78 0.832 . . . . 0.0 110.585 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.02 -38.38 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.836 0.744 . . . . 0.0 111.268 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.31 69.48 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.429 0.691 . . . . 0.0 112.144 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -27.36 68.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.723 -1.236 . . . . 0.0 112.238 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.67 -48.94 77.13 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.891 0.768 . . . . 0.0 110.194 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.42 -46.79 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.374 1.07 . . . . 0.0 110.0 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.63 -25.15 65.59 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.156 -0.965 . . . . 0.0 113.032 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.5 m -65.2 -47.5 76.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.586 0.754 . . . . 0.0 110.967 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.17 -30.16 60.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.462 1.028 . . . . 0.0 112.306 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.71 -28.28 69.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.444 -1.41 . . . . 0.0 113.371 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.87 95.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.218 0.607 . . . . 0.0 112.098 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.9 -21.07 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.509 1.523 . . . . 0.0 112.422 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.96 -25.98 67.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.507 1.923 . . . . 0.0 113.516 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -105.68 0.22 26.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.991 1.316 . . . . 0.0 114.054 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtp-105 -92.9 -55.33 3.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.271 1.429 . . . . 0.0 112.157 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.34 -36.9 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mt -69.4 -16.89 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.623 -0.673 . . . . 0.0 110.865 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.04 -39.8 72.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.513 1.125 . . . . 0.0 112.851 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -72.8 -35.17 67.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.3 0.64 . . . . 0.0 111.931 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.35 -40.71 73.92 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.646 0.779 . . . . 0.0 112.509 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.75 -31.47 59.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.97 -29.28 65.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.015 0.926 . . . . 0.0 112.171 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 53.95 45.6 27.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.092 1.757 . . . . 0.0 112.517 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -33.47 71.9 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -157.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.42 18.25 13.68 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.551 1.548 . . . . 0.0 114.435 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.53 -176.64 4.47 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.851 1.66 . . . . 0.0 112.547 -166.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -57.81 134.84 56.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.992 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -161.36 105.76 1.3 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.208 1.403 . . . . 0.0 110.2 168.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -133.05 -55.23 0.92 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 113.185 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -148.12 38.58 0.89 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.378 1.071 . . . . 0.0 111.89 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.02 -38.37 75.88 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.112 -0.992 . . . . 0.0 113.414 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 126.785 2.034 . . . . 0.0 112.859 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.07 135.18 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.449 1.5 . . . . 0.0 109.996 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -130.6 156.39 44.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.551 1.54 . . . . 0.0 111.558 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.2 t -133.2 150.37 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.248 1.419 . . . . 0.0 109.734 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.29 52.46 0.6 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.805 1.642 . . . . 0.0 112.611 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.5 -54.39 5.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.722 1.609 . . . . 0.0 112.509 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.37 169.49 17.17 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.575 2.184 . . . . 0.0 112.821 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.69 143.27 3.85 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.165 1.364 . . . . 0.0 113.388 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 3.7 pp -143.71 34.54 1.27 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.14 121.75 12.08 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.7 m -125.44 140.82 52.45 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.245 1.018 . . . . 0.0 110.477 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.15 61.06 0.83 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.985 1.714 . . . . 0.0 111.777 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.45 44.73 0.44 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.934 1.294 . . . . 0.0 110.325 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 65.3 p -135.12 132.18 37.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.614 1.566 . . . . 0.0 111.736 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.39 35.25 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.552 1.141 . . . . 0.0 114.024 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.77 151.4 45.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.737 1.615 . . . . 0.0 111.787 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.2 p -59.06 -34.09 71.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -93.03 -42.62 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.157 1.383 . . . . 0.0 111.73 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.99 -28.41 73.42 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.307 -1.496 . . . . 0.0 114.433 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.47 -33.49 64.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.502 1.151 . . . . 0.0 111.434 172.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.48 -34.89 68.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.246 -0.909 . . . . 0.0 111.145 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -55.72 -42.79 75.82 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.376 0.989 . . . . 0.0 111.215 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -52.89 -53.81 43.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.408 0.549 . . . . 0.0 111.73 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -66.65 -45.56 78.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.997 0.919 . . . . 0.0 111.584 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -42.72 88.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.123 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.75 -52.36 64.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.382 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.41 -28.32 69.16 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -64.44 -32.9 74.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.545 1.138 . . . . 0.0 113.437 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -111.34 0.63 16.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 177.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.32 133.7 55.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.121 0.968 . . . . 0.0 112.784 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.56 138.53 14.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.208 1.803 . . . . 0.0 109.008 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.2 p -151.58 152.27 32.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -90.8 -25.94 19.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.213 1.005 . . . . 0.0 113.449 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -80.65 -171.26 3.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.829 1.252 . . . . 0.0 111.998 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -6.01 36.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.471 1.508 . . . . 0.0 113.991 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 23.31 68.54 Favored Glycine 0 N--CA 1.474 1.214 0 O-C-N 120.336 -1.478 . . . . 0.0 115.946 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.55 66.25 9.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.139 -1.212 . . . . 0.0 112.382 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.65 151.41 39.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 114.423 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -135.94 161.07 36.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.884 1.274 . . . . 0.0 111.737 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.04 127.49 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 108.68 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.67 143.41 50.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.106 1.362 . . . . 0.0 108.164 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.68 152.18 50.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.6 1.091 . . . . 0.0 113.345 170.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -115.37 116.94 41.4 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.092 0.957 . . . . 0.0 109.474 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.22 127.47 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.877 2.385 . . . . 0.0 110.104 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -139.74 76.49 1.56 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.154 1.381 . . . . 0.0 108.843 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -15.01 10.63 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -51.73 -28.35 14.81 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.921 1.689 . . . . 0.0 114.282 164.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.25 -30.39 0.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.17 -116.92 0.77 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.042 1.292 . . . . 0.0 112.829 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -138.37 145.68 41.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.421 1.088 . . . . 0.0 113.142 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -82.41 132.68 35.21 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 159.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.62 132.2 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.165 1.386 . . . . 0.0 109.108 171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -137.99 115.86 11.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.735 1.214 . . . . 0.0 109.198 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.92 130.07 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.983 0.913 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 139.18 52.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.753 1.221 . . . . 0.0 110.963 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.94 115.82 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.279 1.432 . . . . 0.0 108.313 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 55.16 -73.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.828 2.451 . . . . 0.0 113.754 -167.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.53 7.32 1.71 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.61 1.964 . . . . 0.0 113.515 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -118.88 131.06 56.05 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.964 1.305 . . . . 0.0 111.446 -172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.78 138.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.168 -0.957 . . . . 0.0 111.183 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.78 -26.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -150.64 145.95 26.19 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.519 0.6 . . . . 0.0 110.763 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.7 146.63 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.876 0.87 . . . . 0.0 111.985 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.86 163.19 40.64 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.949 1.3 . . . . 0.0 111.957 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.71 130.82 41.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.899 0.88 . . . . 0.0 111.067 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.4 mt -102.37 143.29 32.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.031 1.332 . . . . 0.0 111.674 170.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -125.44 131.89 24.17 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.682 1.193 . . . . 0.0 110.997 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.5 -29.09 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.748 2.965 . . . . 0.0 113.811 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -27.0 31.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.478 1.111 . . . . 0.0 111.887 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.7 163.73 20.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.242 1.417 . . . . 0.0 111.926 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -106.11 16.16 25.36 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.565 1.546 . . . . 0.0 114.208 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.75 -16.78 59.39 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -46.49 -49.02 19.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.587 1.085 . . . . 0.0 113.574 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.35 -41.79 98.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.442 0.639 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.83 -44.77 80.25 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.669 1.188 . . . . 0.0 110.632 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -62.21 -38.99 91.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.42 1.488 . . . . 0.0 112.172 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -61.7 -54.27 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.39 0.996 . . . . 0.0 110.478 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.69 -38.48 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.806 0.73 . . . . 0.0 111.211 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.44 -32.42 70.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 112.196 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.58 -27.42 68.41 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.704 -1.248 . . . . 0.0 112.187 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.68 -48.69 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.952 0.797 . . . . 0.0 110.07 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.18 -47.35 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.438 1.095 . . . . 0.0 110.031 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.54 -25.69 65.94 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.181 -0.95 . . . . 0.0 112.837 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.78 -48.0 76.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.56 0.744 . . . . 0.0 111.038 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.89 -30.23 61.24 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.079 -1.013 . . . . 0.0 112.285 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.31 -28.3 69.11 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.522 -1.361 . . . . 0.0 113.304 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.82 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.034 0.533 . . . . 0.0 112.002 169.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.52 -21.66 30.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.61 1.164 . . . . 0.0 112.416 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -61.52 -25.69 67.44 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.269 1.827 . . . . 0.0 113.62 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -103.96 -4.3 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.032 1.333 . . . . 0.0 114.179 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.24 -55.92 3.41 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.197 1.399 . . . . 0.0 112.449 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -141.26 -37.38 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -166.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mt -69.72 -18.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.01 -41.57 75.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.86 1.264 . . . . 0.0 112.556 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -69.56 -42.31 74.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.907 0.483 . . . . 0.0 111.307 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.2 92.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.665 0.786 . . . . 0.0 112.427 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.31 -30.78 62.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 tp -73.67 -38.6 64.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.697 0.799 . . . . 0.0 111.738 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -57.33 -26.51 61.06 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -114.69 13.46 17.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.191 1.796 . . . . 0.0 113.448 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.91 53.16 0.32 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.157 1.36 . . . . 0.0 112.476 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.07 157.58 18.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.161 0.982 . . . . 0.0 113.578 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.29 160.34 31.41 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.42 1.088 . . . . 0.0 113.184 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.23 25.15 1.01 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -115.67 -49.76 2.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.27 43.97 2.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.794 1.638 . . . . 0.0 112.113 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.7 -42.69 84.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.556 1.142 . . . . 0.0 113.451 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.254 1.422 . . . . 0.0 112.62 -167.238 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.62 160.72 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.778 1.631 . . . . 0.0 111.779 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -137.88 146.02 42.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.009 1.324 . . . . 0.0 111.059 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 32.28 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.151 1.381 . . . . 0.0 111.76 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 57.48 35.62 26.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.902 . . . . 0.0 112.9 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.8 -51.53 38.44 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 117.507 -1.235 . . . . 0.0 113.499 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -79.55 168.61 19.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.461 2.107 . . . . 0.0 112.939 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.44 144.67 4.1 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.172 1.367 . . . . 0.0 113.426 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -142.96 34.14 1.37 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.94 122.34 13.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.7 m -125.75 140.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.266 1.026 . . . . 0.0 110.5 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.5 59.82 0.63 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.472 1.909 . . . . 0.0 111.965 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.39 44.45 0.51 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.863 1.265 . . . . 0.0 110.342 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.7 p -133.17 133.97 43.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.463 1.505 . . . . 0.0 112.167 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.03 33.4 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -122.57 150.31 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.785 1.634 . . . . 0.0 112.179 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.4 m -59.13 -28.5 66.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.143 0.977 . . . . 0.0 113.603 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.7 -43.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.158 1.383 . . . . 0.0 112.165 167.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.06 -28.62 73.84 Favored Glycine 0 CA--C 1.538 1.509 0 O-C-N 120.43 -1.419 . . . . 0.0 114.505 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -65.95 -37.72 86.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.464 1.105 . . . . 0.0 111.675 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.78 -33.01 58.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.956 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -54.93 -43.18 73.12 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.734 1.152 . . . . 0.0 111.206 173.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -52.21 -54.47 30.51 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.348 0.522 . . . . 0.0 111.965 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -68.33 -44.78 74.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.078 0.951 . . . . 0.0 111.861 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.47 94.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.318 0.647 . . . . 0.0 112.057 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.0 -52.83 62.4 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.506 -0.746 . . . . 0.0 110.398 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.23 -28.24 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.19 -33.24 75.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.712 1.205 . . . . 0.0 113.306 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -111.15 1.18 17.13 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.74 130.3 43.64 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.978 . . . . 0.0 113.162 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.46 137.03 9.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.461 1.905 . . . . 0.0 108.772 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.27 165.41 33.07 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.79 -24.43 25.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -83.68 -170.55 3.12 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.84 1.256 . . . . 0.0 112.266 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -4.84 30.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.191 1.796 . . . . 0.0 113.971 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.73 23.69 70.85 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 120.066 -1.646 . . . . 0.0 115.852 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.33 65.44 8.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.13 -1.218 . . . . 0.0 112.516 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.13 152.72 38.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.173 1.389 . . . . 0.0 114.301 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -137.33 161.25 36.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.938 1.295 . . . . 0.0 111.855 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.31 127.09 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.493 1.517 . . . . 0.0 108.798 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.95 143.63 50.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.122 1.369 . . . . 0.0 108.193 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.57 153.23 51.21 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.695 1.134 . . . . 0.0 113.619 170.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -116.69 116.88 38.33 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 124.094 0.958 . . . . 0.0 109.94 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.93 123.47 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.155 2.57 . . . . 0.0 109.759 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.0 m -140.81 100.35 3.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.137 0.975 . . . . 0.0 110.423 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.55 -10.25 17.26 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.67 -32.39 42.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 113.612 165.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.9 -24.49 0.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.38 -113.7 0.62 Allowed Glycine 0 N--CA 1.474 1.207 0 CA-C-N 120.613 1.551 . . . . 0.0 113.04 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -135.8 143.91 45.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.984 0.914 . . . . 0.0 113.224 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -80.46 132.24 35.69 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.13 131.92 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.084 1.354 . . . . 0.0 108.981 170.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 m -137.27 116.27 12.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.818 1.247 . . . . 0.0 109.221 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.71 129.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.005 0.922 . . . . 0.0 109.43 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -119.07 139.15 52.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.686 1.194 . . . . 0.0 110.823 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.33 1.452 . . . . 0.0 108.291 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.09 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.964 2.506 . . . . 0.0 113.769 -168.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.8 7.44 1.66 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.62 1.968 . . . . 0.0 113.489 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -118.88 131.33 56.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.065 1.346 . . . . 0.0 111.441 -172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.93 137.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.202 -0.936 . . . . 0.0 111.136 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 pt -128.39 -26.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -150.73 146.03 26.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.506 0.593 . . . . 0.0 110.823 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.59 146.89 23.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.958 0.903 . . . . 0.0 111.876 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.67 163.26 40.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.893 1.277 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.18 130.29 41.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.824 0.85 . . . . 0.0 111.065 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -101.4 143.17 31.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 111.65 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.89 130.5 24.4 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.693 1.197 . . . . 0.0 110.91 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.88 -29.04 2.93 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.735 2.957 . . . . 0.0 113.605 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.8 tp -81.19 -25.27 36.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.492 1.117 . . . . 0.0 112.508 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.91 163.27 15.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.259 1.424 . . . . 0.0 112.104 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -100.47 10.18 41.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.108 1.363 . . . . 0.0 114.422 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -46.22 -49.02 17.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.702 1.137 . . . . 0.0 113.41 -170.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.0 -42.1 97.28 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.913 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.82 -45.29 82.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.75 1.22 . . . . 0.0 110.584 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -62.56 -38.8 91.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.704 1.601 . . . . 0.0 112.081 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.29 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.515 1.052 . . . . 0.0 110.417 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.05 -38.67 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.843 0.747 . . . . 0.0 111.199 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.54 70.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 112.206 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.27 68.39 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.723 -1.236 . . . . 0.0 112.224 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.73 -48.69 78.11 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.908 0.776 . . . . 0.0 110.072 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.9 mt -67.99 -47.36 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 110.026 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -67.62 -25.63 65.84 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.277 -0.889 . . . . 0.0 112.861 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.2 m -64.91 -48.43 74.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.702 0.801 . . . . 0.0 111.149 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.92 -29.91 61.1 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.067 -1.021 . . . . 0.0 112.318 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.88 -30.13 68.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.171 1.35 . . . . 0.0 113.19 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.78 -44.03 91.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.151 0.581 . . . . 0.0 111.887 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.14 -23.07 33.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.604 1.162 . . . . 0.0 112.113 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.07 -28.92 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.899 1.68 . . . . 0.0 113.062 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -93.3 -15.0 26.27 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.027 1.331 . . . . 0.0 113.5 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.17 -53.76 4.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.364 1.466 . . . . 0.0 112.465 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -140.64 -39.54 0.42 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -165.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -69.2 -18.98 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.84 0.745 . . . . 0.0 110.71 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.01 -41.45 71.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.226 1.41 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.99 -42.43 69.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.181 0.592 . . . . 0.0 111.335 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.09 87.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.012 0.925 . . . . 0.0 112.054 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.28 -18.86 60.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -84.71 -56.39 3.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 112.084 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -147.16 -22.2 0.4 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -171.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.8 m -89.45 50.79 1.98 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -159.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.93 9.99 85.59 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.061 1.315 . . . . 0.0 116.149 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -109.82 171.83 7.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.323 1.449 . . . . 0.0 113.286 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -58.88 158.07 8.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.691 0.796 . . . . 0.0 112.488 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.86 27.12 0.72 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -85.48 -43.27 13.72 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.19 35.15 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.618 1.167 . . . . 0.0 111.814 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.06 -25.26 25.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -161.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.9 p90 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 128.062 2.545 . . . . 0.0 113.555 -168.742 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.18 134.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.371 1.468 . . . . 0.0 110.199 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -147.93 123.73 10.58 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.142 1.377 . . . . 0.0 110.061 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.46 148.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.834 1.254 . . . . 0.0 109.463 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.3 54.8 0.92 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.466 1.506 . . . . 0.0 112.416 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -73.19 -55.53 3.73 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.596 1.558 . . . . 0.0 112.879 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.82 169.42 14.97 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.539 2.159 . . . . 0.0 112.883 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.99 143.98 3.95 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.305 1.431 . . . . 0.0 113.36 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.255 3.8 pp -143.05 34.05 1.36 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.11 121.5 11.44 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -124.98 140.44 52.92 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.169 0.988 . . . . 0.0 110.549 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -73.27 60.55 0.6 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.356 1.862 . . . . 0.0 111.897 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.96 44.39 0.47 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.618 1.167 . . . . 0.0 110.284 171.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.6 p -134.73 132.22 38.55 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.447 1.499 . . . . 0.0 112.004 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.42 34.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.598 1.159 . . . . 0.0 114.073 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.31 150.64 45.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.756 1.622 . . . . 0.0 111.666 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -57.92 -34.13 69.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.5 pt -92.4 -42.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.651 1.18 . . . . 0.0 112.174 169.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.31 -28.48 73.27 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.251 -1.531 . . . . 0.0 114.46 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -69.2 -38.69 78.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.298 1.049 . . . . 0.0 111.059 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -70.15 -35.0 73.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.418 -0.801 . . . . 0.0 111.187 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.73 -43.64 76.78 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.592 1.087 . . . . 0.0 111.115 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -54.24 -53.55 52.06 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.507 0.594 . . . . 0.0 111.676 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.87 -44.02 82.04 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.932 0.893 . . . . 0.0 111.72 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.43 -43.34 81.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.612 0.765 . . . . 0.0 112.137 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -60.93 -52.12 66.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.433 -0.792 . . . . 0.0 110.442 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.8 p -65.36 -28.35 69.22 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -64.75 -32.85 74.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.475 1.11 . . . . 0.0 113.409 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -110.97 1.29 17.39 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 177.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -62.52 133.74 55.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.251 1.021 . . . . 0.0 112.967 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.77 138.45 14.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.416 1.886 . . . . 0.0 109.005 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p -151.48 153.33 34.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -87.16 -28.38 22.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.064 0.946 . . . . 0.0 113.423 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -82.44 -169.22 2.33 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.0 1.32 . . . . 0.0 112.402 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -4.45 28.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.705 1.602 . . . . 0.0 113.898 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.34 23.38 68.26 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.257 -1.527 . . . . 0.0 115.821 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.82 65.87 8.8 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.209 -1.171 . . . . 0.0 112.587 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.64 152.0 38.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.986 1.315 . . . . 0.0 114.406 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.75 161.73 35.14 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.884 1.274 . . . . 0.0 111.693 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.74 128.1 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.403 1.481 . . . . 0.0 108.86 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -124.94 142.86 51.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.128 1.371 . . . . 0.0 108.325 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.04 153.04 50.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.766 1.166 . . . . 0.0 113.574 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -117.09 116.04 37.97 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 124.228 1.011 . . . . 0.0 110.006 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.63 123.18 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.256 2.637 . . . . 0.0 109.972 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.2 m -140.77 98.6 3.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.342 1.057 . . . . 0.0 110.251 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -10.26 18.15 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.64 -31.12 46.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.034 1.334 . . . . 0.0 113.634 165.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.01 -26.15 0.09 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.45 0.62 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 120.484 1.493 . . . . 0.0 112.796 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.62 144.05 43.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 113.196 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -79.96 133.82 36.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.9 mm -110.81 131.86 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.191 1.397 . . . . 0.0 109.096 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 m -137.69 116.5 12.29 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.746 1.218 . . . . 0.0 109.354 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.15 129.77 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.098 0.959 . . . . 0.0 109.582 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.5 138.45 53.15 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.817 1.247 . . . . 0.0 110.861 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -100.3 116.4 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 108.328 171.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.03 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.987 2.515 . . . . 0.0 113.738 -168.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.3 7.46 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.662 1.985 . . . . 0.0 113.508 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.4 130.28 55.9 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.3 137.92 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.312 -0.868 . . . . 0.0 111.167 173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.33 -26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -150.72 145.9 26.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.537 0.608 . . . . 0.0 110.838 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.52 146.88 23.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.976 0.91 . . . . 0.0 111.976 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -154.54 162.77 40.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.926 1.29 . . . . 0.0 111.729 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.44 130.64 40.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.68 0.792 . . . . 0.0 111.057 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.4 mt -102.27 143.3 32.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.071 1.349 . . . . 0.0 111.782 170.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.3 131.67 24.22 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.935 1.294 . . . . 0.0 110.721 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.21 -29.67 2.44 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 113.534 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.06 -28.23 27.74 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.337 1.055 . . . . 0.0 112.627 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -84.51 163.37 19.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.792 1.237 . . . . 0.0 111.962 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -106.96 19.87 19.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.603 1.561 . . . . 0.0 115.083 -173.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.84 -15.74 56.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -46.87 -48.53 21.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.602 1.092 . . . . 0.0 113.639 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.06 -41.91 99.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.431 0.634 . . . . 0.0 111.895 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.75 -44.47 81.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.625 1.17 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.6 m -62.2 -39.09 91.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.112 1.365 . . . . 0.0 112.165 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.9 -53.81 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.304 0.956 . . . . 0.0 110.473 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.92 -38.44 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.818 0.736 . . . . 0.0 111.256 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.45 -32.51 70.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.506 0.722 . . . . 0.0 112.214 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.62 68.76 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.703 -1.248 . . . . 0.0 112.274 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.43 -48.36 80.04 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.825 0.739 . . . . 0.0 110.14 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.55 -47.04 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.43 1.092 . . . . 0.0 109.89 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.65 -24.61 65.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.044 -1.035 . . . . 0.0 113.038 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.2 m -65.55 -46.93 77.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.699 0.8 . . . . 0.0 111.434 170.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -74.04 -30.9 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.665 1.121 . . . . 0.0 112.157 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.54 -26.69 68.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.713 1.142 . . . . 0.0 113.769 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.847 0.459 . . . . 0.0 111.957 167.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.6 mt -82.7 -20.04 36.87 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.563 1.145 . . . . 0.0 112.387 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -63.3 -27.9 69.64 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.118 2.167 . . . . 0.0 113.174 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -94.41 -18.38 21.6 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -85.51 -56.75 3.36 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.142 1.377 . . . . 0.0 112.945 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.8 -40.32 0.45 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 mt -65.4 -21.83 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.317 0.58 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -47.38 -39.11 14.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.277 2.231 . . . . 0.0 113.482 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.41 -31.6 54.21 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.726 0.811 . . . . 0.0 112.554 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.5 61.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.883 0.873 . . . . 0.0 112.05 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.39 -20.89 59.9 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.43 -26.56 68.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 113.699 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.5 m 52.5 65.49 1.49 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.354 1.461 . . . . 0.0 112.966 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.3 p -65.79 -19.04 65.74 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.95 -1.0 87.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.091 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -77.75 163.27 26.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.342 1.057 . . . . 0.0 111.771 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.24 137.49 58.24 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.487 -0.758 . . . . 0.0 112.102 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.01 34.94 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.891 1.276 . . . . 0.0 112.112 166.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.33 123.19 47.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.171 1.388 . . . . 0.0 111.907 -162.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t0 54.34 35.93 24.12 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.007 1.723 . . . . 0.0 113.743 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.88 -30.5 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.249 1.82 . . . . 0.0 112.086 -174.791 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.53 127.81 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.12 1.368 . . . . 0.0 110.497 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -139.96 144.74 37.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.391 1.876 . . . . 0.0 110.31 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.99 148.5 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.358 1.463 . . . . 0.0 109.163 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.14 53.55 0.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.04 1.336 . . . . 0.0 112.69 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.18 -55.39 3.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.909 1.684 . . . . 0.0 112.981 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -81.59 169.57 15.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.605 2.203 . . . . 0.0 112.908 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.48 143.07 3.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.205 1.384 . . . . 0.0 113.357 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.5 34.54 1.3 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mt -59.1 122.25 13.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.1 m -125.55 141.23 52.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.038 0.935 . . . . 0.0 110.467 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -72.78 60.19 0.5 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.581 1.952 . . . . 0.0 111.858 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -78.0 43.65 0.44 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.959 1.304 . . . . 0.0 110.463 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.4 p -132.94 134.16 44.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.66 1.584 . . . . 0.0 111.879 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.44 35.31 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 124.695 1.198 . . . . 0.0 113.985 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.98 152.35 44.3 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.687 1.595 . . . . 0.0 111.588 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 p -59.26 -36.33 75.32 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.281 -0.887 . . . . 0.0 113.231 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -90.88 -41.18 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.491 1.516 . . . . 0.0 111.721 171.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 -29.13 73.28 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.373 -1.454 . . . . 0.0 114.159 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -68.41 -37.28 80.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.243 1.021 . . . . 0.0 111.346 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.66 -35.63 67.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.634 -0.667 . . . . 0.0 111.237 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.74 -43.12 76.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.544 1.065 . . . . 0.0 111.193 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -53.12 -54.12 40.42 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.383 0.538 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -67.67 -44.58 77.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.045 0.938 . . . . 0.0 111.753 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.86 90.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.283 0.633 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -61.72 -52.17 65.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.893 0.77 . . . . 0.0 110.368 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.8 p -65.26 -28.58 69.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -64.66 -32.98 74.89 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.502 1.121 . . . . 0.0 113.339 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -110.78 1.08 17.57 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -62.8 131.78 50.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.184 0.993 . . . . 0.0 112.742 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.25 137.69 12.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.432 1.893 . . . . 0.0 108.861 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -152.27 157.17 41.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.11 -19.19 22.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -89.1 -168.01 2.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.29 1.436 . . . . 0.0 111.903 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -5.54 39.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.335 1.454 . . . . 0.0 113.879 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.91 23.93 67.96 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.387 -1.446 . . . . 0.0 115.93 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.43 66.84 9.64 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.115 -1.227 . . . . 0.0 112.355 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.34 152.04 39.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.942 1.297 . . . . 0.0 114.478 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.41 161.08 36.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 111.764 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -117.88 126.77 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.419 1.488 . . . . 0.0 108.77 -171.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.87 144.03 49.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.035 1.334 . . . . 0.0 108.225 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.17 152.46 50.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.583 1.083 . . . . 0.0 113.376 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -116.54 117.24 38.35 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.036 0.934 . . . . 0.0 109.795 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.31 125.39 6.36 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.97 2.447 . . . . 0.0 110.063 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.1 m -141.24 89.95 2.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.558 1.143 . . . . 0.0 109.996 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.04 -10.62 14.87 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.11 -28.65 54.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.11 1.364 . . . . 0.0 113.711 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.67 -28.0 0.13 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.25 -113.68 0.64 Allowed Glycine 0 N--CA 1.474 1.187 0 CA-C-N 120.288 1.404 . . . . 0.0 112.658 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 p -136.85 144.43 43.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.125 0.97 . . . . 0.0 113.124 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.34 133.3 35.92 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.85 132.07 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.925 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.2 m -137.99 115.38 11.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.767 1.227 . . . . 0.0 109.15 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 130.12 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.942 0.897 . . . . 0.0 109.447 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -119.67 139.41 52.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.74 1.216 . . . . 0.0 110.955 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.25 115.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.308 1.443 . . . . 0.0 108.258 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 55.48 -72.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.91 2.484 . . . . 0.0 113.712 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.76 7.3 1.66 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.722 2.009 . . . . 0.0 113.647 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -119.1 130.75 55.75 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.001 1.32 . . . . 0.0 111.428 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.38 138.25 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.171 -0.956 . . . . 0.0 111.242 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.56 -27.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -150.34 145.78 26.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.525 0.602 . . . . 0.0 110.777 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.36 146.61 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.901 0.881 . . . . 0.0 112.064 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.36 163.41 40.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.831 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.58 130.02 42.57 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.72 0.808 . . . . 0.0 111.243 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.9 mt -101.99 143.0 32.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.009 1.324 . . . . 0.0 111.685 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.78 132.55 24.33 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.637 1.175 . . . . 0.0 111.132 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.37 -29.84 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.641 2.894 . . . . 0.0 114.016 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.24 -16.55 37.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.983 0.913 . . . . 0.0 113.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -89.57 163.23 15.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.707 1.203 . . . . 0.0 111.86 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -104.03 15.76 27.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -79.28 -16.81 55.84 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -46.76 -49.04 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.756 1.162 . . . . 0.0 113.2 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.17 -41.86 99.31 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.625 -0.672 . . . . 0.0 111.858 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.79 -44.34 81.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.707 1.203 . . . . 0.0 110.656 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -62.37 -38.95 91.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.297 1.439 . . . . 0.0 112.258 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.53 -54.1 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.329 0.968 . . . . 0.0 110.477 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.89 -38.6 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.747 0.703 . . . . 0.0 111.197 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.32 -32.56 70.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.533 0.733 . . . . 0.0 112.091 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.48 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.748 -1.22 . . . . 0.0 112.186 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.78 -48.54 78.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.018 0.826 . . . . 0.0 110.035 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.1 mt -67.91 -47.22 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.36 1.064 . . . . 0.0 109.963 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -68.02 -25.38 65.36 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.01 -1.056 . . . . 0.0 112.946 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 m -64.68 -47.27 79.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.628 0.771 . . . . 0.0 111.286 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.78 -31.31 63.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.684 1.129 . . . . 0.0 112.227 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.87 -27.04 68.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.731 1.151 . . . . 0.0 113.715 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.9 90.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 122.075 -0.391 . . . . 0.0 111.827 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.53 -20.49 33.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.364 1.065 . . . . 0.0 112.855 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -61.69 -28.79 69.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 112.577 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.267 0.2 OUTLIER -108.62 1.26 21.2 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 175.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -90.21 -55.58 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.439 1.496 . . . . 0.0 112.027 171.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -139.66 -39.38 0.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -166.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.42 -19.04 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 119.18 0.9 . . . . 0.0 110.586 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.53 -38.56 63.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.489 1.116 . . . . 0.0 112.276 169.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -66.41 -27.8 68.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 112.861 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.76 -40.77 14.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.233 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.22 -29.61 42.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.66 -52.54 50.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.835 0.854 . . . . 0.0 112.029 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -155.32 -71.01 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 0.0 111.9 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -175.87 106.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.707 2.003 . . . . 0.0 110.401 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.82 28.33 72.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.478 1.037 . . . . 0.0 114.265 172.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.7 170.74 4.85 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.362 1.465 . . . . 0.0 114.219 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -65.44 161.54 19.71 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.577 -0.702 . . . . 0.0 112.622 167.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.87 29.71 1.68 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.307 1.043 . . . . 0.0 112.5 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.31 125.14 39.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.291 1.037 . . . . 0.0 112.355 -165.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 55.74 29.35 13.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.157 1.783 . . . . 0.0 113.964 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -74.74 -25.95 59.45 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -172.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.456 1.902 . . . . 0.0 112.096 -173.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.38 160.47 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.661 1.584 . . . . 0.0 111.88 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 158.3 33.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 112.277 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.39 150.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.007 1.323 . . . . 0.0 109.833 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.54 45.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.551 1.941 . . . . 0.0 114.231 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.95 -53.44 34.19 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.776 1.63 . . . . 0.0 113.11 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.26 169.05 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.433 2.089 . . . . 0.0 112.876 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.48 143.61 4.06 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.298 1.427 . . . . 0.0 113.433 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.253 3.7 pp -143.67 34.54 1.28 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.9 122.72 14.34 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.7 m -125.38 140.79 52.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.3 1.04 . . . . 0.0 110.54 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -73.05 60.38 0.55 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.476 1.91 . . . . 0.0 111.885 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -78.17 43.53 0.45 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.429 171.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.3 p -132.96 134.79 44.98 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.559 1.544 . . . . 0.0 111.987 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.7 34.12 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 124.686 1.194 . . . . 0.0 114.059 -169.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -124.75 150.35 46.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.475 1.51 . . . . 0.0 111.741 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -57.94 -33.9 69.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.391 -0.818 . . . . 0.0 113.158 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -92.4 -41.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.713 1.205 . . . . 0.0 112.295 170.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.71 -28.94 73.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.552 -1.343 . . . . 0.0 114.184 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -67.37 -38.06 84.17 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.519 -0.989 . . . . 0.0 111.458 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -73.08 -35.37 66.63 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.489 -0.757 . . . . 0.0 111.245 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -55.86 -43.44 77.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.336 0.971 . . . . 0.0 111.239 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.92 -54.18 38.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.362 0.528 . . . . 0.0 111.776 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -67.77 -44.45 77.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.998 0.919 . . . . 0.0 111.775 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.56 87.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.363 0.665 . . . . 0.0 112.143 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.6 -52.35 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.854 0.752 . . . . 0.0 110.327 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.7 p -65.16 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -63.95 -33.25 75.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.587 1.155 . . . . 0.0 113.344 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -110.92 2.86 18.38 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -65.56 124.07 21.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.964 0.905 . . . . 0.0 113.15 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -149.96 137.91 20.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.198 2.199 . . . . 0.0 108.302 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -153.47 164.75 37.65 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -84.64 -27.68 26.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -82.67 -169.62 2.57 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.23 1.412 . . . . 0.0 112.462 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -6.43 44.48 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.948 1.699 . . . . 0.0 113.947 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.37 24.36 72.18 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.176 -1.578 . . . . 0.0 115.833 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -84.31 67.06 9.68 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.182 -1.187 . . . . 0.0 112.371 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.4 152.8 39.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.026 1.33 . . . . 0.0 114.482 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.95 161.61 35.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.868 1.267 . . . . 0.0 111.848 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.75 127.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.571 1.548 . . . . 0.0 108.878 -170.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -123.99 143.67 50.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.168 1.387 . . . . 0.0 108.299 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -132.65 152.65 51.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.701 1.137 . . . . 0.0 113.749 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -118.71 113.75 36.12 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.588 1.155 . . . . 0.0 110.085 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.54 134.07 8.6 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.269 2.646 . . . . 0.0 110.622 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 p -149.48 120.52 7.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.248 1.023 . . . . 0.0 112.504 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -12.67 57.83 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -51.61 -35.19 40.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.61 1.564 . . . . 0.0 113.624 168.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.05 -25.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.1 -112.82 0.58 Allowed Glycine 0 N--CA 1.474 1.167 0 CA-C-N 120.772 1.624 . . . . 0.0 113.395 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 p -139.0 144.18 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.094 0.958 . . . . 0.0 113.292 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -80.64 133.01 35.67 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 158.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.23 132.18 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.265 1.426 . . . . 0.0 109.192 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.2 m -137.42 116.05 12.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 109.283 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.89 130.07 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.052 0.941 . . . . 0.0 109.524 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 p -119.87 139.07 52.95 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.807 1.243 . . . . 0.0 110.984 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.58 116.09 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.412 1.485 . . . . 0.0 108.329 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.936 2.494 . . . . 0.0 113.786 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.54 1.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.556 1.942 . . . . 0.0 113.516 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -119.28 131.47 55.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.024 1.33 . . . . 0.0 111.558 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.76 138.62 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.167 -0.958 . . . . 0.0 111.316 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.74 -26.97 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -150.81 146.2 26.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.634 0.652 . . . . 0.0 110.853 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.83 146.71 23.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.982 0.913 . . . . 0.0 112.017 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.4 164.62 38.48 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.979 1.312 . . . . 0.0 111.911 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.71 132.67 40.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.899 0.88 . . . . 0.0 111.389 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -104.45 145.05 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.424 . . . . 0.0 112.451 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -126.58 130.86 23.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.115 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.73 -31.26 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.701 2.934 . . . . 0.0 114.067 -173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -82.61 -24.37 33.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.025 . . . . 0.0 112.574 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -86.26 150.66 24.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 111.717 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -86.35 2.83 46.03 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -83.66 -5.29 59.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -48.35 -46.71 37.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.834 1.254 . . . . 0.0 113.109 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.03 -42.08 99.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.578 0.704 . . . . 0.0 111.477 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -42.08 77.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.954 0.902 . . . . 0.0 110.693 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.7 m -60.34 -40.5 90.92 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 112.191 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.22 -53.62 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.192 0.905 . . . . 0.0 110.472 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -38.76 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.791 0.723 . . . . 0.0 111.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.8 -31.96 68.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.59 0.756 . . . . 0.0 112.121 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 -27.3 68.56 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.814 -1.179 . . . . 0.0 112.277 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.77 -48.61 78.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.795 0.725 . . . . 0.0 110.059 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.86 -47.43 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 110.076 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.57 -25.43 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.274 -0.891 . . . . 0.0 112.928 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -65.02 -47.87 75.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.561 0.744 . . . . 0.0 111.193 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.11 -29.81 60.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.3 0.954 . . . . 0.0 112.213 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.9 -30.51 69.07 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.539 -1.351 . . . . 0.0 113.484 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.21 95.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.03 0.532 . . . . 0.0 111.998 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.74 -22.3 29.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.901 1.28 . . . . 0.0 112.188 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -61.59 -29.21 69.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.826 1.65 . . . . 0.0 113.042 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -98.77 -7.02 28.26 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.573 1.149 . . . . 0.0 113.776 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.43 -53.61 4.59 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.385 1.474 . . . . 0.0 112.098 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -141.08 -39.56 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -166.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.5 mt -69.12 -19.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.813 0.733 . . . . 0.0 110.791 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -42.87 80.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.734 1.214 . . . . 0.0 112.412 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -69.52 -40.32 76.99 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.963 0.505 . . . . 0.0 111.462 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.85 75.41 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.422 0.689 . . . . 0.0 111.816 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 pp -69.93 -34.12 73.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.84 -41.76 91.33 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.635 0.774 . . . . 0.0 111.036 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -30.84 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -168.98 108.83 0.47 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.534 1.533 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.09 67.2 1.04 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.545 168.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.24 159.6 9.63 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.912 0.863 . . . . 0.0 113.097 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -70.84 158.64 36.02 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.241 1.016 . . . . 0.0 113.685 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.85 25.54 0.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -148.11 -62.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.38 -0.825 . . . . 0.0 113.075 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -85.76 46.21 1.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.426 1.09 . . . . 0.0 112.485 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.87 -28.05 55.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.057 1.343 . . . . 0.0 114.489 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.239 1.816 . . . . 0.0 113.029 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.69 150.04 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.064 1.346 . . . . 0.0 111.257 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.92 161.78 35.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.956 1.702 . . . . 0.0 112.351 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.23 148.33 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.201 1.4 . . . . 0.0 109.43 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.67 52.78 0.3 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.474 1.91 . . . . 0.0 113.471 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.78 -52.67 31.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.169 1.788 . . . . 0.0 112.921 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.16 168.55 18.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.43 2.087 . . . . 0.0 112.734 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.58 144.11 4.12 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.245 1.402 . . . . 0.0 113.326 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.01 35.69 1.25 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.4 110.33 1.41 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.096 0.558 . . . . 0.0 110.049 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.0 m -111.45 139.85 46.53 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.752 0.821 . . . . 0.0 110.827 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -71.4 59.74 0.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.601 1.96 . . . . 0.0 111.985 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.32 44.89 0.53 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.627 1.171 . . . . 0.0 110.273 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.4 p -133.2 134.3 43.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.549 1.54 . . . . 0.0 112.047 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.71 35.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 0.0 113.996 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.19 151.3 46.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.826 1.65 . . . . 0.0 111.417 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p -58.28 -35.76 72.27 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.298 -0.877 . . . . 0.0 113.224 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.29 -41.69 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 0.0 111.841 171.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.37 -29.13 73.88 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 120.399 -1.438 . . . . 0.0 114.117 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -67.93 -35.88 79.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.446 1.098 . . . . 0.0 111.706 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.36 -35.51 61.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.375 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -55.69 -42.52 75.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.42 1.009 . . . . 0.0 111.448 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -51.23 -53.5 34.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.422 0.555 . . . . 0.0 111.972 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.45 -44.21 65.22 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.921 0.889 . . . . 0.0 112.007 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.84 97.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.058 0.543 . . . . 0.0 112.037 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.54 -52.42 63.51 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.588 -0.695 . . . . 0.0 110.404 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.0 p -65.91 -28.09 68.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.91 -33.19 75.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.922 1.289 . . . . 0.0 113.355 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.17 0.83 16.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 177.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -63.01 132.71 52.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.178 0.991 . . . . 0.0 112.908 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -156.57 139.02 14.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.434 1.894 . . . . 0.0 108.953 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -151.08 153.37 34.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.61 -27.98 23.53 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.84 -169.94 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.866 1.266 . . . . 0.0 112.128 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -5.16 31.37 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.781 1.632 . . . . 0.0 113.828 -174.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.09 23.13 69.45 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.238 -1.539 . . . . 0.0 115.801 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.63 66.28 8.9 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.142 -1.21 . . . . 0.0 112.626 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.96 152.08 38.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.854 1.262 . . . . 0.0 114.378 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.34 160.42 38.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.873 1.269 . . . . 0.0 111.927 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.37 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.504 1.522 . . . . 0.0 108.864 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.67 142.87 49.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.142 1.377 . . . . 0.0 108.264 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -130.66 153.22 49.18 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.652 1.115 . . . . 0.0 113.501 169.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -119.78 114.82 33.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.752 1.221 . . . . 0.0 109.663 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.15 126.67 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.131 2.554 . . . . 0.0 110.209 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.2 m -140.64 92.62 2.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.638 1.175 . . . . 0.0 109.995 -171.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -10.73 14.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -53.91 -30.74 47.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.964 1.306 . . . . 0.0 113.602 165.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.6 -25.69 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.98 -114.77 0.67 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.492 1.496 . . . . 0.0 113.063 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.4 p -137.39 145.38 43.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.355 1.062 . . . . 0.0 113.236 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -82.32 132.99 35.22 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.8 mm -109.33 132.08 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 109.028 170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.9 m -137.16 116.36 12.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.811 1.244 . . . . 0.0 109.138 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.96 129.44 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.064 0.946 . . . . 0.0 109.432 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 p -119.23 138.61 52.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.796 1.238 . . . . 0.0 110.856 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.45 116.82 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.228 1.411 . . . . 0.0 108.254 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.02 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.883 2.473 . . . . 0.0 113.643 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.45 7.12 1.72 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.554 1.942 . . . . 0.0 113.551 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -116.47 130.33 56.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.112 1.365 . . . . 0.0 111.291 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.91 138.0 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.22 -0.925 . . . . 0.0 111.217 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.74 -26.61 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -151.01 146.02 25.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.593 0.633 . . . . 0.0 110.885 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -154.71 145.95 22.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.985 0.914 . . . . 0.0 112.013 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -154.98 165.09 37.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.848 1.259 . . . . 0.0 111.93 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.64 131.93 41.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.885 0.874 . . . . 0.0 111.275 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.9 144.1 31.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.133 1.373 . . . . 0.0 111.832 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -125.92 132.95 24.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.821 1.249 . . . . 0.0 110.862 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.58 -30.85 1.74 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.762 2.975 . . . . 0.0 113.692 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.6 -32.67 28.27 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.459 1.103 . . . . 0.0 112.306 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -79.1 163.94 24.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.806 1.242 . . . . 0.0 111.665 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.99 17.8 23.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.49 -17.05 54.95 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.28 -48.66 24.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.862 1.21 . . . . 0.0 113.559 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.47 -41.38 98.61 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.632 -0.667 . . . . 0.0 112.0 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -67.15 -44.81 78.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.635 1.174 . . . . 0.0 110.654 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.9 m -61.98 -38.95 90.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.325 1.45 . . . . 0.0 112.134 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.38 -54.55 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.295 0.952 . . . . 0.0 110.5 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.93 -38.51 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 111.203 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.51 70.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 112.207 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.62 68.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.782 -1.198 . . . . 0.0 112.194 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.65 -48.6 78.62 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.863 0.756 . . . . 0.0 110.113 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.5 mt -68.36 -47.37 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.35 -25.6 66.07 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.216 -0.928 . . . . 0.0 112.959 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.6 m -65.27 -47.86 75.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 111.168 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.02 -29.81 60.93 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.008 -1.057 . . . . 0.0 112.243 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.89 -29.26 69.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.279 1.399 . . . . 0.0 113.207 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.13 91.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.086 0.554 . . . . 0.0 111.961 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.95 -21.81 33.96 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.09 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.91 -28.36 70.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.905 1.682 . . . . 0.0 112.978 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -96.49 -10.85 26.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.912 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -88.88 -54.19 4.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.398 1.479 . . . . 0.0 112.515 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -138.77 -39.82 0.5 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 mt -68.82 -18.46 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.848 0.749 . . . . 0.0 110.577 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.62 -40.44 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.366 1.466 . . . . 0.0 112.47 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -72.7 -39.39 67.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.257 0.623 . . . . 0.0 111.822 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.29 82.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.336 0.654 . . . . 0.0 111.923 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.0 -33.07 70.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.6 tp -62.6 -43.06 99.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 110.803 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -69.62 -35.26 75.09 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.1 m -156.54 97.28 1.72 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.249 1.82 . . . . 0.0 109.921 -171.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.55 63.74 0.82 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.305 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.28 157.99 5.85 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.56 159.99 33.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.247 1.019 . . . . 0.0 113.218 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.74 1.36 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -108.27 -47.04 3.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.494 1.118 . . . . 0.0 113.469 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.77 58.93 1.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.507 1.123 . . . . 0.0 111.508 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.68 -40.86 93.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.908 1.683 . . . . 0.0 112.121 -176.511 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -147.87 147.15 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.108 1.363 . . . . 0.0 111.144 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -133.47 146.22 50.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 0.0 111.785 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.52 24.39 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 56.9 38.36 29.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.059 1.744 . . . . 0.0 112.937 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.17 -52.35 15.9 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.587 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.1 168.7 18.5 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.329 2.019 . . . . 0.0 112.979 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.14 143.53 3.93 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.198 1.38 . . . . 0.0 113.171 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.49 34.0 1.46 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 121.89 12.44 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.7 m -125.34 141.12 52.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.267 1.027 . . . . 0.0 110.565 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.55 60.33 0.47 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 111.898 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -77.87 44.29 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.958 1.303 . . . . 0.0 110.418 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 76.4 p -132.97 138.87 47.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.76 1.624 . . . . 0.0 111.847 -171.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.03 38.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.705 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -127.58 150.34 49.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.346 1.459 . . . . 0.0 112.121 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -59.8 -28.13 67.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.207 1.003 . . . . 0.0 113.659 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.78 -42.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.115 1.366 . . . . 0.0 112.057 167.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.33 -28.44 73.67 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.55 -1.344 . . . . 0.0 114.661 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -67.41 -37.03 82.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.428 1.114 . . . . 0.0 111.674 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.96 -33.19 59.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.49 -0.756 . . . . 0.0 111.785 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -55.05 -43.61 73.96 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.733 1.151 . . . . 0.0 111.139 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -52.27 -53.86 38.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.501 0.591 . . . . 0.0 112.015 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -67.76 -45.09 75.88 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.085 0.954 . . . . 0.0 111.902 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.68 91.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 112.191 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.85 -52.23 64.97 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.523 -0.736 . . . . 0.0 110.277 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.5 p -65.52 -28.4 69.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -64.2 -32.76 74.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.594 1.157 . . . . 0.0 113.415 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.39 1.65 17.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -63.02 131.7 49.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.127 0.971 . . . . 0.0 113.073 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -157.75 132.67 8.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.498 1.919 . . . . 0.0 108.754 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.7 p -149.63 154.77 39.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.43 -23.39 24.52 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -85.12 -169.13 2.5 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.833 1.253 . . . . 0.0 111.823 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.74 -5.08 31.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.418 1.487 . . . . 0.0 113.846 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.95 23.63 69.55 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.208 -1.557 . . . . 0.0 115.799 170.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -84.1 66.71 9.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.182 -1.187 . . . . 0.0 112.565 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.52 152.59 39.0 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.956 1.303 . . . . 0.0 114.43 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.47 161.25 36.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 111.974 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.65 125.68 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.553 1.541 . . . . 0.0 108.895 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.82 143.45 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 108.075 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -129.7 160.11 34.4 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.565 1.075 . . . . 0.0 113.144 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 116.63 21.19 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.591 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.87 134.18 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.752 2.301 . . . . 0.0 111.159 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -153.07 120.26 5.84 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.418 0.687 . . . . 0.0 112.53 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -9.6 42.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -54.97 -31.53 60.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.981 1.313 . . . . 0.0 113.471 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.53 -27.78 0.08 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.17 -113.49 0.71 Allowed Glycine 0 N--CA 1.474 1.23 0 CA-C-N 120.674 1.579 . . . . 0.0 113.006 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 p -137.83 143.04 40.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.298 1.039 . . . . 0.0 113.003 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -75.31 137.34 41.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 156.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 131.62 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.167 1.387 . . . . 0.0 108.86 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -137.45 115.62 11.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.052 1.341 . . . . 0.0 109.035 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.64 129.61 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.979 0.912 . . . . 0.0 109.478 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -119.09 138.48 52.85 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.806 1.242 . . . . 0.0 110.904 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.76 116.68 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.256 1.422 . . . . 0.0 108.334 171.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.16 -73.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.907 2.483 . . . . 0.0 113.788 -167.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -143.3 7.93 1.58 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.607 1.963 . . . . 0.0 113.42 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -119.12 130.49 55.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.171 1.389 . . . . 0.0 111.469 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.17 138.41 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.214 -0.929 . . . . 0.0 111.269 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.6 -26.83 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -150.67 146.08 26.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.67 0.668 . . . . 0.0 110.856 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.33 146.7 23.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.878 0.871 . . . . 0.0 111.992 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.43 164.35 38.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.949 1.3 . . . . 0.0 111.533 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.23 130.1 44.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.605 0.762 . . . . 0.0 111.297 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.2 mt -100.18 144.16 29.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.037 1.335 . . . . 0.0 111.751 171.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -124.51 130.5 24.28 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.699 1.2 . . . . 0.0 111.152 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.99 -27.16 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.586 2.858 . . . . 0.0 113.749 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.53 -13.67 45.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.177 0.991 . . . . 0.0 113.195 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -101.05 161.82 13.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.417 1.487 . . . . 0.0 111.85 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -102.79 14.6 31.54 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -71.1 -17.34 62.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -45.86 -48.84 15.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.522 -171.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.77 -42.05 97.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.628 -0.67 . . . . 0.0 111.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.99 -45.43 81.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.768 1.227 . . . . 0.0 110.696 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.8 m -62.48 -38.76 91.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.644 1.578 . . . . 0.0 112.165 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.37 -54.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.446 1.021 . . . . 0.0 110.255 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.07 -38.8 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 118.712 0.687 . . . . 0.0 111.233 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.28 70.14 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.502 0.721 . . . . 0.0 112.241 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.43 -27.63 68.66 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.704 -1.248 . . . . 0.0 112.159 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.6 -48.37 79.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.926 0.784 . . . . 0.0 110.195 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.55 -47.43 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 110.013 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -67.27 -25.75 66.22 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 112.911 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.8 m -64.94 -47.75 76.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.638 0.775 . . . . 0.0 111.242 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.85 -29.6 61.09 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.539 1.063 . . . . 0.0 112.264 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -28.55 69.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.405 -1.434 . . . . 0.0 113.15 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.64 91.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.189 0.595 . . . . 0.0 112.331 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.1 -21.27 26.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 112.477 -174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -61.58 -29.16 69.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.947 1.699 . . . . 0.0 113.064 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -100.2 -4.35 29.69 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.615 1.166 . . . . 0.0 113.794 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -89.3 -53.62 4.47 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.196 1.398 . . . . 0.0 111.845 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -143.08 -37.89 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.23 -20.78 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 119.324 0.965 . . . . 0.0 110.701 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -35.32 65.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.942 1.297 . . . . 0.0 112.827 171.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.3 -43.0 61.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.14 75.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.56 -30.27 69.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.417 -0.802 . . . . 0.0 112.809 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.56 -41.83 59.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.638 1.175 . . . . 0.0 111.639 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t -66.06 -20.72 66.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.736 0.815 . . . . 0.0 112.72 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -97.55 34.05 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.068 1.747 . . . . 0.0 111.411 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.44 40.82 1.56 Allowed Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.139 1.828 . . . . 0.0 114.58 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.67 163.61 26.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.123 1.369 . . . . 0.0 113.737 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.86 156.85 38.45 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.4 25.81 0.6 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.97 1.308 . . . . 0.0 112.887 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.39 -33.25 17.98 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.94 26.09 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.926 1.291 . . . . 0.0 112.715 -172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -74.4 -30.03 61.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.133 0.973 . . . . 0.0 113.407 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.481 1.912 . . . . 0.0 111.823 -177.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.77 -34.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -144.65 123.48 12.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.234 . . . . 0.0 110.39 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.91 149.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.255 1.422 . . . . 0.0 109.397 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.09 42.97 0.12 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.305 1.842 . . . . 0.0 114.42 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.75 -53.16 29.44 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.758 1.623 . . . . 0.0 113.294 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.08 168.47 18.8 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.213 1.942 . . . . 0.0 112.774 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.34 143.89 4.18 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.281 1.419 . . . . 0.0 113.341 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.32 34.62 1.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.17 120.9 10.06 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.7 m -120.65 137.35 54.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.384 1.074 . . . . 0.0 110.312 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -75.39 67.2 1.93 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.893 1.677 . . . . 0.0 111.412 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -2.69 19.17 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.343 -0.848 . . . . 0.0 112.893 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -92.02 139.07 31.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.279 1.432 . . . . 0.0 113.154 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.68 35.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 122.457 1.122 . . . . 0.0 113.67 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -120.95 151.61 39.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.944 1.698 . . . . 0.0 111.681 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -59.56 -29.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.271 1.028 . . . . 0.0 113.602 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.79 -42.68 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.628 1.571 . . . . 0.0 111.835 168.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.41 -28.02 73.59 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.483 -1.386 . . . . 0.0 114.485 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -66.2 -40.37 90.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.642 1.221 . . . . 0.0 111.302 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.78 -31.96 65.26 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.396 -0.815 . . . . 0.0 112.114 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -55.06 -44.07 74.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.805 1.184 . . . . 0.0 111.126 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.63 -53.89 45.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.359 0.527 . . . . 0.0 111.713 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -66.5 -45.01 80.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.21 1.004 . . . . 0.0 111.615 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.89 -43.19 84.1 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.11 -52.4 65.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.961 0.801 . . . . 0.0 110.448 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.5 p -65.39 -28.33 69.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.46 -32.96 74.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.46 1.104 . . . . 0.0 113.409 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -111.13 1.2 17.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.82 129.62 40.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 113.235 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.67 137.04 9.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.499 1.919 . . . . 0.0 108.715 171.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.04 165.54 33.46 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.04 -28.03 29.89 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -83.34 -169.2 2.42 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.346 1.458 . . . . 0.0 112.552 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 -6.71 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.915 1.686 . . . . 0.0 113.895 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.71 24.29 72.65 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 120.166 -1.584 . . . . 0.0 115.735 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.02 67.37 9.63 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.201 -1.176 . . . . 0.0 112.282 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.74 153.83 38.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.98 1.312 . . . . 0.0 114.364 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -139.07 160.93 38.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.01 1.324 . . . . 0.0 111.903 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -118.05 130.35 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.32 1.448 . . . . 0.0 108.932 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.93 139.99 51.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.828 1.251 . . . . 0.0 108.192 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -130.07 153.19 48.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.622 1.101 . . . . 0.0 113.957 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 115.7 41.98 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.267 1.027 . . . . 0.0 109.97 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 121.81 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.2 2.6 . . . . 0.0 109.648 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -139.51 99.61 3.77 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.035 0.934 . . . . 0.0 110.441 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.39 -9.96 14.74 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.47 -33.29 43.96 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.045 1.338 . . . . 0.0 113.427 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 -23.28 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.41 -114.42 0.65 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.742 1.61 . . . . 0.0 113.102 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 p -136.32 143.6 44.22 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.959 0.904 . . . . 0.0 113.271 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -81.65 130.83 35.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 160.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.21 131.92 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.18 1.392 . . . . 0.0 109.152 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 m -137.69 116.51 12.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.879 1.272 . . . . 0.0 109.222 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.51 129.96 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.112 0.965 . . . . 0.0 109.447 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.2 139.49 51.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.834 1.254 . . . . 0.0 110.906 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.19 116.73 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.362 1.465 . . . . 0.0 108.371 172.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.83 -72.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.887 2.475 . . . . 0.0 113.854 -167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -143.18 7.7 1.59 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.577 1.951 . . . . 0.0 113.462 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -118.69 131.32 56.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.072 1.349 . . . . 0.0 111.471 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.65 138.26 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.129 -0.982 . . . . 0.0 111.282 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 pt -128.73 -27.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.34 145.74 26.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.577 0.626 . . . . 0.0 110.752 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.4 146.71 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.906 0.882 . . . . 0.0 111.815 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.61 163.08 40.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.892 1.277 . . . . 0.0 111.816 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.85 130.7 41.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.836 0.855 . . . . 0.0 111.057 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.1 mt -101.58 142.95 32.17 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.031 1.332 . . . . 0.0 111.648 170.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 131.13 24.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.761 1.224 . . . . 0.0 110.908 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 -29.41 2.33 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.732 2.955 . . . . 0.0 113.684 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -81.64 -28.38 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.266 1.026 . . . . 0.0 112.497 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.61 163.25 19.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.097 1.359 . . . . 0.0 111.94 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -106.06 18.69 21.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.49 1.516 . . . . 0.0 113.969 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -75.63 -17.17 60.09 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -46.33 -48.79 18.26 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.536 1.062 . . . . 0.0 113.482 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.13 -41.93 99.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.524 0.678 . . . . 0.0 111.925 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -67.01 -44.82 79.34 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.737 1.215 . . . . 0.0 110.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.4 m -62.17 -38.76 90.28 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.353 1.461 . . . . 0.0 112.211 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.89 -54.29 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.635 1.107 . . . . 0.0 110.444 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.85 -38.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.908 0.776 . . . . 0.0 111.096 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.08 69.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.665 0.786 . . . . 0.0 112.149 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.61 -27.53 68.47 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.668 -1.27 . . . . 0.0 112.189 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.72 -48.21 80.24 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.91 0.777 . . . . 0.0 110.068 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.04 -47.74 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.579 1.152 . . . . 0.0 110.063 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.64 -25.43 65.73 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.22 -0.925 . . . . 0.0 112.943 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.89 -48.03 75.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.613 0.765 . . . . 0.0 111.0 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.61 -30.25 61.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.383 0.992 . . . . 0.0 112.307 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.36 -28.49 69.27 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.508 -1.37 . . . . 0.0 113.244 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.39 93.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.068 0.547 . . . . 0.0 111.948 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.35 -21.22 33.19 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 112.13 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -61.69 -27.25 68.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.232 1.813 . . . . 0.0 113.65 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -100.52 -7.37 24.23 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.808 1.243 . . . . 0.0 113.951 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -89.67 -55.87 3.47 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.248 1.419 . . . . 0.0 112.442 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -141.05 -38.95 0.41 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -167.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.61 -18.57 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.361 -0.837 . . . . 0.0 110.499 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.67 -35.81 63.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.056 1.343 . . . . 0.0 112.86 172.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -73.45 -44.25 58.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.661 0.784 . . . . 0.0 110.978 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.69 91.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.863 0.865 . . . . 0.0 112.861 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.37 -23.19 57.11 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.3 tp -87.83 -34.48 18.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.095 1.358 . . . . 0.0 112.924 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -88.17 39.01 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.726 1.61 . . . . 0.0 112.778 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -85.63 24.1 1.27 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.928 2.091 . . . . 0.0 113.98 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.45 56.44 2.45 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.723 2.106 . . . . 0.0 114.247 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.02 -174.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.468 2.307 . . . . 0.0 114.735 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.13 132.78 47.11 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.035 -1.04 . . . . 0.0 110.92 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.64 24.64 0.39 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -150.52 -51.2 0.13 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.351 -0.843 . . . . 0.0 113.257 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.99 41.7 0.52 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.51 . . . . 0.0 112.827 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.2 -36.84 84.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.548 1.539 . . . . 0.0 114.19 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.038 1.335 . . . . 0.0 112.745 -167.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.5 159.8 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.325 1.45 . . . . 0.0 112.063 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 26.14 9.58 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.177 1.791 . . . . 0.0 113.949 -167.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.47 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 113.883 -167.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.33 38.14 29.48 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.429 1.892 . . . . 0.0 112.569 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -66.97 -53.26 26.98 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.293 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -81.27 169.03 16.25 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.608 2.205 . . . . 0.0 113.01 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.08 144.51 3.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.139 1.352 . . . . 0.0 113.582 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.34 35.21 1.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.78 121.43 11.69 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.1 m -123.42 141.05 52.38 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.52 1.128 . . . . 0.0 110.166 173.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -73.8 64.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.341 1.857 . . . . 0.0 111.843 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 41.52 0.3 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.591 1.186 . . . . 0.0 111.206 172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.0 p -132.59 128.36 37.01 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.96 1.304 . . . . 0.0 112.145 -167.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.63 35.95 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.1 p -136.69 158.24 44.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.62 1.168 . . . . 0.0 111.859 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.4 p -56.5 -42.2 77.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.039 -1.038 . . . . 0.0 113.383 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.78 -42.25 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.542 1.537 . . . . 0.0 112.321 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.69 -30.47 74.72 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.506 -1.372 . . . . 0.0 113.075 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -64.46 -39.94 94.76 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.152 0.981 . . . . 0.0 111.32 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.85 -35.41 64.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.748 -0.595 . . . . 0.0 111.668 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -55.59 -43.23 75.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.467 1.03 . . . . 0.0 111.182 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.73 -54.52 32.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.368 0.531 . . . . 0.0 111.992 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -67.43 -45.12 77.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.039 0.936 . . . . 0.0 111.741 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.48 -42.5 92.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.486 0.714 . . . . 0.0 112.026 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.86 -52.47 64.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.865 0.757 . . . . 0.0 110.389 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.2 p -65.52 -28.13 68.96 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.25 -33.02 74.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.58 1.152 . . . . 0.0 113.46 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -111.28 1.34 17.08 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.94 133.16 54.22 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.121 0.968 . . . . 0.0 112.924 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -157.22 133.0 9.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.433 1.893 . . . . 0.0 108.903 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -150.14 152.11 34.19 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.94 -27.99 19.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.27 1.028 . . . . 0.0 113.772 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.66 -171.39 2.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.468 1.107 . . . . 0.0 111.815 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -4.42 26.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.128 1.371 . . . . 0.0 113.996 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.65 23.07 66.71 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 120.396 -1.44 . . . . 0.0 115.932 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -84.9 67.13 10.04 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.188 -1.184 . . . . 0.0 112.149 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.35 152.31 39.12 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -137.88 160.13 40.12 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.752 1.221 . . . . 0.0 111.907 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.6 mt -117.8 128.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.356 1.463 . . . . 0.0 108.761 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.06 141.68 51.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.751 1.22 . . . . 0.0 108.492 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.6 pp20? -126.78 153.04 46.1 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 168.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -116.19 118.95 37.36 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.181 1.392 . . . . 0.0 108.724 168.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.45 122.61 6.12 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -136.04 88.13 2.37 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.517 1.127 . . . . 0.0 110.094 -168.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -8.48 6.26 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -52.1 -32.25 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.691 1.196 . . . . 0.0 113.167 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -31.62 0.07 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.27 -117.88 0.67 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 120.476 1.489 . . . . 0.0 114.178 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.1 p -138.16 142.83 40.09 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -90.87 117.98 29.91 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.441 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mm -98.41 132.84 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 109.412 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -137.81 116.49 12.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.395 1.078 . . . . 0.0 109.147 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.82 129.45 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.885 0.874 . . . . 0.0 109.352 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -119.64 138.65 53.12 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.755 1.222 . . . . 0.0 110.793 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.7 t -100.23 116.48 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.102 1.361 . . . . 0.0 108.246 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.9 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.89 2.476 . . . . 0.0 113.784 -167.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.14 7.58 1.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.632 1.973 . . . . 0.0 113.519 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -118.53 129.88 55.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.096 1.359 . . . . 0.0 111.511 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 137.93 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.193 -0.942 . . . . 0.0 111.184 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -128.89 -27.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -150.69 147.54 27.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.471 0.578 . . . . 0.0 110.626 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.89 147.04 22.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.044 0.938 . . . . 0.0 111.86 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -153.48 158.19 40.96 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.873 1.269 . . . . 0.0 112.313 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -102.2 118.11 36.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.421 1.088 . . . . 0.0 110.699 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.5 mt -91.02 147.81 22.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 112.155 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.38 134.88 25.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.281 1.432 . . . . 0.0 110.995 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.88 -32.77 0.73 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.848 3.032 . . . . 0.0 113.365 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.83 -34.91 26.76 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.47 1.108 . . . . 0.0 112.1 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.88 148.49 28.76 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.769 1.227 . . . . 0.0 111.359 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -92.19 21.16 5.33 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.74 -16.72 55.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -46.83 -48.45 20.87 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.712 1.142 . . . . 0.0 113.552 -168.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.17 -41.76 99.28 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.638 -0.664 . . . . 0.0 111.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.79 -44.48 81.19 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.694 1.197 . . . . 0.0 110.586 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -61.64 -39.39 91.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.183 1.393 . . . . 0.0 112.165 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.24 -53.87 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 119.396 0.998 . . . . 0.0 110.572 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.69 -38.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 118.839 0.745 . . . . 0.0 111.187 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.4 -32.22 69.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.526 0.73 . . . . 0.0 112.185 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.31 -28.07 69.05 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.763 -1.211 . . . . 0.0 112.163 175.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 -48.35 79.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.807 0.73 . . . . 0.0 110.134 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.6 -47.38 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.488 1.115 . . . . 0.0 109.912 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.92 -25.23 65.37 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.927 -1.108 . . . . 0.0 112.994 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 m -64.67 -46.89 80.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.795 . . . . 0.0 111.452 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.26 -31.62 62.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.628 1.104 . . . . 0.0 111.993 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.98 -26.01 68.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.986 1.266 . . . . 0.0 113.68 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.9 81.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.739 0.416 . . . . 0.0 111.669 166.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.83 -20.99 37.86 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.395 1.078 . . . . 0.0 112.616 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -63.53 -25.01 68.05 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 127.025 2.13 . . . . 0.0 112.099 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -113.01 7.22 18.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.099 1.759 . . . . 0.0 115.559 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -97.69 -55.48 2.8 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.01 1.724 . . . . 0.0 112.295 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.32 -38.98 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -167.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -69.88 -19.13 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.738 -0.601 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.46 -41.61 80.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.923 1.289 . . . . 0.0 112.448 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -71.75 -41.52 68.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.126 0.57 . . . . 0.0 111.24 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.52 93.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.266 0.626 . . . . 0.0 111.915 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.1 -35.26 71.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -68.9 -30.95 69.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.514 1.125 . . . . 0.0 111.575 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.5 m -79.52 38.67 0.38 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.397 1.479 . . . . 0.0 112.503 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m 57.4 56.12 5.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.956 2.103 . . . . 0.0 112.058 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -126.86 22.05 5.8 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.205 1.383 . . . . 0.0 115.354 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -67.36 161.48 25.05 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.53 1.165 . . . . 0.0 113.047 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.39 165.27 16.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.011 0.924 . . . . 0.0 112.926 166.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.01 32.57 2.17 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.485 1.114 . . . . 0.0 112.22 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -96.1 112.08 23.92 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.992 0.917 . . . . 0.0 112.05 -161.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t0 50.31 41.04 23.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.055 1.742 . . . . 0.0 113.947 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.55 -33.22 68.95 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -167.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.052 1.741 . . . . 0.0 112.173 -174.66 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.06 52.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 125.339 1.456 . . . . 0.0 111.467 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -123.48 26.68 7.75 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.382 1.473 . . . . 0.0 112.291 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.1 t -129.45 151.24 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.846 1.658 . . . . 0.0 109.823 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.83 55.51 0.69 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.931 1.693 . . . . 0.0 112.384 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -70.91 -53.83 8.32 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.793 1.637 . . . . 0.0 112.66 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.89 169.43 16.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.553 2.168 . . . . 0.0 112.811 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.24 143.34 3.83 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.258 1.409 . . . . 0.0 113.457 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.47 35.13 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mt -58.84 122.0 12.53 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -122.08 137.89 54.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.386 1.074 . . . . 0.0 110.352 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -75.17 67.32 1.8 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.936 1.694 . . . . 0.0 111.363 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -0.33 12.16 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.323 -0.86 . . . . 0.0 112.986 175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -93.25 140.62 29.33 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.455 1.502 . . . . 0.0 113.055 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.35 37.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 122.502 1.144 . . . . 0.0 113.597 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -125.71 150.7 47.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.787 1.635 . . . . 0.0 111.146 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 m -57.82 -33.27 68.42 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.37 -0.831 . . . . 0.0 113.195 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.26 -42.05 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.858 1.263 . . . . 0.0 112.131 170.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.7 -30.1 75.76 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 120.384 -1.447 . . . . 0.0 114.084 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.15 -37.53 85.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.597 1.159 . . . . 0.0 111.576 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -74.26 -35.12 63.77 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.389 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -55.46 -43.28 75.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.452 1.024 . . . . 0.0 111.222 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -51.92 -54.68 26.68 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.36 0.527 . . . . 0.0 111.91 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.51 -44.78 73.94 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 111.784 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.64 94.54 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -62.08 -52.61 63.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.869 0.759 . . . . 0.0 110.384 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -65.37 -28.46 69.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -64.24 -33.21 75.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.69 1.196 . . . . 0.0 113.421 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.93 1.04 17.31 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 177.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -62.7 131.48 49.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.097 0.959 . . . . 0.0 112.891 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -157.87 138.45 12.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.455 1.902 . . . . 0.0 108.907 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.3 p -152.34 159.96 43.38 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.69 -7.81 30.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -100.56 -166.3 1.3 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.757 1.623 . . . . 0.0 111.385 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -5.66 38.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.261 1.424 . . . . 0.0 113.9 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.17 67.4 Favored Glycine 0 N--CA 1.475 1.28 0 O-C-N 120.35 -1.469 . . . . 0.0 116.06 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.75 67.84 10.21 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.299 -1.118 . . . . 0.0 112.343 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.22 153.34 38.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -138.88 161.2 37.88 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.847 1.259 . . . . 0.0 111.899 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.64 130.17 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.408 1.483 . . . . 0.0 108.9 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -128.43 139.82 52.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.779 1.231 . . . . 0.0 108.151 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.74 152.37 48.5 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -115.32 116.21 41.99 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.23 1.012 . . . . 0.0 109.745 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.44 124.18 5.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.173 2.582 . . . . 0.0 109.891 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -140.15 87.25 2.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.654 1.181 . . . . 0.0 109.857 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.5 -10.53 12.14 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -54.5 -29.12 49.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.999 1.319 . . . . 0.0 113.862 164.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.37 -27.94 0.14 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.87 -114.63 0.67 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-N 120.259 1.391 . . . . 0.0 112.84 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -137.78 145.44 42.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.045 0.938 . . . . 0.0 113.154 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -81.44 132.45 35.32 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 158.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.37 132.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.109 1.364 . . . . 0.0 109.079 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.5 m -137.77 116.64 12.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.868 1.267 . . . . 0.0 109.063 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.49 130.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.044 0.938 . . . . 0.0 109.449 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -119.53 139.43 52.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.799 1.239 . . . . 0.0 110.837 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -101.07 116.46 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.329 1.452 . . . . 0.0 108.369 172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.83 -73.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.864 2.465 . . . . 0.0 113.795 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.95 7.59 1.63 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.672 1.989 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -118.73 131.31 56.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.035 1.334 . . . . 0.0 111.45 -172.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -73.97 138.47 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.159 -0.963 . . . . 0.0 111.263 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.66 -27.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -150.51 145.89 26.26 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.515 0.598 . . . . 0.0 110.77 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.54 146.68 23.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.902 0.881 . . . . 0.0 111.881 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -154.73 163.77 39.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.9 1.28 . . . . 0.0 111.885 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.02 130.76 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.798 0.839 . . . . 0.0 111.153 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.8 mt -102.75 143.44 32.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.055 1.342 . . . . 0.0 111.491 170.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -125.14 133.02 24.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.0 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 -29.72 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.742 2.962 . . . . 0.0 113.674 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -82.87 -25.36 32.62 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.419 1.088 . . . . 0.0 112.613 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -84.06 163.8 19.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.976 1.311 . . . . 0.0 111.802 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -103.82 13.09 33.65 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.187 1.395 . . . . 0.0 114.292 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -73.99 -16.81 61.06 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -46.77 -49.05 20.36 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.679 1.127 . . . . 0.0 113.451 -169.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.67 -41.94 98.11 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.523 0.678 . . . . 0.0 111.945 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.83 -45.28 82.83 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 110.524 178.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 m -62.53 -38.87 91.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.608 1.563 . . . . 0.0 112.223 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.44 -54.26 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.482 1.037 . . . . 0.0 110.461 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.96 -38.61 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.814 0.733 . . . . 0.0 111.117 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.51 70.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 112.193 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.32 68.37 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.773 -1.204 . . . . 0.0 112.234 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.74 -48.7 78.07 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.887 0.767 . . . . 0.0 110.119 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.7 mt -68.19 -47.12 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.455 1.102 . . . . 0.0 110.061 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.7 -25.57 65.74 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.09 -1.006 . . . . 0.0 112.882 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.9 m -64.82 -47.9 76.32 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.549 0.74 . . . . 0.0 111.175 170.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -30.03 61.27 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.34 -28.24 69.08 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.385 -1.447 . . . . 0.0 113.352 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.24 -42.61 93.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 mt -84.74 -22.51 29.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 112.211 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -61.11 -27.95 68.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.124 1.77 . . . . 0.0 113.306 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -97.84 -9.87 25.7 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.894 1.278 . . . . 0.0 113.681 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.25 -54.61 4.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.192 1.397 . . . . 0.0 112.331 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.93 -37.71 0.4 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.55 -17.46 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 118.656 0.662 . . . . 0.0 110.805 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.59 -39.28 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 113.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.89 -42.06 67.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.357 0.663 . . . . 0.0 111.23 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.1 90.13 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 0.0 112.414 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.24 -28.97 62.45 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.2 tp -76.97 -42.14 40.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.43 1.092 . . . . 0.0 112.021 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.2 t -153.91 -46.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.8 p -89.67 -9.58 49.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -155.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.7 -44.75 6.31 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.002 0.819 . . . . 0.0 113.862 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -156.36 167.69 29.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.576 1.55 . . . . 0.0 112.157 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -63.95 162.41 13.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.814 0.845 . . . . 0.0 112.924 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.18 32.92 1.34 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.3 1.04 . . . . 0.0 113.047 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -71.37 -43.39 66.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.58 36.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.908 0.883 . . . . 0.0 112.961 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.07 -35.75 74.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.765 -1.209 . . . . 0.0 113.602 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.195 1.798 . . . . 0.0 112.006 -174.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.61 143.93 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.273 1.429 . . . . 0.0 111.157 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -144.52 105.43 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.288 1.035 . . . . 0.0 110.39 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 52.9 t -143.03 150.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.963 1.705 . . . . 0.0 108.889 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -74.91 53.24 0.58 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.21 1.404 . . . . 0.0 112.899 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.21 -53.98 7.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.838 1.655 . . . . 0.0 112.543 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.17 169.55 18.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.417 2.078 . . . . 0.0 112.604 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.9 142.79 3.98 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.2 1.381 . . . . 0.0 113.29 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.7 pp -143.22 35.48 1.35 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.3 mt -61.28 110.04 1.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.824 -0.547 . . . . 0.0 110.014 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -111.06 139.69 46.22 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.719 0.807 . . . . 0.0 110.672 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -71.76 59.93 0.35 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.552 1.941 . . . . 0.0 111.839 170.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.13 44.62 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.636 1.174 . . . . 0.0 110.403 171.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 70.0 p -133.59 133.73 42.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.54 1.536 . . . . 0.0 111.967 -172.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.83 35.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.608 1.163 . . . . 0.0 114.026 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -125.1 150.48 46.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.68 1.592 . . . . 0.0 111.641 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 m -58.01 -33.62 69.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.07 -42.16 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.757 1.223 . . . . 0.0 112.131 170.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.5 -29.3 73.92 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.354 -1.466 . . . . 0.0 114.219 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -66.95 -37.45 84.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.472 1.109 . . . . 0.0 111.503 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.98 -35.25 64.44 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.731 -0.605 . . . . 0.0 111.296 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -56.01 -42.53 76.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.511 1.05 . . . . 0.0 111.442 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -51.9 -53.73 37.48 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.518 0.599 . . . . 0.0 111.759 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -69.22 -45.13 70.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.996 0.918 . . . . 0.0 111.971 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.19 95.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.302 0.641 . . . . 0.0 112.107 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -62.14 -52.54 63.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.722 0.692 . . . . 0.0 110.286 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.4 p -65.5 -28.97 69.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.51 -32.62 74.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.72 1.208 . . . . 0.0 113.344 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -112.03 4.41 18.06 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 176.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -68.86 129.5 40.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 113.19 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.83 145.41 18.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.113 2.165 . . . . 0.0 109.444 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -156.14 166.83 32.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.36 -30.57 25.34 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.93 -171.19 2.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.492 1.117 . . . . 0.0 112.481 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -5.71 37.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.78 1.632 . . . . 0.0 114.033 -171.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.08 71.23 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 120.212 -1.555 . . . . 0.0 115.814 169.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.47 66.06 9.27 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.148 -1.207 . . . . 0.0 112.293 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.84 151.34 39.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.952 1.301 . . . . 0.0 114.387 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -136.46 160.68 38.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.828 1.251 . . . . 0.0 111.872 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.15 126.65 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 108.906 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.0 142.66 50.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.124 1.369 . . . . 0.0 108.249 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.22 152.71 50.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.647 1.112 . . . . 0.0 113.573 170.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -116.84 116.46 38.25 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 109.925 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.74 124.11 5.55 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.233 2.622 . . . . 0.0 109.881 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.5 m -140.26 93.75 2.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.478 1.111 . . . . 0.0 110.089 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.08 -10.2 13.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.55 -31.32 45.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 113.642 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.6 -25.16 0.1 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.66 -113.86 0.63 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.603 1.547 . . . . 0.0 112.928 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -137.02 145.06 43.61 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.042 0.937 . . . . 0.0 113.289 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -81.0 133.48 35.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 158.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.2 mm -110.03 132.03 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.287 1.435 . . . . 0.0 109.167 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.9 m -137.33 116.52 12.58 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.795 1.238 . . . . 0.0 109.309 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.62 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.045 0.938 . . . . 0.0 109.493 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -119.5 139.49 52.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.722 1.209 . . . . 0.0 110.914 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.27 116.22 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.274 1.43 . . . . 0.0 108.285 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 54.68 -72.96 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.022 2.529 . . . . 0.0 113.831 -168.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -142.64 7.48 1.69 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.586 1.954 . . . . 0.0 113.507 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -119.23 131.93 55.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.059 1.344 . . . . 0.0 111.519 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.3 138.71 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 111.332 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.92 -27.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -150.98 146.34 26.17 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.568 0.622 . . . . 0.0 110.921 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.49 146.88 23.95 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.032 0.933 . . . . 0.0 112.011 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 t -155.15 164.25 39.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 111.892 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.12 131.98 40.55 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.836 0.854 . . . . 0.0 111.239 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.0 mt -103.97 144.31 31.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.211 1.404 . . . . 0.0 111.898 170.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -125.67 132.33 24.28 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.73 1.212 . . . . 0.0 110.954 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.51 -31.01 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.687 2.924 . . . . 0.0 114.284 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -20.35 29.73 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.884 0.874 . . . . 0.0 113.021 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -92.09 152.06 20.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.21 1.404 . . . . 0.0 111.389 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -97.27 20.82 10.87 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.161 1.384 . . . . 0.0 114.429 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.09 -17.24 58.85 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.65 -48.52 19.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.584 1.084 . . . . 0.0 113.441 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -63.44 -41.85 98.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.588 -0.695 . . . . 0.0 111.977 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -66.51 -44.98 81.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.675 1.19 . . . . 0.0 110.539 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -62.61 -38.64 90.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.384 1.473 . . . . 0.0 112.166 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.43 -54.46 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.325 0.966 . . . . 0.0 110.506 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.47 -38.81 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.776 0.716 . . . . 0.0 111.118 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.73 71.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.472 0.709 . . . . 0.0 112.266 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.37 68.25 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.765 -1.209 . . . . 0.0 112.292 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.97 -48.72 77.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.865 0.757 . . . . 0.0 109.992 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.76 -47.35 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.517 1.127 . . . . 0.0 109.97 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.64 -24.03 64.5 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.83 -1.168 . . . . 0.0 112.986 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 m -65.95 -47.28 75.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.686 0.794 . . . . 0.0 111.375 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.41 -31.44 63.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.588 1.085 . . . . 0.0 112.041 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.6 -27.57 69.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.917 1.235 . . . . 0.0 113.729 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.49 94.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.909 0.483 . . . . 0.0 111.984 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.15 -22.55 30.98 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.051 1.34 . . . . 0.0 112.393 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -61.23 -30.97 70.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.681 1.992 . . . . 0.0 112.511 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -97.94 -8.8 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.06 1.344 . . . . 0.0 114.19 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.97 -51.33 6.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.603 1.161 . . . . 0.0 111.72 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -145.55 -37.31 0.27 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.84 -19.76 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.43 1.014 . . . . 0.0 111.234 -169.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 p30 -49.14 -39.53 29.12 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.504 1.122 . . . . 0.0 113.068 170.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -59.58 -38.88 82.36 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.955 0.902 . . . . 0.0 112.159 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.4 -50.88 9.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.673 0.789 . . . . 0.0 112.08 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.6 pp -66.45 -20.54 66.07 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -20.22 65.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.482 1.513 . . . . 0.0 113.559 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 m 59.15 40.63 21.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.553 1.541 . . . . 0.0 114.487 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.4 m -134.45 75.88 1.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.563 1.545 . . . . 0.0 109.08 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.27 -3.6 9.62 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.437 1.494 . . . . 0.0 115.721 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -133.33 166.43 22.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.056 1.743 . . . . 0.0 112.148 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.37 159.19 18.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.947 0.899 . . . . 0.0 113.051 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.12 27.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -78.52 -47.4 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.66 37.32 0.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.906 1.282 . . . . 0.0 113.225 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.36 -41.57 89.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.348 1.059 . . . . 0.0 113.79 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.263 1.825 . . . . 0.0 111.871 -173.136 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.06 155.44 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 125.454 1.502 . . . . 0.0 111.929 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.33 156.11 33.61 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.925 0.89 . . . . 0.0 112.442 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.65 150.43 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.072 1.349 . . . . 0.0 109.59 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.07 55.52 0.93 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.325 1.45 . . . . 0.0 112.493 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.44 -53.84 9.56 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.968 1.707 . . . . 0.0 112.84 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.08 169.29 17.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.542 2.161 . . . . 0.0 112.729 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.81 144.01 3.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.082 1.325 . . . . 0.0 113.502 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.251 3.7 pp -143.66 34.69 1.28 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.92 123.64 17.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.3 m -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.318 1.047 . . . . 0.0 110.623 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.28 59.38 0.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.629 1.972 . . . . 0.0 112.166 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.6 44.35 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.847 1.259 . . . . 0.0 110.535 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 82.5 p -132.47 134.85 45.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.326 1.45 . . . . 0.0 112.284 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.6 33.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.644 1.178 . . . . 0.0 114.169 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -121.95 151.12 41.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.94 1.696 . . . . 0.0 111.949 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -59.08 -32.69 70.02 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.1 pt -93.99 -42.21 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.512 1.525 . . . . 0.0 111.777 169.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.57 -27.64 73.57 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.488 -1.382 . . . . 0.0 114.224 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.513 ' CD2' HH21 ' A' ' 24' ' ' ARG . 14.6 t60 -68.01 -37.07 80.99 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.566 1.146 . . . . 0.0 111.517 171.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.46 -33.98 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.238 -0.914 . . . . 0.0 112.269 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -55.59 -43.51 76.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.649 1.113 . . . . 0.0 111.316 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -51.16 -55.01 20.07 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.226 0.466 . . . . 0.0 111.939 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.513 HH21 ' CD2' ' A' ' 20' ' ' HIS . 7.4 mtm105 -70.18 -43.82 70.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.433 1.093 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.75 95.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.356 0.662 . . . . 0.0 112.049 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -62.35 -52.46 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.942 0.792 . . . . 0.0 110.353 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -28.34 69.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -63.92 -33.17 75.11 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.618 1.167 . . . . 0.0 113.325 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -111.01 1.83 17.64 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.76 129.62 40.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.985 0.914 . . . . 0.0 113.172 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -160.75 131.69 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.632 1.973 . . . . 0.0 108.577 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -149.64 161.96 41.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.08 -29.85 39.19 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.99 -169.79 2.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.069 1.348 . . . . 0.0 112.377 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -4.62 32.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.675 1.59 . . . . 0.0 113.95 -172.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.56 69.78 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 120.161 -1.587 . . . . 0.0 115.958 169.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -84.43 66.37 9.41 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.052 -1.264 . . . . 0.0 112.314 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.46 152.14 39.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.086 1.355 . . . . 0.0 114.453 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 160.91 37.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.877 1.271 . . . . 0.0 111.831 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.55 125.62 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.449 1.5 . . . . 0.0 108.561 -171.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.32 145.3 48.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.058 1.343 . . . . 0.0 108.058 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.77 148.59 52.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.555 1.07 . . . . 0.0 113.64 168.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -109.46 115.39 56.18 Favored Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.375 1.47 . . . . 0.0 109.46 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 124.96 7.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.589 2.193 . . . . 0.0 109.842 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -135.64 92.08 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.824 1.249 . . . . 0.0 109.587 -173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -9.15 8.29 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -52.64 -31.52 37.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.812 1.245 . . . . 0.0 113.439 164.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.12 -35.91 0.07 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.41 -127.79 1.32 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 120.477 1.49 . . . . 0.0 114.74 -169.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -132.01 132.86 43.81 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.427 1.091 . . . . 0.0 113.387 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -88.25 107.04 18.6 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.461 -0.774 . . . . 0.0 109.339 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.09 132.73 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.081 1.353 . . . . 0.0 109.766 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -138.06 114.99 10.77 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.628 1.171 . . . . 0.0 109.02 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.04 129.23 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.909 0.884 . . . . 0.0 109.344 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.47 139.31 52.27 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.57 1.148 . . . . 0.0 110.839 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.69 115.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.367 1.467 . . . . 0.0 108.265 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.87 -72.55 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.899 2.48 . . . . 0.0 113.954 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.71 7.56 1.68 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.657 1.983 . . . . 0.0 113.543 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -120.02 131.95 55.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.022 1.329 . . . . 0.0 111.532 -172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.0 138.71 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.174 -0.954 . . . . 0.0 111.258 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 pt -128.96 -26.68 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -151.33 147.63 27.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.733 0.697 . . . . 0.0 110.94 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.37 146.54 21.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.978 0.911 . . . . 0.0 112.326 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.2 t -155.21 156.62 35.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.793 1.237 . . . . 0.0 112.331 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -98.75 118.21 34.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.13 0.972 . . . . 0.0 110.831 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB3' HD12 ' A' ' 18' ' ' ILE . 17.1 mt -86.78 148.51 25.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.752 1.221 . . . . 0.0 112.017 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -124.32 132.7 24.33 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.897 1.279 . . . . 0.0 111.485 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.51 -31.37 0.86 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.078 3.186 . . . . 0.0 114.282 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.54 -26.34 32.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.607 0.763 . . . . 0.0 112.643 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -82.96 160.11 22.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.718 1.207 . . . . 0.0 111.876 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -100.09 11.68 38.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.415 1.486 . . . . 0.0 114.099 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.83 -18.47 62.72 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -45.69 -48.79 15.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.69 1.132 . . . . 0.0 113.39 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -64.14 -42.53 96.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.617 -0.677 . . . . 0.0 111.816 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.66 -45.45 82.9 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.804 1.242 . . . . 0.0 110.543 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -61.87 -39.44 91.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.992 1.717 . . . . 0.0 112.159 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.81 -53.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.493 1.042 . . . . 0.0 110.479 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.71 -39.16 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.955 0.798 . . . . 0.0 111.121 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.94 -32.28 70.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.661 0.784 . . . . 0.0 112.104 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.71 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.761 -1.212 . . . . 0.0 112.184 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.69 -48.79 77.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.842 0.746 . . . . 0.0 109.969 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -46.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.408 1.083 . . . . 0.0 110.194 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.82 -26.24 66.84 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.955 -1.091 . . . . 0.0 113.01 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.6 m -64.54 -47.8 77.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.601 0.761 . . . . 0.0 111.131 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.85 -29.87 61.18 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.018 -1.051 . . . . 0.0 112.246 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.95 -30.27 70.14 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.368 -1.458 . . . . 0.0 113.255 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.64 97.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.129 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.19 -21.67 29.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.155 1.382 . . . . 0.0 112.136 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.78 -29.48 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.836 1.655 . . . . 0.0 112.495 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -96.38 -9.62 29.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.861 1.264 . . . . 0.0 114.059 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -86.53 -50.59 6.74 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.871 1.268 . . . . 0.0 111.539 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -143.92 -38.31 0.31 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 mt -67.68 -18.68 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.655 1.116 . . . . 0.0 111.572 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -51.14 -35.89 37.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.144 0.978 . . . . 0.0 113.372 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -63.23 -45.73 90.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.848 0.859 . . . . 0.0 111.452 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.82 54.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.146 0.978 . . . . 0.0 111.925 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.09 -27.61 67.49 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.57 -45.82 64.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.893 0.877 . . . . 0.0 111.041 168.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.1 t -63.12 -33.18 74.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.331 0.652 . . . . 0.0 112.664 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.3 p -84.5 -39.46 18.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.083 0.953 . . . . 0.0 112.739 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.06 14.91 76.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.693 1.14 . . . . 0.0 115.3 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -72.88 159.43 33.74 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.327 1.063 . . . . 0.0 113.301 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.48 138.52 55.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.96 87.2 0.85 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.282 1.433 . . . . 0.0 110.631 164.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -113.34 -51.89 2.79 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.76 36.7 0.96 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.617 1.167 . . . . 0.0 111.952 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.12 -28.14 62.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -171.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.405 1.882 . . . . 0.0 111.943 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.05 -2.09 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.53 149.92 39.74 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.141 1.376 . . . . 0.0 111.385 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.37 27.11 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.321 1.448 . . . . 0.0 112.13 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.15 38.68 30.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.269 1.828 . . . . 0.0 112.897 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.24 -50.95 47.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.906 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.78 168.29 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.388 2.058 . . . . 0.0 113.084 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.76 144.95 4.12 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.22 1.391 . . . . 0.0 113.46 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -142.92 34.18 1.38 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.15 122.08 12.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.4 m -125.33 140.88 52.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.196 0.998 . . . . 0.0 110.442 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -72.91 60.31 0.52 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.45 1.9 . . . . 0.0 111.873 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -77.89 44.0 0.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.877 1.271 . . . . 0.0 110.425 171.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 72.3 p -133.37 134.68 44.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.579 1.552 . . . . 0.0 111.96 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.4 34.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 124.801 1.24 . . . . 0.0 114.058 -170.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -124.65 152.03 44.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.548 1.539 . . . . 0.0 111.678 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.9 p -58.82 -36.36 74.38 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.252 -0.905 . . . . 0.0 113.047 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -91.26 -41.21 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.363 1.465 . . . . 0.0 111.84 171.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.14 -28.95 73.17 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 120.45 -1.407 . . . . 0.0 114.114 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.58 -37.21 79.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.28 1.04 . . . . 0.0 111.407 170.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -72.97 -35.46 66.91 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.639 -0.663 . . . . 0.0 111.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.8 -43.31 76.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.422 1.01 . . . . 0.0 111.116 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -52.82 -53.98 40.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.471 0.578 . . . . 0.0 111.83 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -67.83 -45.01 75.88 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.991 0.917 . . . . 0.0 111.699 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.69 -42.6 91.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.466 0.706 . . . . 0.0 112.099 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -61.65 -52.62 63.59 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.822 0.737 . . . . 0.0 110.339 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.23 -28.43 69.36 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -64.28 -33.11 75.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.65 1.18 . . . . 0.0 113.365 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -111.15 1.5 17.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -63.78 130.81 45.7 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.22 1.008 . . . . 0.0 113.194 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.67 136.91 9.63 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.414 1.886 . . . . 0.0 108.793 171.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -150.4 165.55 32.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.95 -26.05 25.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -82.69 -169.98 2.75 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.021 1.328 . . . . 0.0 112.267 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -4.42 30.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.124 1.769 . . . . 0.0 113.876 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.85 23.47 70.94 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 120.073 -1.642 . . . . 0.0 115.842 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.67 65.98 8.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.14 -1.212 . . . . 0.0 112.554 -176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.35 152.47 38.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 114.456 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -137.02 161.73 35.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.961 1.304 . . . . 0.0 111.796 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.91 126.93 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.439 1.496 . . . . 0.0 108.848 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -123.51 143.44 50.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.092 1.357 . . . . 0.0 108.343 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -132.09 153.71 50.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.704 1.138 . . . . 0.0 113.702 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -121.15 114.74 31.93 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 110.337 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.67 135.23 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.234 2.623 . . . . 0.0 110.831 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 t -153.43 123.36 6.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.545 0.738 . . . . 0.0 112.475 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -9.5 38.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -53.71 -32.78 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.123 1.369 . . . . 0.0 113.516 168.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.69 -26.98 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.25 -112.22 0.64 Allowed Glycine 0 N--CA 1.474 1.181 0 CA-C-N 120.579 1.536 . . . . 0.0 113.028 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -137.49 142.54 41.5 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.224 1.01 . . . . 0.0 113.223 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -77.28 134.75 38.46 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 157.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -111.06 131.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.214 1.405 . . . . 0.0 108.879 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -137.42 115.53 11.65 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.88 1.272 . . . . 0.0 109.194 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.01 129.44 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.005 0.922 . . . . 0.0 109.418 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -119.12 138.97 52.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.768 1.227 . . . . 0.0 110.854 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.32 116.94 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.192 1.397 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 54.9 -73.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.849 2.46 . . . . 0.0 113.751 -168.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -142.6 7.37 1.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.595 1.958 . . . . 0.0 113.528 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -117.79 130.73 56.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.066 1.346 . . . . 0.0 111.429 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.62 138.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.66 -26.8 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -150.79 146.08 26.15 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.637 0.653 . . . . 0.0 110.881 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.47 147.05 24.12 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.046 0.938 . . . . 0.0 112.189 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.87 163.85 39.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.959 1.304 . . . . 0.0 111.723 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.9 128.91 44.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.762 0.825 . . . . 0.0 111.275 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.7 mt -100.08 143.02 30.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.087 1.355 . . . . 0.0 111.813 171.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.62 133.75 24.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.928 1.291 . . . . 0.0 110.934 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.11 -30.22 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.75 2.967 . . . . 0.0 113.524 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.56 -25.93 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.403 1.081 . . . . 0.0 112.615 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -84.32 163.4 19.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.37 8.73 44.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.211 1.404 . . . . 0.0 114.46 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.92 -17.23 61.05 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -46.94 -49.23 20.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.819 1.19 . . . . 0.0 113.515 -169.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -63.75 -42.02 97.92 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -65.56 -45.39 83.56 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.837 1.255 . . . . 0.0 110.552 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.2 m -62.4 -39.14 92.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.643 1.577 . . . . 0.0 112.164 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.35 -54.19 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.487 1.04 . . . . 0.0 110.435 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.17 -38.74 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.771 0.714 . . . . 0.0 111.172 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.28 69.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.582 0.753 . . . . 0.0 112.206 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.18 68.23 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.786 -1.196 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.8 -48.45 79.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.883 0.765 . . . . 0.0 110.054 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.9 mt -68.43 -47.35 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.528 1.131 . . . . 0.0 110.017 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.45 -25.59 65.97 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.098 -1.001 . . . . 0.0 112.932 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.4 m -64.9 -47.89 76.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 111.089 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.73 -29.72 61.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.17 -29.72 69.97 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.405 -1.435 . . . . 0.0 113.261 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.44 96.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.193 0.597 . . . . 0.0 112.081 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.16 -21.62 31.28 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.885 1.274 . . . . 0.0 112.152 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.97 -29.73 70.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.774 1.63 . . . . 0.0 112.592 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -95.57 -11.03 28.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.689 1.196 . . . . 0.0 114.139 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -86.5 -50.83 6.57 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.752 1.221 . . . . 0.0 111.618 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -143.78 -38.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.4 mt -66.04 -20.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.01 1.277 . . . . 0.0 111.416 -169.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 3.1 p30 -50.1 -38.75 40.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.958 0.903 . . . . 0.0 113.136 168.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.57 -33.04 74.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.323 1.049 . . . . 0.0 112.482 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.87 -47.72 10.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.422 1.089 . . . . 0.0 112.31 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.5 pp -69.12 -23.36 63.98 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -176.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.26 -15.42 62.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.624 1.57 . . . . 0.0 113.641 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.4 m 51.17 44.24 28.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.06 1.344 . . . . 0.0 114.1 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m 57.62 36.1 26.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.399 1.48 . . . . 0.0 113.524 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.44 -14.6 64.75 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 124.605 1.098 . . . . 0.0 114.802 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -131.88 167.87 18.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.706 2.002 . . . . 0.0 111.138 170.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.88 154.26 26.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.731 0.812 . . . . 0.0 113.116 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -153.91 23.27 0.51 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.309 1.044 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -75.8 -32.25 59.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -160.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -140.84 24.7 2.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.871 1.268 . . . . 0.0 112.401 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -82.58 -36.35 26.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.099 -1.0 . . . . 0.0 113.168 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.915 2.086 . . . . 0.0 111.531 -177.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.659 0.266 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t 54.38 60.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.934 1.694 . . . . 0.0 112.447 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -119.88 124.07 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.412 1.485 . . . . 0.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.53 25.12 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.757 1.223 . . . . 0.0 112.127 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 57.57 38.03 27.76 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.215 1.806 . . . . 0.0 112.929 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.18 -53.27 11.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.595 -1.193 . . . . 0.0 113.297 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.89 168.82 18.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.425 2.083 . . . . 0.0 112.872 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.09 144.56 4.04 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.104 1.335 . . . . 0.0 113.286 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 4.0 pp -142.29 33.66 1.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 mt -59.53 120.87 10.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -124.86 140.76 52.63 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.161 0.985 . . . . 0.0 110.495 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.39 59.91 0.61 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.427 1.891 . . . . 0.0 111.907 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -77.94 44.97 0.5 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.837 1.255 . . . . 0.0 110.338 171.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 68.3 p -133.25 133.17 42.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.493 1.517 . . . . 0.0 111.965 -172.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.18 34.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 124.695 1.198 . . . . 0.0 113.936 -169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -123.44 152.36 41.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.886 1.674 . . . . 0.0 111.48 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -59.17 -36.11 74.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.363 -0.836 . . . . 0.0 113.119 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -91.11 -41.28 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.328 1.451 . . . . 0.0 111.761 171.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.65 73.34 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.662 -1.274 . . . . 0.0 114.163 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.93 -42.39 97.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.235 1.017 . . . . 0.0 111.138 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -75.2 -29.77 60.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.533 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -54.99 -43.62 73.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 0.0 110.736 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.26 -53.65 54.74 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.327 0.512 . . . . 0.0 111.734 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -64.41 -39.7 94.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.718 0.807 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.72 -44.63 48.98 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.233 1.013 . . . . 0.0 112.454 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.36 -51.74 68.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.147 0.885 . . . . 0.0 110.564 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.6 p -64.4 -28.02 69.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.31 -32.19 73.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.327 1.051 . . . . 0.0 113.358 175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -109.77 -0.04 18.63 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 176.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -62.07 136.65 58.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.308 1.043 . . . . 0.0 113.208 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.05 144.26 18.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.155 1.782 . . . . 0.0 108.972 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 p -155.35 146.85 22.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.02 -32.25 25.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.871 0.869 . . . . 0.0 113.234 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.87 -171.89 2.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.647 1.179 . . . . 0.0 112.215 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -4.59 24.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.591 1.556 . . . . 0.0 113.984 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.65 22.96 70.3 Favored Glycine 0 N--CA 1.473 1.143 0 O-C-N 120.12 -1.613 . . . . 0.0 115.796 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -84.28 66.33 9.3 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.158 -1.201 . . . . 0.0 112.627 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.74 151.98 38.87 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.839 1.255 . . . . 0.0 114.374 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -136.49 161.28 36.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.278 . . . . 0.0 111.777 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.52 127.74 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.449 1.499 . . . . 0.0 108.868 -171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -124.3 143.71 50.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.044 1.338 . . . . 0.0 108.163 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.72 152.52 50.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.694 1.133 . . . . 0.0 113.512 169.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -115.92 116.84 40.15 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 124.148 0.979 . . . . 0.0 109.696 169.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.01 124.37 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.043 2.495 . . . . 0.0 109.904 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.5 m -140.51 93.52 2.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 109.969 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -10.76 14.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -54.3 -30.39 50.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.015 1.326 . . . . 0.0 113.714 165.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.98 -24.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.4 -113.41 0.62 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 120.532 1.515 . . . . 0.0 112.907 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 p -136.7 144.47 43.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 113.212 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -81.23 132.11 35.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 158.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.67 132.01 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.117 1.367 . . . . 0.0 108.967 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.1 m -137.94 115.9 11.61 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.831 1.252 . . . . 0.0 109.264 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.94 129.77 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.429 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -119.28 138.37 53.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.827 1.251 . . . . 0.0 110.821 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.71 116.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.18 1.392 . . . . 0.0 108.412 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.04 -73.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.873 2.469 . . . . 0.0 113.747 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 7.04 1.79 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 113.524 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -117.46 129.88 56.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 111.352 -172.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.9 137.8 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.259 -0.9 . . . . 0.0 111.062 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.88 -27.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -150.41 145.8 26.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.534 0.606 . . . . 0.0 110.689 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -154.55 146.8 23.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 111.933 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.9 t -154.64 162.56 41.08 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.952 1.301 . . . . 0.0 111.846 -177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.19 130.77 40.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.834 0.854 . . . . 0.0 111.137 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' A' ' 18' ' ' ILE . 12.6 mt -102.71 143.06 32.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.955 1.302 . . . . 0.0 111.716 170.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -123.22 132.14 24.3 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.874 1.27 . . . . 0.0 110.834 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.88 -29.54 2.7 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 113.535 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.91 -25.66 34.77 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 0.0 112.534 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.11 161.17 15.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.161 1.384 . . . . 0.0 112.134 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.86 10.72 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.62 -16.81 61.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -45.96 -48.92 16.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.548 1.067 . . . . 0.0 113.572 -170.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.57 -42.63 98.31 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.641 -0.662 . . . . 0.0 111.794 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -44.71 85.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.7 1.2 . . . . 0.0 110.6 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -62.52 -39.35 93.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.415 1.486 . . . . 0.0 112.13 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.84 -53.29 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.444 1.02 . . . . 0.0 110.503 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.19 -38.65 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.846 0.748 . . . . 0.0 111.249 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.32 69.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.545 0.738 . . . . 0.0 112.195 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.49 68.81 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.733 -1.23 . . . . 0.0 112.275 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.68 -48.54 78.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.848 0.749 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -68.73 -46.08 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.421 1.088 . . . . 0.0 109.932 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -68.5 -24.78 64.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.851 -1.156 . . . . 0.0 112.948 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 m -64.87 -47.4 78.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.658 0.783 . . . . 0.0 111.306 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.77 -30.48 64.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.678 1.126 . . . . 0.0 112.152 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.05 -22.02 66.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.813 -1.179 . . . . 0.0 113.95 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.65 76.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.03 0.532 . . . . 0.0 112.123 166.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.16 -21.92 33.41 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.131 1.372 . . . . 0.0 112.462 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -60.67 -31.5 70.73 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 113.233 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.43 -12.13 28.43 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 171.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.24 -51.19 7.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.162 0.985 . . . . 0.0 111.801 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.7 -35.6 0.26 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.5 mt -69.19 -18.05 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 119.32 0.963 . . . . 0.0 111.291 -169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.4 p30 -48.64 -36.91 16.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.332 1.053 . . . . 0.0 113.388 169.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.55 -31.61 70.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.04 0.936 . . . . 0.0 112.873 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.14 -49.25 6.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.763 1.225 . . . . 0.0 112.844 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.6 pp -68.31 -19.81 64.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.57 -21.67 66.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.187 1.395 . . . . 0.0 113.183 170.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.4 m 55.23 72.95 0.44 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.909 1.684 . . . . 0.0 112.783 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -60.48 -29.84 69.32 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.63 36.85 1.62 Allowed Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.678 1.609 . . . . 0.0 114.542 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.68 -172.25 0.08 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.283 2.233 . . . . 0.0 114.298 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 tp -63.75 128.21 34.81 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.61 -1.306 . . . . 0.0 110.927 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -166.67 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.58 -61.55 0.4 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.4 95.32 1.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.635 0.774 . . . . 0.0 110.951 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.42 -44.58 64.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -171.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.255 1.368 0 C-N-CA 125.853 1.661 . . . . 0.0 112.238 -173.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.08 143.56 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.775 1.63 . . . . 0.0 110.267 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 55.27 56.44 6.43 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.443 1.497 . . . . 0.0 113.13 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.3 148.41 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.082 1.353 . . . . 0.0 109.842 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.86 49.66 0.24 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.426 1.891 . . . . 0.0 113.642 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 t -67.54 -53.17 23.84 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.241 1.816 . . . . 0.0 112.878 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.8 168.86 17.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.485 2.123 . . . . 0.0 112.764 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.79 143.98 4.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.204 1.383 . . . . 0.0 113.409 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.7 pp -143.79 34.71 1.26 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.85 122.24 13.12 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.4 m -125.41 140.96 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.34 1.056 . . . . 0.0 110.576 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -72.61 60.42 0.48 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.407 1.883 . . . . 0.0 111.873 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -77.87 43.14 0.41 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.833 1.253 . . . . 0.0 110.441 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.2 p -132.91 134.53 44.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.666 1.586 . . . . 0.0 111.863 -172.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.62 34.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.602 1.161 . . . . 0.0 113.952 -170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -125.68 150.53 47.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.43 1.492 . . . . 0.0 111.839 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -58.28 -33.48 69.47 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.423 -0.798 . . . . 0.0 113.14 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.58 -41.92 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.621 1.168 . . . . 0.0 112.273 170.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.02 -28.92 73.26 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.473 -1.392 . . . . 0.0 114.193 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.74 -37.19 81.84 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.128 0.964 . . . . 0.0 111.537 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -73.36 -35.58 65.99 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.492 -0.755 . . . . 0.0 111.173 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.71 -43.34 76.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.299 0.954 . . . . 0.0 111.217 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -53.02 -54.25 38.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.496 0.589 . . . . 0.0 111.826 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -67.71 -44.61 77.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.836 0.854 . . . . 0.0 111.743 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.3 90.3 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.408 0.683 . . . . 0.0 112.135 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -61.92 -52.44 64.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.411 -0.806 . . . . 0.0 110.375 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -64.32 -33.47 75.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.567 1.147 . . . . 0.0 113.35 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -110.71 0.85 17.57 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 177.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -63.54 129.81 41.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.179 0.992 . . . . 0.0 113.14 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -159.72 136.12 9.0 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.4 1.88 . . . . 0.0 108.665 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -151.03 165.28 34.26 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.34 -26.24 30.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -84.97 -168.45 2.22 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 112.625 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.09 -6.01 42.82 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.975 1.71 . . . . 0.0 113.903 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.26 24.25 70.45 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.293 -1.505 . . . . 0.0 115.747 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -83.85 66.07 8.92 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.162 -1.199 . . . . 0.0 112.384 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.55 152.04 39.65 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.119 1.368 . . . . 0.0 114.384 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -136.35 161.13 36.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.786 1.234 . . . . 0.0 111.673 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.86 126.49 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.519 1.527 . . . . 0.0 108.708 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -122.49 144.0 49.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.987 1.315 . . . . 0.0 108.187 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.1 pp20? -131.6 152.22 50.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.549 1.068 . . . . 0.0 113.374 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -116.02 117.14 39.67 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.04 0.936 . . . . 0.0 109.765 169.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.11 123.65 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.034 2.489 . . . . 0.0 109.766 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.9 m -139.91 94.04 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.309 1.044 . . . . 0.0 110.2 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.7 10.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -52.6 -32.98 44.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.866 1.266 . . . . 0.0 113.461 165.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.71 -23.48 0.09 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.55 -114.2 0.62 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-N 120.668 1.576 . . . . 0.0 113.251 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -136.11 145.11 45.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.015 0.926 . . . . 0.0 113.193 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -81.53 133.04 35.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 158.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.49 132.08 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 109.083 170.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -137.75 115.61 11.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.775 1.23 . . . . 0.0 109.2 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 129.91 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.949 0.9 . . . . 0.0 109.382 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.52 139.23 52.44 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.726 1.21 . . . . 0.0 110.904 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.05 116.33 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 108.294 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 55.0 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.797 2.439 . . . . 0.0 113.896 -167.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.9 7.47 1.64 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.613 1.965 . . . . 0.0 113.551 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -118.74 130.95 56.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.968 1.307 . . . . 0.0 111.421 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.5 138.3 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.272 -0.893 . . . . 0.0 111.221 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.81 -27.0 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.65 146.17 26.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.528 0.604 . . . . 0.0 110.788 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -154.65 146.75 23.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.892 0.877 . . . . 0.0 111.975 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -155.0 163.91 39.65 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.01 1.324 . . . . 0.0 111.838 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.05 131.79 42.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.904 0.882 . . . . 0.0 111.207 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 18' ' ' ILE . 13.5 mt -103.66 145.38 30.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.343 1.457 . . . . 0.0 112.577 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.99 130.27 24.04 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 111.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.05 -30.4 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.784 2.989 . . . . 0.0 114.29 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.09 -13.97 48.65 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.239 1.016 . . . . 0.0 112.921 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -99.19 148.26 24.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.478 1.511 . . . . 0.0 111.79 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -91.3 15.88 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -94.54 -5.38 46.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.68 -46.9 41.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.814 1.246 . . . . 0.0 113.17 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -62.88 -41.14 99.3 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.584 0.707 . . . . 0.0 111.507 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -70.91 -41.17 71.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.931 0.893 . . . . 0.0 110.647 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.6 m -59.72 -40.65 88.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.46 1.104 . . . . 0.0 112.019 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.14 -53.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.115 0.87 . . . . 0.0 110.553 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.52 -38.59 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.72 0.691 . . . . 0.0 111.309 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -32.11 69.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.651 0.78 . . . . 0.0 112.187 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.15 68.45 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.77 -1.206 . . . . 0.0 112.287 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.7 -48.68 78.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.9 0.773 . . . . 0.0 110.099 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.44 -47.08 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.375 1.07 . . . . 0.0 109.935 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -67.74 -25.3 65.57 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.127 -0.983 . . . . 0.0 112.95 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.5 m -64.8 -48.1 75.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.678 0.791 . . . . 0.0 111.056 170.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.25 -30.75 62.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.087 -1.008 . . . . 0.0 112.233 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.13 -27.86 68.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.616 -1.302 . . . . 0.0 113.419 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.38 92.1 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 169.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 -20.6 33.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.673 1.189 . . . . 0.0 112.242 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.97 -25.82 67.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.803 2.041 . . . . 0.0 113.812 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -101.63 -9.49 20.88 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.275 1.43 . . . . 0.0 114.098 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -89.79 -57.15 2.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.915 1.286 . . . . 0.0 112.869 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.24 -17.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.85 -0.531 . . . . 0.0 110.285 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.89 -41.24 64.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 113.065 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -70.98 -35.58 72.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.27 0.628 . . . . 0.0 112.243 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.66 -38.72 70.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.815 0.846 . . . . 0.0 112.454 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.5 -25.33 36.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 66.1 tp -61.48 -33.34 73.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.367 1.067 . . . . 0.0 112.621 172.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 52.33 52.56 13.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.773 1.229 . . . . 0.0 113.352 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 m -57.72 -28.63 64.04 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.131 1.373 . . . . 0.0 114.437 -168.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.68 -0.01 83.13 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 115.35 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -126.88 -158.52 0.87 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.108 2.563 . . . . 0.0 110.268 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.71 131.17 43.03 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.912 -1.117 . . . . 0.0 110.667 162.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -158.31 99.33 1.62 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.818 1.247 . . . . 0.0 110.37 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -143.08 -53.1 0.38 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -141.99 36.13 1.57 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.168 0.987 . . . . 0.0 112.428 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.73 -27.48 61.21 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.825 2.05 . . . . 0.0 112.887 177.256 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.34 140.33 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.717 1.607 . . . . 0.0 109.823 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.23 157.86 23.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.153 1.381 . . . . 0.0 112.332 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.24 24.08 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.813 1.245 . . . . 0.0 112.564 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 56.79 38.48 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.906 1.682 . . . . 0.0 112.705 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.92 -52.37 41.45 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.295 -173.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -79.73 168.57 19.26 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.442 2.095 . . . . 0.0 112.705 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 144.74 4.25 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.113 1.34 . . . . 0.0 113.393 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 3.9 pp -143.28 35.36 1.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.7 109.55 1.25 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.05 0.54 . . . . 0.0 110.025 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -111.34 140.03 46.25 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.706 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 59.72 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.556 1.942 . . . . 0.0 111.947 169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -77.99 43.55 0.44 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.627 1.171 . . . . 0.0 110.368 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.9 p -132.25 132.19 42.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.728 1.611 . . . . 0.0 111.843 -172.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.87 36.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.1 p -136.44 157.73 46.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.432 1.093 . . . . 0.0 111.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 p -56.39 -41.77 76.81 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.011 -1.055 . . . . 0.0 113.33 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -84.33 -42.8 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 112.435 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.04 -29.6 73.56 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.262 1.392 . . . . 0.0 113.114 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -65.51 -39.5 91.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.281 1.033 . . . . 0.0 111.303 170.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.07 -35.53 64.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.473 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.16 -43.07 77.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 111.146 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -52.18 -54.55 29.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.463 0.574 . . . . 0.0 111.845 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -67.82 -45.23 75.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.922 0.889 . . . . 0.0 111.738 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.93 -41.83 90.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 0.0 112.059 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.14 -52.25 64.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.85 0.75 . . . . 0.0 110.339 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.3 p -65.77 -28.2 68.84 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -63.85 -33.07 74.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.597 1.159 . . . . 0.0 113.381 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -111.43 1.91 17.24 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -64.35 131.84 48.43 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 113.452 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -159.94 137.74 9.93 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.412 1.885 . . . . 0.0 108.835 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 t -150.69 165.46 33.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -87.47 -24.11 24.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -84.3 -168.84 2.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.048 1.339 . . . . 0.0 112.239 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.04 -5.49 35.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.849 1.66 . . . . 0.0 113.971 -173.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.42 23.56 71.91 Favored Glycine 0 N--CA 1.474 1.169 0 O-C-N 120.079 -1.638 . . . . 0.0 115.791 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -83.79 66.02 8.86 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.118 -1.225 . . . . 0.0 112.59 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -120.91 151.39 39.75 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.999 1.319 . . . . 0.0 114.232 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -135.83 160.37 38.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.84 1.256 . . . . 0.0 111.773 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.7 mt -117.92 125.73 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.355 1.462 . . . . 0.0 108.781 -171.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -120.45 144.3 48.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.045 1.338 . . . . 0.0 108.378 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 1.7 pp20? -129.88 150.17 51.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.343 0.974 . . . . 0.0 113.445 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -112.18 116.71 48.78 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.113 1.365 . . . . 0.0 108.903 168.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.69 121.87 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.309 2.673 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -136.1 93.9 2.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.313 1.045 . . . . 0.0 110.29 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.71 -8.84 7.4 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.23 -32.54 37.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.826 1.25 . . . . 0.0 113.172 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.05 -33.9 0.06 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.75 -118.81 0.69 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.244 1.384 . . . . 0.0 114.135 -169.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 p -137.83 141.29 40.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -90.1 114.11 25.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.368 0.667 . . . . 0.0 109.527 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.0 mm -93.79 132.85 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.994 1.318 . . . . 0.0 109.574 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 m -137.66 115.62 11.56 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.324 1.05 . . . . 0.0 109.073 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 129.1 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.758 0.823 . . . . 0.0 109.291 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -119.48 138.06 53.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.643 1.177 . . . . 0.0 110.794 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.6 t -99.65 116.56 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 108.2 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 55.0 -72.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.916 2.486 . . . . 0.0 113.775 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.8 7.13 1.64 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.52 1.928 . . . . 0.0 113.584 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.68 130.07 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 111.415 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.56 137.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.229 -0.92 . . . . 0.0 111.148 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.3 pt -128.85 -27.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -150.8 147.91 27.86 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.628 0.649 . . . . 0.0 110.745 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -156.24 147.03 21.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.982 0.913 . . . . 0.0 111.926 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.6 t -153.93 157.58 39.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.066 1.346 . . . . 0.0 112.333 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -101.7 118.9 37.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 110.949 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 18' ' ' ILE . 15.0 mt -91.41 147.67 22.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.376 1.47 . . . . 0.0 112.444 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.98 131.29 24.37 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 111.069 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.21 -31.07 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.118 3.212 . . . . 0.0 113.637 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -80.7 -25.82 37.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.535 1.134 . . . . 0.0 112.473 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -87.19 150.6 23.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.486 1.514 . . . . 0.0 111.49 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -97.42 17.05 18.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.299 1.439 . . . . 0.0 114.756 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -89.45 -4.23 58.06 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -47.11 -45.58 22.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.775 1.23 . . . . 0.0 113.176 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -63.06 -39.99 96.37 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.633 0.73 . . . . 0.0 111.584 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -69.54 -42.96 73.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.564 1.146 . . . . 0.0 110.54 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -59.07 -41.83 88.91 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.574 1.15 . . . . 0.0 112.172 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.76 -53.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 110.555 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -38.49 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.85 0.75 . . . . 0.0 111.109 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.24 69.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.308 0.643 . . . . 0.0 112.216 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.98 -27.69 69.01 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.827 -1.171 . . . . 0.0 112.243 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.7 mt -62.4 -49.16 76.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.829 0.74 . . . . 0.0 110.24 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.1 -46.59 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.939 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -67.09 -25.4 66.2 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.966 -1.084 . . . . 0.0 113.032 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -65.97 -46.36 78.38 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.691 0.796 . . . . 0.0 111.453 171.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.76 -31.19 63.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.675 1.125 . . . . 0.0 111.987 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.79 -28.87 70.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.77 1.168 . . . . 0.0 113.747 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.13 95.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.841 0.456 . . . . 0.0 111.763 168.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 mt -82.5 -23.34 34.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.152 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -60.79 -31.37 70.74 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.464 1.906 . . . . 0.0 112.856 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.5 -11.75 26.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.764 1.225 . . . . 0.0 113.907 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -84.62 -51.14 7.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.39 1.076 . . . . 0.0 111.745 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -145.8 -37.28 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.663 2.098 . . . . 0.0 116.663 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 9.2 mt -68.69 -18.46 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.49 1.041 . . . . 0.0 111.306 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 p30 -50.53 -38.03 42.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.059 -1.026 . . . . 0.0 113.16 169.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.2 -32.28 72.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.16 0.984 . . . . 0.0 112.742 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.35 -48.51 7.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.351 1.06 . . . . 0.0 112.16 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 94' ' ' ASN . 4.0 pp -67.56 -30.74 70.45 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -174.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.89 -39.65 94.69 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 111.144 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.9 m -80.29 -17.91 50.77 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -169.79 106.84 0.36 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.36 65.27 1.16 Allowed Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.755 1.169 . . . . 0.0 113.579 171.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.71 153.63 10.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.724 0.809 . . . . 0.0 112.561 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.42 135.2 48.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.85 21.37 0.79 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 164.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.17 -49.62 7.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.086 0.954 . . . . 0.0 112.83 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -153.2 91.93 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 110.168 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.98 -42.22 57.99 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.773 1.629 . . . . 0.0 112.131 -175.416 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.2 142.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.26 1.424 . . . . 0.0 111.021 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.94 133.47 33.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.763 1.225 . . . . 0.0 111.986 176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.76 149.61 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.262 1.425 . . . . 0.0 109.329 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.9 54.01 0.8 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.6 1.56 . . . . 0.0 112.558 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.7 -55.84 2.44 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.646 1.578 . . . . 0.0 112.787 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.45 172.1 12.89 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.471 2.114 . . . . 0.0 112.78 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.97 135.85 3.23 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.264 1.411 . . . . 0.0 112.682 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.259 1.2 pt? -135.17 33.97 3.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.266 1.026 . . . . 0.0 113.46 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.25 111.1 1.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.038 0.535 . . . . 0.0 109.785 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.1 m -111.85 139.44 47.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.816 0.817 . . . . 0.0 110.821 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -72.31 59.98 0.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.56 1.944 . . . . 0.0 111.898 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -78.15 46.04 0.58 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.539 1.136 . . . . 0.0 110.275 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 74.3 p -134.7 132.84 39.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.36 1.464 . . . . 0.0 112.113 -171.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.1 32.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.814 1.246 . . . . 0.0 114.27 -168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -123.61 149.76 44.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.544 1.538 . . . . 0.0 112.194 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -59.32 -28.94 67.27 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.14 0.976 . . . . 0.0 113.479 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.3 pt -96.44 -43.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.004 1.322 . . . . 0.0 112.132 167.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.48 -27.26 73.54 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 120.555 -1.341 . . . . 0.0 114.601 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -67.08 -40.36 86.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.501 1.15 . . . . 0.0 111.276 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.35 -31.62 64.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.244 -0.91 . . . . 0.0 112.084 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -55.02 -43.31 73.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.821 1.191 . . . . 0.0 111.218 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -54.02 -52.97 59.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.536 0.607 . . . . 0.0 111.553 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -66.64 -45.05 80.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.18 0.992 . . . . 0.0 111.677 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.0 81.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.796 0.838 . . . . 0.0 112.129 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.15 -51.89 67.16 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.911 0.778 . . . . 0.0 110.325 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 82.6 p -65.47 -28.59 69.32 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.35 -32.39 73.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.4 1.08 . . . . 0.0 113.524 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.75 0.94 16.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -63.25 131.93 50.01 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.174 0.989 . . . . 0.0 113.311 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.2 144.67 14.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.175 1.79 . . . . 0.0 108.676 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -157.27 161.3 39.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.7 -25.74 30.39 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -83.12 -168.38 2.06 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.026 1.331 . . . . 0.0 112.196 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -5.84 34.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.778 1.631 . . . . 0.0 113.966 -175.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.39 72.37 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 120.424 -1.422 . . . . 0.0 115.678 170.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -87.35 75.61 9.23 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.558 -0.966 . . . . 0.0 112.408 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.48 159.5 31.82 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -140.15 162.38 35.39 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 170.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.98 128.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.517 1.527 . . . . 0.0 109.096 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -124.84 143.23 50.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.204 1.401 . . . . 0.0 108.29 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.0 pp20? -131.79 154.6 48.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.875 1.216 . . . . 0.0 113.572 170.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.28 116.81 30.79 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.945 0.898 . . . . 0.0 110.441 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.81 134.92 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 110.776 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.8 t -152.1 119.22 5.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.544 0.738 . . . . 0.0 112.202 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.93 42.97 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -54.49 -31.67 56.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.133 1.373 . . . . 0.0 113.691 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.15 -27.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.67 -113.35 0.66 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.44 1.473 . . . . 0.0 113.316 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 p -136.12 141.9 44.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.261 1.025 . . . . 0.0 113.046 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -77.81 133.44 38.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 158.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.16 132.18 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.922 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -137.23 115.27 11.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.923 1.289 . . . . 0.0 109.172 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 129.84 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.038 0.935 . . . . 0.0 109.465 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 p -119.37 137.86 53.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.708 1.203 . . . . 0.0 110.644 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.0 115.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.104 1.362 . . . . 0.0 108.336 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.76 -74.02 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.04 2.536 . . . . 0.0 114.131 -166.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -139.99 7.53 2.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.356 1.862 . . . . 0.0 113.684 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -118.07 129.41 55.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.906 1.282 . . . . 0.0 111.47 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.71 137.65 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.273 -0.892 . . . . 0.0 111.03 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.04 -26.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -150.89 146.13 26.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.568 0.622 . . . . 0.0 110.837 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -154.77 147.01 23.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 112.085 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -155.1 165.18 37.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.961 1.305 . . . . 0.0 111.739 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.63 127.94 45.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.878 0.871 . . . . 0.0 111.294 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.9 mt -97.78 143.74 28.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.063 1.345 . . . . 0.0 112.065 172.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.48 133.69 24.06 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.026 1.33 . . . . 0.0 111.111 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.64 -29.93 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.813 3.009 . . . . 0.0 113.547 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 tt -78.94 -34.55 44.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 0.0 112.065 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.33 158.98 18.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.995 1.318 . . . . 0.0 112.058 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -100.16 21.65 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.116 1.366 . . . . 0.0 114.236 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.79 -17.91 60.55 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -46.16 -47.81 17.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.468 1.107 . . . . 0.0 113.409 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.57 -42.41 98.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.589 -0.695 . . . . 0.0 111.98 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -66.26 -45.34 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.592 1.157 . . . . 0.0 110.522 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.7 m -62.13 -39.0 91.07 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.32 1.448 . . . . 0.0 112.166 175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.85 -54.41 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.415 1.007 . . . . 0.0 110.513 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.07 -38.69 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.826 0.739 . . . . 0.0 111.128 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.49 -32.24 69.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.766 . . . . 0.0 112.062 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 -27.43 68.47 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.73 -1.231 . . . . 0.0 112.268 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -62.76 -48.28 79.88 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.954 0.797 . . . . 0.0 109.962 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.51 -47.43 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.563 1.145 . . . . 0.0 110.017 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -67.54 -25.63 65.91 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.113 -0.992 . . . . 0.0 112.92 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.6 m -64.55 -47.8 77.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.51 0.724 . . . . 0.0 111.008 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -74.84 -30.36 61.34 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.442 1.019 . . . . 0.0 112.314 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.95 -28.59 69.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.442 -1.411 . . . . 0.0 113.269 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.85 94.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.59 -22.53 32.26 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 112.193 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -60.95 -28.55 69.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.904 1.682 . . . . 0.0 113.182 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -100.34 -6.34 25.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.665 1.186 . . . . 0.0 113.94 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -88.72 -54.24 4.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.265 1.426 . . . . 0.0 112.173 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -140.65 -39.65 0.42 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -166.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.11 -19.09 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -34.41 70.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.978 1.311 . . . . 0.0 113.158 175.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.44 -44.95 41.63 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.071 0.548 . . . . 0.0 111.089 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.55 -36.43 83.76 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.15 -25.17 61.6 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -87.93 -40.01 14.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.365 1.466 . . . . 0.0 112.931 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.4 p -74.54 -7.17 52.22 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.0 t -60.55 -19.98 58.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.346 1.458 . . . . 0.0 114.496 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.57 47.71 1.48 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.86 1.695 . . . . 0.0 114.791 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -66.5 164.56 16.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.215 1.406 . . . . 0.0 113.631 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -64.22 162.73 14.04 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.112 0.965 . . . . 0.0 113.032 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.13 26.8 1.64 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.499 1.119 . . . . 0.0 112.856 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.5 -43.69 54.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.924 0.89 . . . . 0.0 113.095 -163.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -137.65 23.8 2.89 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.761 1.624 . . . . 0.0 111.761 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -80.36 -30.59 37.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -168.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.302 1.841 . . . . 0.0 112.079 -176.337 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 145.45 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.865 1.666 . . . . 0.0 110.224 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 56.11 53.07 9.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.278 1.431 . . . . 0.0 113.03 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.69 152.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.011 1.325 . . . . 0.0 110.209 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.61 53.79 0.57 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.891 1.677 . . . . 0.0 112.585 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.68 -54.45 3.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.783 1.633 . . . . 0.0 112.725 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.51 170.07 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.37 142.45 3.97 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.334 1.445 . . . . 0.0 113.345 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.256 3.8 pp -143.62 35.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.47 111.53 1.83 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.721 -0.612 . . . . 0.0 110.094 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -112.84 140.13 47.89 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.799 0.84 . . . . 0.0 110.863 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.44 60.08 0.31 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.599 1.959 . . . . 0.0 111.993 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.0 43.57 0.44 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.781 1.233 . . . . 0.0 110.443 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 42' ' ' GLU . 73.1 p -133.11 134.68 44.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.574 1.549 . . . . 0.0 112.043 -172.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.0 34.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.632 1.173 . . . . 0.0 114.025 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -124.71 150.53 46.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.602 1.561 . . . . 0.0 111.799 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 m -58.24 -33.71 69.65 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 66' ' ' LEU . 1.4 pt -92.35 -42.3 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.717 1.207 . . . . 0.0 112.109 170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -28.56 73.41 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.374 -1.454 . . . . 0.0 114.337 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -67.91 -37.78 82.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.255 1.027 . . . . 0.0 111.432 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -72.82 -34.99 67.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.594 -0.692 . . . . 0.0 111.121 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.254 0.934 . . . . 0.0 111.458 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.13 -53.75 45.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.559 0.618 . . . . 0.0 111.705 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -67.54 -44.98 77.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.833 0.853 . . . . 0.0 111.79 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.29 88.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.387 0.675 . . . . 0.0 112.177 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.88 -52.07 65.59 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.496 -0.753 . . . . 0.0 110.318 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.4 p -65.77 -28.18 68.83 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -64.07 -33.11 75.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.652 1.181 . . . . 0.0 113.35 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -111.36 0.68 16.71 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 177.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -63.68 130.37 43.96 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.192 0.997 . . . . 0.0 113.285 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -160.25 136.87 8.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.408 1.883 . . . . 0.0 108.797 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -151.22 165.32 34.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.81 -27.38 28.83 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -82.78 -169.49 2.51 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.114 1.366 . . . . 0.0 112.411 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -7.24 48.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.762 1.625 . . . . 0.0 114.09 -172.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.74 24.46 71.28 Favored Glycine 0 N--CA 1.476 1.302 0 O-C-N 120.271 -1.518 . . . . 0.0 115.868 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.56 65.29 8.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.175 -1.191 . . . . 0.0 112.336 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.02 151.46 38.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.972 1.309 . . . . 0.0 114.401 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 t -137.03 161.59 35.65 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.816 1.246 . . . . 0.0 111.815 172.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.6 mt -118.32 125.47 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.398 1.479 . . . . 0.0 108.797 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -122.24 142.96 49.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.033 1.333 . . . . 0.0 108.278 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 14' ' ' THR . 2.2 pp20? -131.58 152.83 50.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.539 1.063 . . . . 0.0 113.585 171.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -117.62 116.03 37.0 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 124.199 0.999 . . . . 0.0 109.98 170.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.86 121.67 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.302 2.668 . . . . 0.0 109.953 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -140.76 100.45 3.85 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.307 1.043 . . . . 0.0 110.471 -169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -9.87 17.72 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -170.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -53.03 -31.42 41.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 113.631 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.54 -25.19 0.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.52 -112.82 0.61 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 120.586 1.539 . . . . 0.0 112.968 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 p -135.06 142.79 46.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.031 0.932 . . . . 0.0 113.159 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -78.99 133.66 36.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 158.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.99 131.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.118 1.367 . . . . 0.0 108.893 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.0 m -135.93 113.17 10.56 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.752 1.221 . . . . 0.0 108.556 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 128.89 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.814 0.846 . . . . 0.0 109.226 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -116.4 139.15 50.74 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.626 1.171 . . . . 0.0 111.256 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.49 115.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.515 1.126 . . . . 0.0 108.059 168.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 55.21 -72.22 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.946 2.499 . . . . 0.0 114.049 -168.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.43 7.28 1.73 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.525 1.93 . . . . 0.0 113.763 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.13 129.06 53.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.813 1.245 . . . . 0.0 111.485 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.23 133.88 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.5 -26.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -149.5 146.31 27.33 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.159 0.583 . . . . 0.0 110.574 174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.58 146.46 24.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.671 0.788 . . . . 0.0 111.817 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -154.34 163.4 40.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.905 1.282 . . . . 0.0 111.806 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.61 129.88 43.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.907 0.883 . . . . 0.0 111.195 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 18' ' ' ILE . 14.8 mt -101.08 143.53 31.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.173 1.389 . . . . 0.0 112.24 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -123.35 128.1 25.37 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.83 1.252 . . . . 0.0 111.415 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.53 -27.45 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.938 3.092 . . . . 0.0 113.777 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.96 -11.83 56.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.367 1.067 . . . . 0.0 112.974 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -107.29 152.17 24.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.901 1.681 . . . . 0.0 111.662 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -99.21 21.0 12.51 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.22 1.408 . . . . 0.0 114.251 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -87.98 -6.89 57.76 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -47.71 -47.37 30.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.201 1.401 . . . . 0.0 113.168 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.08 -41.05 99.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.604 0.716 . . . . 0.0 111.564 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -69.69 -42.46 74.06 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.18 0.992 . . . . 0.0 110.498 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -60.0 -40.48 89.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.801 1.24 . . . . 0.0 112.292 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.33 -53.79 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.216 0.916 . . . . 0.0 110.47 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.47 -38.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.842 0.747 . . . . 0.0 111.148 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.79 -31.97 68.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 112.189 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.24 68.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.721 -1.237 . . . . 0.0 112.248 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.83 -48.74 77.77 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.878 0.763 . . . . 0.0 110.091 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.5 mt -68.4 -46.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.389 1.075 . . . . 0.0 110.087 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.48 -25.61 65.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.113 -0.992 . . . . 0.0 112.914 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.7 m -64.8 -48.41 74.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 111.145 170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.23 -29.78 61.86 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.305 0.957 . . . . 0.0 112.274 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -60.66 -29.38 69.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.53 -1.356 . . . . 0.0 113.191 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.09 94.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.02 0.528 . . . . 0.0 112.118 170.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.7 mt -87.42 -21.19 25.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.073 1.349 . . . . 0.0 112.567 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -60.77 -27.05 67.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.262 1.825 . . . . 0.0 113.401 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -105.19 0.21 27.1 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.835 1.254 . . . . 0.0 114.034 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -92.89 -54.32 3.8 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.38 1.472 . . . . 0.0 112.182 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -140.84 -37.98 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.36 -19.56 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.627 -0.67 . . . . 0.0 110.714 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -40.37 81.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.715 1.206 . . . . 0.0 112.636 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -71.99 -42.14 66.81 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.869 0.467 . . . . 0.0 111.129 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.75 98.19 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.44 -31.9 64.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.75 -39.97 91.6 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.463 0.705 . . . . 0.0 110.634 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.4 m -65.08 -16.29 63.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 m -76.29 -27.17 56.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.218 1.007 . . . . 0.0 112.205 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.84 12.82 82.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.253 0.93 . . . . 0.0 114.916 -176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -139.19 166.07 25.51 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.239 1.816 . . . . 0.0 111.672 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -66.85 157.43 33.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -152.68 28.14 0.55 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.277 1.031 . . . . 0.0 113.467 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -135.45 -50.68 0.74 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -168.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -80.04 39.43 0.44 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.331 1.453 . . . . 0.0 112.763 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.35 -25.39 46.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.52 1.528 . . . . 0.0 114.012 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.569 1.947 . . . . 0.0 112.138 -176.489 . . . . . . . . 0 0 . 1 stop_ save_